High-throughput transgenic mouse phenotyping using microscopic-MRI by Cleary, JOS
! -1- 
High-throughput Transgenic 











A volume rendering of a segmented  
atlas image of nineteen 15.5dpc mouse embryos  
 
Jon Orlando Sollas Hawke Cleary 
Centre for Advanced Biomedical Imaging 
 
Division of Medicine  
& Department of Medical Physics and Bioengineering 
University College London 
July 2011 
MPhil/PhD 
Supervisors: Dr. Mark Lythgoe 
   Prof. Roger Ordidge 
   Dr. Anthony Price 
 
This thesis is submitted as partial fulfilment of requirements for 






“Always remember that this whole thing started with a 




I, Jon O. S. H. Cleary, confirm that the work presented in this thesis is my own work 
except where acknowledged in the text. This work is based on research that was 
undertaken by me at University College London during the period 26th September 












With the completion of the human genome sequence in 2003, efforts have 
shifted towards elucidating gene function. Such phenotypic investigations are aided 
by advances in techniques for genetic modification of mice, with whom we share 
~99% of genes. Mice are key models for both examination of basic gene function and 
translational study of human conditions. Furthering these efforts, ambitious 
programmes are underway to produce knockout mice for the ~25,000 mouse genes. In 
the coming years, methods to rapidly phenotype mouse morphology will be in great 
demand.  
This thesis demonstrates the development of non-invasive microscopic 
magnetic resonance imaging (!MRI) methods for high-resolution ex-vivo 
phenotyping of mouse embryo and mouse brain morphology. It then goes on to show 
the application of computational atlasing techniques to these datasets, enabling 
automated analysis of phenotype.  
First, the issue of image quality in high-throughput embryo MRI was 
addressed. After investigating preparation and imaging parameters, substantial gains 
in signal- and contrast-to-noise were achieved. This protocol was applied to a study of 
Chd7+/- mice (a model of CHARGE syndrome), identifying cardiac defects. 
Combining this protocol with automated segmentation-propagation techniques, 
phenotypic differences were shown between three groups of mice in a volumetric 
analysis involving a number of organ systems.  
Focussing on the mouse brain, the optimal preparation and imaging 
parameters to maximise image quality and structural contrast were investigated, 
producing a high-resolution in-skull imaging protocol. Enhanced delineation of 
hippocampal and cerebellar structures was observed, correlating well to detailed 
histological comparisons. Subsequently this protocol was applied to a phenotypic 
investigation of the Tc1 model of Down syndrome. Using both visual inspection and 
automated, tensor based morphometry, novel phenotypic findings were identified in 
brain and inner ear structures.   
It is hoped that a combination of !MRI with computational analysis 
techniques, as presented in this work, may help ease the burden of current 
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Organisation of Chapters 
This thesis is comprised of three introductory chapters, four experimental chapters 
and a final discussion and summary. 
 
Chapter 1 is an overview of the creation of genetically modified mice and 
introduction to the imaging techniques other than magnetic resonance imaging that 
may be used to phenotype them. Specific examples are used to illustrate models 
where non-invasive imaging may be useful in cardiac and neuroanatomical 
applications. 
 
Chapter 2 provides an outline to the basic principles of MRI, the background of MRI 
contrast agents and an overview and examples of the use of microscopic MRI (!MRI) 
in mouse phenotyping applications. 
 
Chapter 3 outlines some of the basic concepts in image analysis techniques, as 
applied to current animal and human phenotyping studies, going on to describe some 
current applications of automated, morphometric to research, particularly in the field 
of neuroscience.   
 
Chapter 4 is the first experimental chapter, describing the preparation and 
measurement of tissue parameters relevant to cardiac phenotyping in the mouse 
embryo and the utilisation of these parameters to provide improved signal and 
contrast-to-noise in the visualisation of subtle cardiac defects.  
 
Chapter 5 is the second experimental chapter. This applies the embryo !MRI 
protocol (developed in chapter 4) to imaging of the embryo CNS, demonstrating 
delineation of subtle structural definition in anatomical imaging of the phenotyping of 
mutant. This work is then extended through the application of non-linear image 
registration to create an embryo atlas comprised of multiple subjects. Using this atlas 
protocol segmentation-propagation is then used to compare phenotype in a number of 
body structures in three groups of mice with different genetic backgrounds.   
 
Chapter 6 is the third experimental chapter. In this chapter, further to the 
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investigation of the mouse embryo, a contrast-enhanced !MRI protocol is developed 
to produce high-resolution images of the adult mouse brain. Detailed optimisations 
allow improved visualisation of substructures of the brain, such as in the thalamus and 
hippocampus.  
 
Chapter 7 is the fourth experimental chapter. Using the contrast enhanced micro-
MRI protocol developed in Chapter 6, visual inspection and image registration 
techniques are applied in a morphometric analysis of the transchromosomic Tc1 
model of Down syndrome, where novel brain phenotypes are identified. 
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Introduction 
The first three chapters introduce the main topics discussed in this thesis: (1) the need 
and methods for the creation of genetically modified mice and a discussion of current 
methods of morphological phenotyping methods; (2) a background to magnetic 
resonance imaging (MRI), specifically microscopic MRI (!MRI) and the theory 
behind its application to phenotyping; (3) a discussion of the issues involved in data 
analysis and an introduction to automated image analysis methods. I aim to provide an 
overview of the literature, highlight important themes discussed in research chapters 
and set the context within which the research in subsequent chapters is formulated. 
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Chapter 1: 
Genetically Modified Mice: Models and 
Morphometric Phenotyping 
 
1.1 Overview: the Mouse as a Model for Studying the Genetic Basis of 
Human Disease  
The humble mouse is a highly relevant model to the study of the basis of human 
disease, as we share mammalian development, biochemistry and physiology. The key 
unifying element between the two species, which comprises all these aspects, is the 
commonality of the mammalian genome. The announcement of the completion of the 
first draft of the mouse genome in 2002 (Mouse Genome Sequencing Consortium et 
al., 2002) and the increased sophistication of genomic analysis over the past two 
decades, have strengthened the evidence of similarity. For example, 99% of mouse 
genes have a human homologue (Rosenthal and Brown, 2007). In addition, the 
products of these genes such as proteins and biochemical pathways, also demonstrate 
strong similarities. This common physiology, coupled with a rapid gestation (~20 
days (Otis and Brent, 1954)) and short time to breeding age, has led to the emergence 
of established techniques to manipulate its genome and cemented the mouse as a key 
model with which to study genetic influences on disease and physiology. While 
modified mouse models may not exactly replicate human conditions, they can lead to 
new insights into the mechanisms of disease. So far several thousand mouse mutants 
have been produced (Capecchi, 2001), with a number of these models created to allow 
the direct investigation of a host of human conditions in a variety of systems, as 
diverse as Down syndrome (O'Doherty et al., 2005), Huntington’s disease (Phillips et 
al., 2005), diabetes (Pechhold et al., 2007) and cancer (Jahid and Lipkin, 2010).  
 
This chapter will provide an outline of the history and creation of mutant mice, as 
well as a discussion of non-invasive methods to aid their phenotyping. Finally, as a 
background to later experimental chapters, subsequent sections will focus in greater 
detail on specific genetic mutations involved with congenital heart disease and 
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examine the role of genetics on neurodegenerative disease, looking in particular at 
mouse models of Down syndrome. 
 
1.2 Historical Perspectives on Mouse Genetic Research 
Although the earliest mention of the use of mice for general scientific research is in 
1664, as part of Boyle and Hooke’s investigations on the need for air by living 
organisms (Beck et al., 2000), the use of mice as a model organism for genetic 
investigations of heredity beginning in the early part of the 20th Century was 
pioneered by William Castle working at the Bussey Institution at Harvard (Rader, 
2001).  
 
The majority of the common mouse lines in use today can trace their origins to the 
Victorian commercial breeders needing to satisfy the demand for ‘fancy mice’ as 
household pets. In particular, the efforts of one breeder, Abbie Lathrop, contributed 
several specific lineages for scientific research, derivatives of which are used in the 
present day. The work of Castle formed the basis for modern mouse studies dependent 
on highly inbred mouse strains – created by performing a large number of brother-
sister matings or other close relatives. With each successive generation of such 
matings, the gene-pool reduces considerably, resulting in mice with background 
homozygous for most gene loci1, which may then be defined and characterised. This 
led to the creation in the 1910s of inbred strains, such as C57BL, C3H, CBA and 
BALB/c mice, all of which continue to be in common use today. In 1929, a student of 
Castle, Clarence Cook Little, continued the formal study, maintenance and storage of 
mouse lines, founding the Roscoe B. Jackson Memorial Laboratory, now a specialist 
institution well known today for its mouse research. 
 
1.3 Generation of Genetically Modified Mice 
Until the investigation of germ-cell mutagens in the mid-20th Century, new mouse 
mutants were often discovered after chance observations of unusual phenotypes often 
caused by spontaneous mutations. An early example is a line of mice commonly used 
                                                
1 A locus is the specific location of a gene or DNA sequence in a chromosome 
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by early researchers known as Japanese ‘waltzing’ mice for their repetitive circling 
behaviour that persisted with each new generation (Gates, 1925). These mice were 
later suspected of possessing a homozygous gene mutation that caused inner ear 
defects, affecting functioning of the vestibular system (Nagy, 2003). A similar 
example is the ob/ob (obese) mouse line (Ingalls et al., 1950), which first appeared in 
a mouse litter at the Jackson Laboratories in 1950. These mice are now an accepted 
model of type II diabetes, becoming obese due to disinhibition of feeding behaviour. 
Although in use as a model for a number of years, the exact cause of the phenotype 
was only elucidated in 1994 and was found to be due to a defect in the gene for the 
hormone leptin (Zhang et al., 1994), which plays a key role in appetite regulation and 
satiety.        
 
Today, there are broadly two approaches for disrupting gene function in the mouse. 
The first is a gene-focussed approach to examine or target specific genes, usually 
where an a priori hypothesis prompts the manipulation of specific gene(s). Given the 
size of the mouse genome –~25,000 genes, of which the function of the majority has 
not been ascertained – this approach may not be suitable for the rapid creation of 
novel mutants. Therefore a second approach is to disrupt genes over the entire 
genome at random, in the hope that new genes may be identified on the basis that a 
random mutation might produce a novel phenotype in an existing mouse. These and 
associated genes may then become suitable candidates for more targeted 
investigations.    
 
Employing these complementary strategies enables researchers to produce a range of 
new mutations and manipulate the entire mouse genome with relative ease. 
 
1.3.1 Approaches for Investigating and Targeting Specific Genes 
 
1.3.1.1 Transgenesis 
The first technique involves transgenesis, where material foreign to the natural 
genome of the mouse, i.e. exogenously-produced DNA sequences (such as copies of 
human genes), is added during development. Two methods are used to achieve this 
result. The earliest technique is pronuclear microinjection, where the foreign DNA is 
simply injected directly into an embryo before the first cleavage (Gordon et al., 1980). 
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An alternative approach is to perform microinjections into mouse embryonic stem 
(ES) cells (Yutzey and Robbins, 2007). Successfully modified ES cells can then be 
genotyped and selected before implantation into a blastocyst, allowing more control 
over the quality of the procedure.    
 
Although conceptually simple and relatively fast to perform, allowing creation of 
models in as little as a few weeks (Yutzey and Robbins, 2007), transgenic methods 
have the disadvantage that there is often no control over the precise number of 
additional copies of a gene which will be added to the genome, and the number of 
gene integrations arising from transgenesis causes variability in the final dosage of 
gene-products to the organism. Conventional transgenic models may have multiple 
copies of the exogenous sequence resulting in dosages typically unseen 
physiologically, even in disease states. Therefore, while these models may give useful 
insights into the mechanisms governing a disease, some caution must be observed in 
generalising experimental findings to the actual disease state.  
 
It should be also noted that the wide adoption of mice as genetic models is partly due 
to the continued viability of mouse embryos despite invasive manipulation. In the rat 
for example, while also commonly used as a research model, techniques such as 
pronuclear microinjection have been less successful and therefore relatively few 
transgenic rat lines exist. 
 
1.3.1.2 Gene-targeting 
Also commonly used are gene-targeted mice (often referred to as ‘knockout’ or 
‘knock-in’ mouse models) (Capecchi, 2001). This powerful approach was pioneered 
in the early work of Capecci, Evans and Smithees, and recognised by the Nobel Prize 
in 2007. In this method a DNA construct is produced that is homologous to the gene 
of interest, consisting of a null gene (in the case of knockout mice) and, usually, a 
reporter. By removing an early-stage embryonic stem cell (ES cell) and using a 
technique to open the plasma membrane, such as electroporation (Neumann et al., 
1982), the construct can then be introduced into the ES cell. 
 
As the cell undergoes division, a recombination event substitutes the construct for the 
gene of interest in the desired chromosome. Once confirmed, this ES cell is removed 
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and injected into a developing blastocyst from a mouse with a contrasting coat colour, 
and placed in a surrogate mother to develop (Figure 1.1). The resulting offspring will 
be chimeric, that is having varying contributions of cells from differing stem cells. 
The vast majority of gene targeting is carried out in ES cells from variants of the 129 
mouse strain which has an agouti coat colour. These cells may then be introduced into 
the blastocyst of a mouse with a black coat colour, typically the C57BL/6, which go 
on to divide and produce a chimeric mouse. If offspring show the agouti coat colour 
in addition to black, the modified ES cell has been successfully integrated and 
indicates the presence of the modified allele.  
 
[Figure removed due to copyright] 
 
Figure 1.1: Schematic diagram showing an outline of the creation of gene-targeted 
mice. a) Cultured mouse embryonic stem cells from a mouse with agouti coat colour 
are electroporated and the targeted gene-construct is introduced. The gene-construct 
confers resistance to cytotoxic agents e.g. G418 (a glycoside antibiotic, similar to 
neomycin) or FIAU (Fialuridine, a nucleoside analogue). b) The targeted ES cells are 
re-introduced into an early-stage blastocyst and implanted into a surrogate mother. 
Successful creation of chimeric offspring is easily identified by coat colour. Adapted 
from (Capecchi, 2001). 
 
Although gene-targeting represents a powerful tool for the creation of new mutants, 
this is an intrinsically low yield technique due to the infrequent nature of an 
homologous recombination event (only 1 in 1000 injections of the vector into ES cells 
will be successful (Capecchi, 2001)).  
 
Additionally, the 129 background is not suitable for many types of study, particularly 
behavioural work (which will be discussed further in a later section). It is therefore 
desirable to backcross2 the chimera with a more suitable strain, such as C57BL/6. 
Initial generations of offspring with have a mixture of 129 and C57BL/6 alleles.  In 
order to produce mice with a defined background, a large number of backcrosses are 
                                                
2 Backcross: Where an F1 hybrid is crossed with one of its parents, or with an 
individual genetically identical to one of its parents 
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needed to further reduce the remaining fraction of 129 alleles. This process can be 
lengthy, taking up to 2 years or more, it is common to see studies in the literature 
performed on mice with a less-defined, mixed genetic background, with some residual 
129 genes (this is illustrated in Figure 1.2). After 12 backcrosses to a C57BL/6 
mouse, approximately 1% of the genome would be 129 in origin, mostly centred 
around the mutant allele (Gerlai, 1996). 
 
[Figure removed due to copyright] 
 
Figure 1.2: After insertion of the gene-targeted construct, indicated by the white line, 
the new allele is moved on to an inbred background of choice, in this case C57BL/6. 
In the F2 generation, the genetic background of resulting mice will still have a strong 
129 genotype. Selecting mice with the construct and with successive backcrosses to 
C57BL/6, the proportion of 129 alleles will reduce considerably. Adapted from 
(Gerlai, 1996). 
 
Although often used for producing KO models, any homologous gene construct may 
be substituted. Therefore using a working allele, recombination events are able to 
replace or introduce additional genes in the mouse genome, creating a ‘knock-in’ 
model.  
 
Although such gene-targeted mice have contributed to nearly 10% of models so far, 
mutations in particular genes (~15% of the genome) can result in embryonic lethality 
in resulting offspring, making adult study impossible. As a result, it is now 
increasingly common to use a selective or inducible system that performs gene-
targeting in only specific tissues or at a desired timepoint.  
 
The main system of this type in current use is the Cre-loxP system, which was first 
described by Sauer in the late 1980s (Sauer and Henderson, 1988).  The bacteriophage 
P1 was found to carry an enzyme (Causes recombination or Cre) that was able to 
trigger a recombination event in a gene flanked by loxP (‘locus of X-over P1’, a 35 
base-pair sequence) sites (termed a ‘floxed’ gene). This system is easily adapted for 
use in the mouse (Sauer, 1998). 
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First, the mouse genome in an ES cell may be modified by conventional gene 
targeting to replace a normal gene with a floxed equivalent. This mouse is then mated 
with another mouse that contains the Cre gene. The resulting offspring now contain 
both the Cre and the floxed gene.  
 
The use of Cre offers a sophisticated mechanism for controlling gene recombination. 
For example it can be made to initiate only in specific tissues during development by 
association with a specific promoter, for example an association with Nkx-2.5 (a gene 
with an integral role in heart development expressed in developing myocytes (Lints et 
al., 1993) would cause Cre expression and thus Cre-medicated gene recombination in 
heart tissue only. The timing of Cre activation can also be made arbitrary to any point 
during development, including adulthood, using an inducible Cre system. In such a 
system the Cre promoter is activated by a specific external stimulus such as an 
activated receptor. One commonly used is the oestrogen receptor (Cre-ER) (Feil et al., 
1997). Administration of the oestrogen analogue tamoxifen to the animal, causes 
activation of the receptor and the downstream Cre, resulting in the gene of interest 
being excised through recombination. 
 
1.3.1.3 RNA Interference 
In addition to these approaches, more recently, so-called ‘knock-down’ models have 
been developed. These use a phenomenon known as RNA interference, where 
administration of either double-strand or short interfering RNA (dsRNA and siRNA) 
sequences can silence the effect of transcribed RNA from an homologous gene 
(Caplen et al., 2001; Elbashir et al., 2001). These models are otherwise genetically 
normal, but the administration of RNA is able to silence particular gene products thus 
producing effects similar to an inducible Cre knockout for a short period.  
 
1.3.2 Non-specific Gene Mutation 
Although it is desirable to specifically target genes in order to investigate function, in 
recent years an attempt to speed up the isolation and discovery of relevant and novel 
genes has lead to a more functional, phenotype-driven approach to genomic study. In 
this approach mutants are created using protocols that produce random changes in the 




One of the first approaches developed for the creation of mouse mutants was the use 
of ionising radiation. In this method, male mice are exposed to high X-ray dosages 
(typically a single fraction of ~600R) (Ehling, 1966) and as such their resulting sperm 
may contain gene mutations which are passed to subsequent generations.   
 
1.3.2.2 ENU Mutagenesis 
In the 1970s, the non-specific mutagen N-ethyl-N-nitrosourea (ENU) was found to 
introduce random point mutations in the DNA of murine sperm with a 5 times greater 
frequency than radiation (Russell et al., 1979). When male mouse germ cells are 
exposed to the agent, a relatively high number of point mutations are created 
(typically ~1 per locus per 1000 gametes (Brown, 1998)). These point mutations may 
cause gene disruption in subsequent generations. The affected locus may then be 
identified. 
[Figure removed due to copyright] 
 
Figure 1.3: Simplified outline of the use of ENU for the creation of new dominant 
mutations. After injection of ENU into male mice, point mutations occur in sperm. 
After mating with wild-type mice, mutant alleles may be present in resulting progeny. 
Adapted from (Acevedo-Arozena et al., 2008) 
 
1.3.2.3 Gene trapping 
Gene trapping involves the random insertion of a DNA (gene trap) cassette 
throughout the genome in an ES-cell line. Such gene trap vectors consist of a gene 
trapping cassette comprised of a promoterless reporter gene and/or selectable genetic 
marker. In addition there is a downstream termination sequence (polyadenylation 
sequence). When the cassette integrates in the middle of a gene sequence, typically in 
an intron region, upon gene transcription the polyadenylation site causes abrupt 
termination of transcription, resulting in an abnormal mRNA transcript and resulting 
protein. The presence of these two gene products, may then be used to assess the 
efficacy of a gene trapping experiment.   
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[Figure removed due to copyright] 
 
Figure 1.4: Outline of gene trap mutation. The gene trap construct is transfected into 
an ES cell and integrates randomly into the genome. The vector may integrate 
between gene exons resulting in an abrupt termination during mRNA translation due 
to the polyA sequence. Adapted from (Castrop, 2010). 
 
1.4 The Effect of Genetic Background on Phenotype 
As previously discussed, most mice used in genetic studies will be in-bred, and 
therefore homozygous at most loci, with alleles specific to one mouse line. As a 
consequence, background may have a strong effect on observed phenotype in mutant 
mice, representing a possible confounder to the characterisation of gene function. For 
example, a review of mice in neurobehavioural studies found that the 129sv 
background was generally considered a poor choice for Morris water maze testing 
(Crawley et al., 1997) although this may be improved by environmental enrichment 
(Kempermann et al., 1998). Mice from the 129 background in general, appear to 
present with a higher frequency of structural brain changes such as agenesis of the 
corpus callosum (Livy and Wahlsten, 1991). As some techniques such as gene-
targeting require the use of specific strains, these ‘innate’ phenotypes must be borne 
in mind when beginning studies and deciding on the eventual background. 
 
1.5 High-throughput Mutagenesis Programmes 
Large-scale programmes, utilising targeted mutations (such as the International 
Knockout Mouse Project) and random mutagenesis techniques, such as ENU, are 
underway to systematically create transgenic knockout models for each of the 
approximately 25,000 mouse genes (International Mouse Knockout Consortium et al., 
2007). The results of these efforts should greatly increase the understanding of the 
significance of genes on the phenotype of systems across the whole animal, as these 
mice are comprehensively analysed in the coming years. 
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1.6 Mouse Phenotyping Screens 
Phenotype is often difficult to assess, as a mutation in a single gene may have effects 
in multiple organ systems, a situation known as pleiotropy. Effective general 
phenotyping depends on the use of a battery of screening tests to identify the changes. 
Two main paradigms exist for such approaches. Genotype-driven screens seek to 
determine the function of a specifically targeted gene, using information from 
previous genetic studies to thoroughly determine the probable effect and system(s) 
affected. More widely used are so-called phenotype driven screens in which mice are 
tested with more general, basic examinations and no underlying assumptions are made 
as to the gene’s probable effect.  
 
1.6.1 Current Techniques in High-throughput Phenotype-driven Screens 
The worldwide consortia producing novel mouse mutants generate large numbers of 
new mutants annually (1000s). The dissemination of the phenotype of these mice is 
thus a high priority. To this end, they have actively developed strategies for screening 
pathways to enable the rapid identification of candidate mutants.  
 
For example the current ENU mutagenesis programmes depend upon phenotype 
driven screens due to the random nature of mutant produced (Brown, 1998). A 
standardised sequence of biochemical, physiological and morphological screens are 
now in place, ranging from blood testing to behavioural studies and bone density 
scans. The aim of this so-called primary screening is to determine which areas of 
physiology and organ systems deviate from baseline measurements established in 
wild-type animals. After this assessment is made, the mutant of interest can then be 
sent to a specialist secondary centre for a secondary phenotypic analysis (Brown et 
al., 2005; de Angelis et al., 2006). 
 
An example of a primary screen, are the two phenotyping pipelines used and 
developed by members of the European Mouse Disease Clinic (EUMODIC) 
programme known as EMPReSSslim. This utilises a small number of mutants 
typically ~10, which are then placed through a series of behavioural, biochemical, 
imaging studies. Incorporated into these may also be system challenges in the form of 
short hearing, nociception tests and immune system challenges. Results from these 
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tests are captured, analysed and placed into an on-line portal (Morgan et al., 2010) for 
wide dissemination.   
 
 
Figure 1.5: Schematic outline of the two-pipeline primary organ systems screen 
(EMPReSSslim) devised by the EUMODIC phenotyping programme. 
 
As seen in Figure 1.5, while there is a comprehensive assortment of testing 
procedures for primary screening for common phenotypic features, the end point for 
morphological assessment remains histology, which presents a bottleneck in the 
throughput in the identification of novel phenotypes. The current high-throughput 
mutagenesis programmes acknowledge that there is key a role for fast, non-invasive 
imaging methods to be integrated as either primary or secondary screens. 
1.7 Methods of Morphological Mouse Phenotyping 
Over the subsequent introductory and study chapters MRI methods for ex-vivo 
phenotyping in the mouse will be discussed. The following sections outline the main 
histological and alternative imaging methods for phenotyping in the mouse embryo 
and the adult mouse brain. 
 
1.7.1 Morphological Phenotyping in the Developing Mouse Embryo 
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Morphological analysis of anatomy is an important part of both phenotype and 
genotype driven screens. Conventionally this is done ex-vivo by microscopic 
examination with histology. In this method embryos are ethanol-dehydrated, 
embedded in paraffin wax and thinly sectioned into 2-8!m slices (Kaufman, 1992). 
This provides high-resolution 2D data and sections that may also be stained for gene 
and protein expression. 
 
[Figure removed due to copyright] 
 
Figure 1.6: Example of a haematoxylin and eosin-stained histology image from an 
E13.5 mouse embryo heart. A: illustration of anatomy, arrow indicates the conal 
septum separating the two ventricular outflow tracts (MB=major bronchus, 
Dao=descending aorta, PT=pulmonary trunk, PA=pulmonary artery, LSV=left 
superior vena cava, RSV=right superior vena cava, E=oespohagus. B: Higher power 
image from the conal septum clearly showing the areas of apoptosis (arrows 
indicating apoptotic debris, small dots) and mitosis (black triangle indicating a 
dividing cell). Adapted from (Savolainen et al., 2009). 
 
A recent refinement of this process is episcopic imaging, where the autofluorescence 
of each histology section can be photographed and combined computationally to 
generate high resolution 3D volume datasets (typically 1-2!m isotropic resolution) 
(Weninger and Mohun, 2002). However these histological approaches are time-
consuming and do not lend themselves readily to rapid screening as only one embryo 
may be imaged at a time. 
 
[Figure removed due to copyright] 
 
Figure 1.7: Axial slice through a 3D episcopic fluorescence image capture (EFIC) 
dataset, showing the heart, great vessels and lungs of a 16 days-post-coitum embryo. 
RA = right atrium, LA=left atrium, LV=left ventricle, RV=right ventricle, CV=left 
superior vena cava. In-plane resolution 2.32!m x 2.32 !m. Adapted from (Weninger 
and Mohun, 2002). 
 
A further complication is that a phenotype may be largely unknown (21) or 
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incompletely penetrant, meaning that a particular genotype does not necessarily lead 
to a phenotypic effect. Therefore relatively large numbers (10s to 100s) of embryos 
are sometimes needed to gain a good measure of the prevalence of the phenotype in a 
population (22).  
 
Compounding this, due to the numbers of lines being generated, the IKMC and ENU 
mutagenesis programmes also may experience a histological bottleneck due to large 
numbers of embryos. In the case of ENU programmes, although 7-10 mutants are 
typically phenotyped in a primary screen, their aim is to process up to several hundred 
mouse lines annually. Thus a high-throughput phenotyping technique is essential to 
meet the demands of modern molecular medicine. 
 
1.7.2 The Role of Non-invasive Imaging in Mouse Embryo Phenotyping  
Due to the low volume of embryos that may be phenotyped with conventional 
histology together with its destructive effects on tissue morphology, there is interest in 
utilising non-invasive imaging methods for morphological screening. These methods, 
such as magnetic resonance imaging (MRI), have the potential to offer large time 
saving advantages and are increasingly becoming used as an adjunct to histology in 
the examination of embryo phenotype. 
 
While most non-invasive methods are able to provide both in-vivo and ex-vivo 
imaging assessments of phenotype, the most successful approach for anatomical 
phenotyping is ex-vivo. This allows high-resolution scans to be performed, as sample 
movement is greatly reduced and the lack of animal anaesthetic and monitoring 
requirements enables long scan times.  
 
!MRI is one such imaging method, allowing assessments of both embryo 
development (Petiet et al., 2008) and phenotype (Bamforth et al., 2004; Goddeeris et 
al., 2008). High-throughput screening can be achieved with multiple mid-gestation 
embryos (typically up to 32 simultaneously) in a single 12-hour scan at ~25!m 
resolution (Schneider et al., 2003c; Schneider et al., 2004). Full 3D datasets for all 
embryos are created, allowing structures to be visualised relative to one another. In 
this method, embryos are fixed in a gadolinium-chelate contrast agent in order to 
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improve signal to noise and image quality. !MRI techniques will be the focus and 
expanded upon in later chapters. 
 
Other whole embryo imaging modalities are available and have been successfully 
used to phenotype transgenic mice. The two main alternatives are photon projection 
techniques, which depend on differences in the photon attenuation properties of tissue 
for contrast. This contrasts with MRI where signal is intrinsically generated within the 
tissue itself. 
 
Microscopic computed tomography (!CT) (Johnson et al., 2006) uses x-rays to image 
tissue and also allows high-throughput imaging. High resolution 3D scans are 
possible, with a single embryo at an 8!m isotropic resolution being acquired in a 12-
hour scan time or 27!m in 2-hours. !CT is ideally suited to imaging dense structures 
such as bone (Oest et al., 2008) but the technique suffers conventionally from the 
limited range of linear attenuation coefficients in soft tissue, leading to similar signal 
intensities for most organ structures, and impairing detailed visualisation (Takeda et 
al., 2000). However, recent innovations in the use of dense radiopaque tissue stains 
such as osmium tetroxide and iodine have gone some way to improve the visibility of 
soft tissue and internal contrast (Degenhardt et al., 2010; Johnson et al., 2006) (Figure 
1.8).  
  
[Figure removed due to copyright] 
 
Figure 1.8: Example slices through a !CT dataset, showing sagittal (A), coronal (B) 
and axial (C) views through a wild-type 12.5dpc embryo after staining with osmium 
tetroxide. The resolution is 27!m isotropic. (a, cardiac atrium; cc, central canal of 
the neural tube; fl, forelimb; sc, semicircular canal; v, cardiac ventricle). Adapted 
from (Johnson et al., 2006). 
 
Optical projection tomography (OPT) (Sharpe et al., 2002) is also a 3D projection-
reconstruction modality but uses photons in the visible spectrum. As an optical 
technique this can provide detailed images of tissue structures through 
autofluorescence but also gene and protein expression using conventional 
fluorophores. High resolutions are achieved (typically down to 5!m (Walls et al., 
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2008)). However the technique requires translucent skin tissue, in order for light to 
penetrate and thus its use in older embryos (>13.5dpc) that are more opaque is more 
limited (Schneider and Bhattacharya, 2004). Examples of both raw projection and 
reconstructed data are shown in Figure 1.9. 
 
[Figure removed due to copyright] 
 
Figure 1.9: Example slices through an OPT dataset of a 10.5dpc mouse embryo. 
Showing: (A) a typical image from raw autofluorescence data as acquired. (B) 
Coronal section through the embryo after 3D reconstruction processing. (C) Raw 
OPT projection data with fluorescence data from double-antibody staining for 
HNF3$ (green) and neurofilament (blue). (D) Coronal slice through dataset as in (C) 
after 3D reconstruction. Adapted from (Sharpe et al., 2002).  
 
An additional technique for both structural and functional imaging in the developing 
mouse is ultrasound biomicroscopy (UBM). UBM uses high-frequency ultrasound, 
operating a greater frequency than conventional clinical ultrasound systems (typically 
30-60MHz (Henkelman, 2010))  achieving resolutions in the 10s of microns (Phoon 
and Turnbull, 2003). Furthermore, UBM is able to produce high-resolution images of 
developing mice in-utero. Imaging is relatively straightforward with the application of 
an acoustic probehead close to the body, and images are immediately viewable. 
Ultrasound images may be difficult to plan and interpret, as it is unlike the previous 
modalities which produce a true 3D reconstruction across a defined tissue volume, the 
picture is created by an acoustic array, typically producing a fan beam whose 
resolution reduces considerably with increasing depth. Contrast is dependent on the 
properties of tissues to reflect acoustic waves, which can appear similar throughout 
most tissues but tissue boundaries provide the most apparent contrast. A key 
application of UBM is in the imaging of vascular structures in the heart and brain as 
these structures are more easily delineated and amenable to Doppler imaging, where 
the frequency shift of moving blood can be measured and quantitative, directional 
flow-rates easily calculated. Examples of vascular imaging in the developing embryo 




Figure 1.10: a) shows the typical arrangement of ultrasound transducers in-utero 
imaging. b) UBM image of an 11.5dpc embryo (P=placenta, U=uterus, Al=alantois, 
V=vitelline arteries, B=brain). c) An example of Doppler flow imaging: after 
identification of the aorta (DAo) on an anatomical scan (H=head, S=spine), a 
Doppler transducer may be oriented perpendicularly to obtain haemodynamic 
information from the vessel. Adapted from (Phoon and Turnbull, 2003). 
 
1.7.3 Morphological Phenotyping in the Adult Mouse Brain 
As may be expected, even small genomic manipulations in the mouse are able to have 
considerable and complex effects on the brain, in terms of physical structure, 
organisation of connectivity, physiology and behaviour. These may manifest 
themselves early, indicating a failure in normal neurogenesis or presenting later in 
adult life indicating a neurodegenerative effect. It is perhaps surprising to note that 
~90% of neurological conditions with a brain phenotype will result in an observed 
structural change. Therefore the morphological phenotyping is a key investigation for 
mouse phenotyping.   
 
! -51- 
As with the embryo, in the adult mouse brain, high-resolution phenotyping is typically 
carried out by histological sectioning either through paraffin embedding as discussed 
previously or cryosectioning to create thin sections. The choice of technique is usually 
determined by the stains needed, with cryosectioning being more suitable for fresh 
tissue and may enable a greater preservation of intact proteins for 
immunohistochemistry. However, due to the distinct number of brain structures, 
which differentiate into glial and neuronal cell-types with defined receptor profiles, 
expression profiles of interest, specialised stains and immunohistochemistry are best 
able to delineate these subtle regional and functional domains However, extraction 
and preparation effects (such as shrinkage) that occur in tissue, in addition to large 
numbers of sections produced, make volumetric measurements challenging as well as 
accurate visual assessments of morphology, particularly of small or easily damaged 
structures such as the pituitary or olfactory bulbs. 
 
Histological approaches have the advantage of highlighting cell and region-specific 
changes with great sensitivity and with a resolution capable of identifying individual 
cells and axonal connections. One example where this has been used to great effect is 
in the production of so-called ‘brainbow’ images of the mouse brain where individual 
cells and axons may be identified and traced using fluorescence microscopy (Livet et 
al., 2007). This is shown in Figure 1.11.  
 
[Figure removed due to copyright] 
 
Figure 1.11: Fluorescence microscopy using an inducible Cre-Lox system in the 
Brainbow transgenic mouse. Upon activation of Cre in these granule cells of the 
cerebellum, differing combinations of fluorescent marker proteins are expressed 
depending on cell-type (a). The connectivity of cells and corresponding axons may 
then be traced by these specific colours (b). Adapted from (Livet et al., 2007). 
 
However as in the embryo, any full characterisation is extremely time-consuming if 
sectioning and staining are performed manually. Histological characterisation studies 
in a population have been attempted in the both the mouse and human brain, although 
this has required the development of highly automated sectioning methods and semi-
automated histological classification techniques which still require many months for 
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comprehensive categorisation of histological structures in the thousands of sections of 
a single brain (Amunts et al., 2000). In addition, if accurate 3D reconstruction of 
histology is required, a high-resolution reference MRI scan is also required and 
sections are aligned (registered) to this dataset in an attempt to correct for geometric 
distortions (Lebenberg et al., 2010; Purger et al., 2009). 
 
1.7.4 The role of Non-invasive Imaging Techniques in Mouse CNS Phenotyping  
In the case of conditions resulting in gene-related atrophy, non-invasive, longitudinal 
imaging studies offer a powerful method for accurately measuring volume-change and 
determining the precise location of atrophy. 
 
In addition to MRI, which is discussed fully in subsequent chapters, microscopic 
computed tomography (!CT) can also produce non-invasive images of the brain. 
However, as in the embryo, without CT contrast enhancement its use is best suited to 
bony structures, such as the skull, a highly dense structure that results in low radiation 
transmission, and therefore high signal on CT images. An example of the use of !CT 
for adult mouse craniofacial phenotyping is shown in Figure 1.12.  
 
[Figure removed due to copyright] 
 
Figure 1.12: Comparison of !CT skull data from population averaged datasets of 5 
wild-type (A) and (B) 5 novel connexin43 ENU mutants (Gja1Jrt). The overall size of 
the skull in the mutant rendering can be seen to be reduced, with notable differences 
in lower jaw morphology. Adapted from (Nieman et al., 2006) 
 
More recently, structural brain imaging using !CT has been optimised to produce 
high-resolution images of ex-vivo brain tissue (9!m isotropic resolution), which has 
been successfully used to identify pathological changes in cancer models (Prajapati et 
al., 2010). However the x-ray dosages required for such resolution are extremely high 
and incompatible with in-vivo imaging (Boone et al., 2004). 
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Figure 1.13: Sagittal, axial and coronal views through a MicroCT dataset without 
contrast enhancement (9!m isotropic) of an ex-vivo wild-type mouse brain at 
postnatal day 43. Adapted from (Prajapati et al., 2010) 
 
Applications to Cardiac and Neuroscience Research 
The following two sections will focus on specific areas and models where non-
invasive imaging approaches may be especially useful, namely in the characterisation 
of phenotype. 
 
1.8 Specific Application of Mouse Models to Cardiac Research 
The use of mouse models in cardiac research in particular is now routine, due in part 
to the high degree of correspondence with human anatomy. The mouse heart is four-
chambered and the basic developmental and regulatory genetic networks are well-
conserved between mice and humans, making mice ideal for investigating the role of 
genes on cardiovascular dysfunction through transgenic and knockout models (Yutzey 
and Robbins, 2007). 
 
The use of the mouse embryo is essential for examining the effects of genes on 
development and congenital disease. They may be of particular use in determining the 
cause and features for a knockout resulting in embryonic lethality or postnatal 
mortality. Given their small size (typically 1-2cm at mid-gestation) and the difficulties 
of in-vivo experiments, examination of phenotype is usually achieved by examining 
ex-vivo morphology and gene expression profiles.  
 
The study of the effect of genes on mouse embryo development is particularly 
applicable to the investigation of congenital heart defects (CHDs). These are a group 
of conditions which affect over 1% of live births and are responsible for 
complications immediately from birth through to later adult life (Hoffman and 
Kaplan, 2002). Inheritable gene mutations and chromosomal effects are the direct 
cause of nearly 20% of CHDs. While the basis of remaining so-called sporadic 
conditions is uncertain, epidemiological studies demonstrate an increased risk of 
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CHDs in siblings and offspring of those affected. This illustrates there is potential 
genetic involvement even in these cases (Bentham and Bhattacharya, 2008). 
 
1.8.1 Genetic Aspects of Heart Development 
The heart is formed early on in development, initially consisting of a single heart tube 
that undergoes several stages of folding, initially to form two chambers, which will 
become the atria and ventricles. These structures will also septate further to form the 
left and right chambers. Complex, timed genetic networks are responsible for 
initiation and completion of heart processes. With striking similarity to CHDs seen in 
humans, failure in the correct functioning of these networks during development 
commonly involves one or more of the following: the simple gross enlargement of the 
heart and surrounding vessels; effects on atrial and ventricular septa (thinning and/or 
absence); enlargement or stenosis of great vessels (such as in tetraology of Fallot); 
and defects in endocardial cushion development affecting valve development. As may 
be expected from the large number of genes implicated in CHDs gene dysfunction 
results in a spectrum of severity and highly dependent on the gene and corresponding 
pathways involved. A summary of genes with known involvement in CHD and an 
indication of their severity is shown in Table 1.1. 
 
[Figure removed due to copyright] 
 
Table 1.1: Table showing genes identified from the online Mouse Genome 
Informatics database that may be implicated in CHD. Each gene is ranked by 
pleiotropy score, indicating the number of heart structures affected, with a score of 1 
indicating one structure, a score of 5 indicating five structures. Adapted from 
(Bentham and Bhattacharya, 2008) 
 
1.8.1.1 Hypotheses of gene involvement on CHDs     
A number of different genetic events may lead to a similar cardiac phenotype and 
hypotheses have been generated to explain the mechanisms behind both the 
spontaneous mutations and Mendelian-inherited alleles. While specific to CHDs, 




1.8.1.1.1 Allelic Heterogeneity 
As CHD has a ~60% infant morality when untreated, reproductive fitness will tend to 
remove highly penetrant alleles from the population. Therefore cases are often the 
result of new spontaneous mutation, usually specific to that individual, causing a 
CHD phenotype. 
 
1.8.1.1.2 Gene Copy-number Variation  
A change in normal the number of genes is strongly linked to the development of 
CHDs. For example, the phenotypes seen in DiGeorge syndrome are the result of a 
deletion (at 22q11.2), whereas those of Down syndrome (trisomy 21) and trisomy 18, 
which also result in CHDs, are caused by an increase in gene dosage. 
 
1.8.1.1.3 Buffering Capacity and Mutational Load of Genetic Networks. 
As heart development is governed by the interplay of complex genetic networks, a 
single gene mutation is unlikely to affect the process and other networks may be able 
to buffer the system. However, in patients with a high mutational load, the capacity of 
networks to compensate may break down, resulting in CHD.  
 
1.8.1.1.4 Gene-environment Factors 
The environmental conditions encountered by the foetus may have an impact on the 
correct function of a specific allele and thus CHD occurrence. For example, the 
maternal methylene tetrahydrofolate reductase alleles known as 677CT and 677TT are 
associated with a threefold and six-fold increase in the risk of CHD risk to their 
children. A clinical study of the effect of folate administration on CHD development 
(Czeizel et al., 2004) found a reduced odds-ratio (0.6) of CHDs in these individuals. 
This shows how genetic and environmental influences can interact in the pathogenesis 
of CHD. Importantly, environmental factors, such as maternal diabetes and obesity, 
also may disrupt buffering mechanisms and result in CHD.  
 
The ultimate goal from the study of these models is to gain an understanding of the 
effect and role of genes in CHDs as a basis of identifying possible targets for 
therapeutic compounds. This approach would aim to parallel the large reductions seen 
in neural tube defects after the identification of the necessity for folate during 
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pregnancy (MRC Vitamin Study Research Group, 1991). The following section 
introduces a specific gene whose absence results in CHDs in mouse models: CHD7.  
 
1.8.2  CHARGE Syndrome and CHD7 
Chromodomain helicase DNA-binding protein 7 (CHD7) is a gene located on human 
chromosome 8, mutations in which strongly correlate to instances of the human 
condition CHARGE syndrome. Children born with this condition show abnormalities 
in a number of organ systems, which were previously used to define the condition. 
Coloboma of the eye, Heart defects, Atresia of the chonae, Retardation of growth, Ear 
abnormalities and/or deafness. The condition affects an estimated 1 in 10,000 in 
newborns and defects in the CHD7 gene specifically (heterozygosity for nonsense, 
deletion, or missense mutations) are thought to be responsible for ~67% of these 
cases. The clinical features of CHARGE in humans and mice are highly variable and 
incompletely penetrant. From reports of CHD7 mutation positive CHARGE 
individuals, the most commonly affected organ in humans with CHD7 mutations is 
the ear. Ear defects in CHARGE include temporal bone abnormalities, external ear 
malformations, and hearing loss. Although olfactory function is less commonly 
analysed, a majority of CHARGE patients analyzed have some form of olfactory 
defect including olfactory bulb hypoplasia and/or aplasia and impaired olfaction 
ranging from mild hyposmia to anosmia. The variability in CHARGE features 
suggests that mutations in CHD7 lead to pleiotropic developmental defects; however, 
the mechanisms underlying these defects have not yet been determined.  
 
CHD proteins are a part of the large group of adenosine triphosphate (ATP)-
dependent chromatin remodelers. The mammalian genome encodes approximately 30 
such genes that appear to be vital for normal embryonic development. Many ATP-
dependent chromatin remodelling genes show haploinsufficiency, indicating that their 
products may be involved in rate-limiting steps during development. CHD7 is one of 
nine ATP-dependent chromatin remodelling enzymes, which are broadly classified 
into three subfamilies based upon their amino acid sequence and functional protein 
domains. CHD7 and the other eight CHD proteins are a class of ATP-dependent 
chromatin remodelers with unique protein motifs that are incompletely characterized. 
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To date, CHD7 is the only member of this class of proteins for which mutations have 
been associated with a well-described human syndrome (Layman et al., 2010). 
 
1.8.3 Cardiac Phenotypes in the Adult Mouse 
This thesis partly focuses on heart development in the embryonic mouse. In the in-
utero conditions the developing mouse is not reliant on functioning left-right heart 
separation for delivery of oxygenated blood. Therefore mutant mice with more severe 
morphological abnormalities may persist until birth.  
 
Gene knockouts compatible with postnatal life while non-lethal, may still have 
notable effects on the phenotype of adult mice. The adult mouse is more amenable 
than the embryo to in-vivo investigations, allowing a dynamic assessment of cardiac 
function, using techniques such as ultrasound, ECG and electrophysiology testing and 
in-vivo MRI.  
 
Although these mice will often show normal physiology in the resting state, they may 
demonstrate heart dysfunction after being subject to pharmacological or interventional 
challenges. For example, the agent dobutamine may be used to simulate the effect of 
exercise on the heart. Interventions such as aortic banding or simulation of myocardial 
infarction through ligation of coronary arteries may also expose phenotypic 
differences such as in functional parameters such as ejection fraction and volumetric 
measurements of the extent of infarction. 
 
1.9 Applications of Mouse Models to Neuroscience Research 
In recent years increasing evidence has accumulated for an underlying genetic 
component in a number of neurological conditions. Genomic and phenotyping studies 
have opened the way for understanding the underlying pathology of many 
neurological disorders. The outcome of current intense research into the genetics of 
neurological disorders will hopefully be the introduction of new diagnostic tools and 




The mouse shares the principal cell-types and functional brain domains common to 
human development. As with applications to heart research, genetically manipulated 
mouse models may be used to understand the fundamental pathways for brain 
development and maintenance through single-gene disruption or through transgenesis 
methods.   
 
Genetic factors make a significant contribution to neurological conditions. The 
process of neurogenesis pathways may also be disrupted through genetic 
manipulation, leading to new insights into these mechanisms of proliferation and 
growth. In addition to neurogenesis, genetic factors also play a strong role in the 
support and maintenance of developed cells and failure of these pathways may lead to 
premature cell-death and atrophy. These are a hallmark of a number of 
neurodegenerative conditions. 
 
Common mouse models of neurological disease now include Alzheimer’s, 
Huntington’s and Parkinson’s diseases; amyotrophic lateral sclerosis (ALS or motor 
neurone disease), epilepsy and certain cancers.  
 
The following sections outline two conditions which will be examined further in later 
chapters: i) septo-optic dysplasia – a developmental abnormality – and ii) Down 
syndrome.     
 
1.9.1 A Gene for Optic Nerve and Pituitary Development: HESX1 
HESX1 is a homeobox gene that has been implicated in certain forms of the human 
condition septo-optic dysplasia (SOD). Clinically, children with this condition are 
characterised by hypopituitarism. Additionally there may be malformation of eyes, 
optic nerves and optic chiasm leading to blindness in a number of cases. Embryonic 
mouse models by have been produced with gene-knockouts and commonly seen 
clinical alleles of the condition have been shown to demonstrate similar phenotypes to 
the human form (Dattani et al., 1999) by the age of 18.5dpc. 
 
SOD is a rare condition, which was first described by Reeves in a 7-month-old baby 
and is sometimes known as de Morsier syndrome. The phenotype is highly variable, 
and may include any two of the three classical features. Pituitary hypoplasia may 
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manifest as endocrine deficits, varying from isolated growth-hormone deficiency to 
panhypopituitarism. Either sexual precocity or the failure to develop in puberty may 
occur. Abnormal hypothalamic neuroanatomy or function may also be a feature. 
Several aetiologies have been proposed to account for the sporadic occurrence of 
SOD, such as viral infections, environmental teratogens and vascular or degenerative 
damage. Familial cases of SOD are rare, and may be associated with an autosomal 
recessive inheritance. In the light of the phenotype demonstrated in Hesx1 null mutant 
mice, Dattani et al. examined patients with SOD for mutations in HESX1. A 
homozygous missense mutation in the homeobox of HESX1 was found in two siblings 
with optic nerve hypoplasia, absence of the corpus callosum, and hypoplasia of the 
pituitary gland with panhypopituitarism born to a highly consanguineous family. 
Heterozygotes for this particular mutation were phenotypically normal.  
 
Additionally, in view of the occasional heterozygous phenotypic manifestation in the 
murine Hesx1 null mutants, Dattani et al. also went on to screen DNA samples from a 
number of patients with sporadic SOD and other pituitary disorders also identified 
heterozygous mutations of HESX1 similar to the mouse model with variable 
penetrance. 
 
1.9.2 Genetic Mouse Models for the Investigation of Down Syndrome 
A particular application of transgenic technology has been to the human condition 
Down syndrome (DS). As first identified by Jérôme Lejeune in 1959 (Lejeune et al., 
1959), this condition results in a non-disjunctive germline transmission of all or part 
of an additional chromosome 21 (Hsa21), resulting in a theoretical 50% increase in 
gene dosage. There is a typical incidence of 1 in 700 live births, although the risk of 
an affected pregnancy greatly increases with maternal age.  
 
Children are often born with congenital heart defects. A characteristic behavioural 
phenotype in infants is a hypotonic demeanour. Craniofacial abnormalities are also a 
feature of these patients. The structural consequences to brain anatomy in DS are 
known from studies and case-reports of MRI findings in the literature. These include: 
overall smaller brain-volume and reduced cerebellar size (Beacher et al., 2010).  
 
In older subjects, ventricular enlargement may be common, as well as early-onset 
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Alzheimer’s Disease which may be related to the increased gene dosage of the 
amyloid precursor protein (APP).  
 
Although there are instances of transmission of part of Hsa21, 95% of DS affected 
individuals carry a complete copy of chromosome 21. Although the smallest of 
human chromosomes, Hsa21 still houses a large number of genes, which initial 
estimates put at ~230 (Hattori et al., 2000), although recent advances in the detection 
of non-protein coding RNA put this figure as high as ~400 (Gardiner and Costa, 
2006). 
 
With such a large number of genes, the effect of this increased dosage is wide-
ranging. The additional copy of Hsa21 results in elevated expression of many of the 
genes encoded on this chromosome, with varying expression levels in different 
tissues. The increased dosage of Hsa21 genes, and the dosage imbalance between 
Hsa21 and non-Hsa21 genes has been proposed to cause the plethora of phenotypic 
alterations that characterize DS. 
 
Although Hsa21 represents a large number of genes, much past work has focussed on 
a small region – the Down Syndrome Critical Region (DSCR) – a distal section of 33 
genes, thought to be responsible for the majority of phenotyping features in DS. 
However, recent investigations comparing mouse models of Mmu16 trisomy and 
DSCR alone, suggests that DSCR alone may not be sufficient to cause the 
characteristic phenotypes of DS, and moreover restoration of normal DSCR gene 
dosage does not rescue cardiac and craniofacial developmental defects (Lange et al., 
2005; Olson et al., 2007).  This accumulating evidence points against a single DSCR. 
Current data suggests that a number of 'susceptibility regions' located on Hsa21, 
which are modified by other loci on Hsa21 and elsewhere in the genome, increasing 
the risk of developing specific DS associated phenotypes. 
 
Work has also focused on the gene DYRK1A, a kinase that appears to be critical 
biochemical step in the development for a number of aspects of the DS phenotype. A 
summary of DYRK1A phosphorylation targets are shown in Figure 1.14. 
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Figure 1.14: The Hsa21-encoded kinase DYRK1A has been shown to phosphorylate a 
multitude of targets, which have been implicated in a number of biological processes 
and DS-associated phenotypes, including endocytosis and AD. Adapted from 
(Wiseman et al., 2009). 
 
Mouse models of DS are instrumental in identifying which genes contribute to DS 
phenotypes, and unravelling the mechanisms by which these phenotypes arise.  
 
Hsa21 is syntenic to three regions of the mouse genome. Most of the genes on Hsa21 
have homologous genes on mouse chromosome 16 (Mmu16), but two smaller gene 
rich regions have syntenic portions on Mmu10 and Mmu17. The majority of mouse 
models used for DS research are either trisomic for large regions of Mmu16, 10, 17 or 
are transgenic animals used to investigate overexpression of a single gene, such as 
DYRK1A.  
 
One of the most well-characterised models so far has been the Ts65Dn mouse 
(Reeves et al., 1995). As the result of an induced translocation, it has partial trisomy 
of Mmu16 and a small part of Mmu17, in total carrying an additional copy of 132 
genes syntenic with Hsa21. This particular mouse demonstrates symptoms similar to 
human DS, including altered facial characteristics, memory and learning problems 
and age-related changes in the forebrain. 
 
Another model of DS that has been of great interest in recent years has been the 
transchromosomic (Tc1) mouse, produced as part of efforts beginning in the late 
1980s, culminating in an initial characterisation reported in 2005 (Hernandez et al., 
1999; O'Doherty et al., 2005). In this mouse an additional, largely complete form of 
Hsa21 has been introduced, with the aim of examining the effects in the mouse but 
using human genetic material to perhaps offer a more translational model of the 
condition. This also opens the possibility to monitor the affects in future drug 
treatments to specifically modulate the human gene and protein expression in an 
animal model.  
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A summary comparison of regions coded by a number of current models of Down 
syndrome, including Tc1 and Ts65Dn mice is shown in Figure 1.15. 
 
[Figure removed due to copyright] 
 
Figure 1.15: Top: comparison of syntenic regions in human and mouse. Middle: 
Comparison of syntenic regions from the Tc1 mouse (human genes) and common 
mouse DS models. Although the Ts65Dn model is largely trisomic for Mmu16, it also 
contains a small portion of Mmu17 (not shown). Bottom: The regions associated with 
some monosomic models are also illustrated. Adapted from (Wiseman et al., 2009). 
 
As has been outlined in the preceding sections, through the use of a number of 
mutants to model DS, spanning from single genes to the length of Hsa21, the key 
genes that control the condition are slowly beginning to be identified. This 
characterisation of Hsa21 should enable the discovery of new pharmacological targets 
and one day even allow the possibility of DNA-based therapies for the condition. 
1.10 Summary 
In this chapter, the rationale and methods for the creation of genetically modified 
mice were outlined and discussed. The use of a variety of novel imaging modalities 
was also introduced, in the context of the morphological phenotyping of these new 
mice. In the following chapter, a background to magnetic resonance imaging and 




Magnetic Resonance Imaging 
This chapter aims to outline the basic theory behind magnetic resonance imaging and 
introduce some of the practical uses of MRI as applied to mouse phenotyping studies.  
 
2.1 Overview 
Magnetic resonance imaging is a non-invasive imaging method, well established in 
human and small-animal imaging. It utilises non-ionising radiation and is capable of 
generating high-resolution 2D and 3D images with excellent soft-tissue discrimination 
both in-vivo and ex-vivo. An illustration of the quality of images now obtainable in a 
high-field human system in-vivo is shown in Figure 2.1. 
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Figure 2.1: Left: example axial MR image of a human subject in a 7 Tesla MRI 
system. Right: enlarged section, showing the detail of structures visible in and around 
the central sulcus of the brain. Image voxel resolution: 214x214!m in-plane, 1mm 
slice thickness. Adapted from (Li et al., 2006). 
2.2 Generation of the Magnetic Resonance Signal 
In simple terms, MRI exploits a phenomenon known as nuclear magnetic resonance 
(NMR) to create an image. This is now a well-studied physical phenomenon that has 
resulted in some of the most seminal work in physics throughout the 20th Century.  
 
An inherent property of atomic nuclei is a nuclear spin, a form of angular momentum. 
MRI is able to detect information about the quantity and local environment of nuclear 
spins present in elements with an unbalanced number of protons, such as hydrogen 
nuclei (1H) found in tissue water molecules.  
 
Atomic nuclei have magnetic moments that are proportional to their spin, I. In the 
case of certain nuclei, this spin is nonzero. 1H for example, has two possible spin 
states, either +" or -". When these protons are placed in an external magnetic field 
! -64- 
(B0) the magnetic moments thus become aligned either parallel (+") or anti-parallel (-
") with the main magnetic field. The parallel state is the lower energy of the two and 
a slightly higher proportion of protons (~4x10-4%) exist in this state (Figure 2.2).  
 
Figure 2.2: Illustration of the two possible orientations of magnetic moments after 
protons have entered an external magnetic field (B0) 
 
The proportion in both states may be determined by the relationship shown in Eq. 2.1:  
 
(Eq. 2.1)  
     
(where kB is the Boltzmann constant, 1.38x10-23 JK-1, %& is the energy 
difference between the two states and T is the temperature in Kelvin) 
 
This imbalance, with a greater number in the parallel state, creates a net magnetisation 
in the tissue, in the direction of the applied field (M0). 
 
Figure 2.3: Illustration of the summation of magnetic moments in a sample in a 
magnetic field leading to the net magnetisation (M0) 
 
At the same time, these spins precess about an axis parallel to the field lines of the 
applied magnetic field. The frequency of precession – known as the Larmor frequency 




















The magnetisation created in the tissue is also very small (of the order of microTesla) 
compared to the main magnetic field. As it is also aligned with the main field, it first 
must be brought out of this alignment before it can be measured. This is achieved by 
the input of energy into the tissue in order to create a transition of protons from the 
lower to the higher energy spin state. The energy needed for this is defined in 
equation shown in Eq. 2.2. 
 
(Eq. 2.2)     
 
(where E=energy to cause a spin-state transition, h=Planck’s 
constant, B0=field strength of the external magnetic field and 
#=gyromagnetic ratio)   
 
This relationship suggests that a high gyromagnetic ratio and a high external magnetic 
field would give the highest degree of energy change and thus signal. This is one 
reason for the use of 1H (the nucleus with the second highest magnetogyric ratio) for 
MRI and the continual push for the use of higher and higher field strengths for 
imaging magnets. Additionally, most tissues contain an approximately 90M 
concentration of water hydrogen and this abundance makes it especially useful in 
MRI studies.    
 
Applying this energy as a radiofrequency (RF) pulse at the Larmor frequency, 
perpendicular to B0, causes the transition of spins to the higher energy level before 
 
E = h" = #hB02$
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returning to the ground state. This has the effect of unbalancing the net magnetisation 
M, moving it into an angle with the main field. The extent of deviation – the flip 
angle ($) – is determined by the duration and magnitude of the RF-pulse used. After 
the application of the RF-pulse, the net magnetisation then returns parallel to the 
magnetic field. This process is illustrated in Figure 2.5. 
 
Figure 2.5: Illustration of the effect of an RF pulse on the magnetisation. After being 
at equilibrium and aligned with the main magnetic field (a), after application of a 90° 
RF the magnetisation (M0) is tipped into the transverse plane (b) giving a new vector 
(M). 
 
The precession of the magnetisation in the transverse plane, in combination with its 
decay, creates an induced, sinusoidal current in a receiver coil near the sample, 
producing the characteristic NMR signal known as the free induction decay (FID).  
 
Figure 2.6: FID Generation: The combined rotation and decay of the transverse 
magnetisation is detected by a receiver coil (left). The induced electromagnetic 
current is known as the free induction decay (FID) (right). 
 
2.2.1 MR Signal Characteristics  
This return, or relaxation of magnetisation to equilibrium, is governed by two 
concurrent processes: spin-lattice relaxation (the longitudinal, z-component of 
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magnetisation: also known as T1) and spin-spin relaxation (the transverse, x-y 
component: known as T2).  
 
Figure 2.7: Outline of the overall path of spin relaxation as seen from the laboratory 
reference frame. The individual contributions of T1 and T2 relaxation processes 
during this process are shown by the arrows, with T1 acting longitudinally and T2 
transversely in the x-y plane. 
 
2.2.2 T1 Relaxation 
Spin-lattice or T1 relaxation – is the gradual loss of energy from excited spins back to 
the main lattice of the sample and is the longitudinal (z) component of the total 
relaxing magnetisation as it returns to the equilibrium position. Spins are unlikely to 
spontaneously return to the lower energy state and instead rely on stimulated emission 
of energy through dipole-dipole interactions with their surroundings. This is brought 
about by the tumbling motion of surrounding dipoles. For a transition to take place 
between spin states, interactions need to take place at near the Larmor frequency. Fast 
tumbling media, such as free protons in liquids, tend to have very long T1 relaxation 
times as the fluctuating magnetic field varies faster than the Larmor frequency 
minimising its effect. Similarly, bound protons tend to have slow rates of tumbling 
and so also have a long T1. The ideal environment is among intermediately bound 
protons, which tumble at the Larmor frequency, resulting in a greater number of spin 
transitions per unit time and thus the shortest T1.  
 
2.2.3 Measurement of Tissue Parameters: T1 
The gold-standard for T1 measurement is a technique known as inversion-recovery. In 
this method, spins are initially inverted in the Z direction yielding a magnetisation of -
M0.  
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Figure 2.8: Illustration of T1 measurement in a sample. Spins are initially inverted by 
a 180° pulse (shown left). The remaining signal after a number of inversions is shown 
in the right graph. A curve corresponding to the recovery may then be fitted to these 
points yielding the value of T1 
 
After a certain delay time – the inversion time (TI) – the remaining Mz magnetisation 
can be recorded. Sampling at multiple inversion times builds up the full recovery 
curve, allowing the tissue T1 to be calculated. The T1 value for a specific tissue is the 
time needed for the longitudinal magnetisation to return to 63% of M0. The full 
recovery curve during inversion-recovery is defined by the following equation: 
 
  (Eq. 2.3)   
 
The repetition time between inversion experiments (TR) is typically five times T1 in 
order to ensure full longitudinal relaxation of the tissue at each stage (Pykett et al., 
1983). An adiabatic inversion pulse will often be used, as this ensures spins are 
exactly inverted by 180°. Otherwise variations in the RF power delivered by the 
scanner may lead to flip angles more or less that the desired amount if a conventional 
pulse is used, leading to inaccurate T1 values.  
 
2.2.4 Measurement of Tissue Parameters: T2 
Spin-spin or T2 relaxation occurs in the x-y plane and is characterised by the gradual 
dephasing of the spins which are initially coherent after the 90° RF pulse. As two 
neighbouring protons (in the same molecular environment and at the same 
precessional frequency) come close together, energy is readily exchanged between 
each other. Inter- and intramolecular interactions can also cause fluctuations in the 
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rates of precession. Both processes lead to the loss of initial coherence as these energy 
exchanges take place and spins dephase with each other. This has the effect of 
reducing the transverse magnetisation with time. This is shown schematically in 
Figure 2.9 below. 
 
 
Figure 2.9: Illustration of the loss of phase coherence of spins in the transverse x-y 
plane. After the initial 90° RF pulse (left), spins are initially in phase with each other, 
resulting in a high received signal. After a short amount of time (~ms) spins begin 
precessing at slightly different rates, becoming out of phase (middle), resulting in a 
reduction in net signal.  After complete T2 relaxation (right), spins are fully dephased 
resulting in zero net signal. 
Solids tend to possess a broader range of precessing frequencies, as bound protons 
tumble slowly and behave more like a static inhomogeneity. Thus T2 decay is fast in 
this case. Fluids have a narrower range of B0 frequencies as their fast tumbling results 
in a fluctuating magnetic field that averages to near zero. This leads to a fairly 
homogenous local field and a slower rate of T2 decay. In contrast to T1 relaxation, 
while there is interaction and energy exchanged between spins, no net energy is lost. 
 
It is possible to measure the relaxation time of the transverse magnetisation 
component. The general equation for remaining MR signal at a certain echo time, due 
to T2 decay is: 
 
  (Eq. 2.4)    
 
The value of T2 is the time after which the signal due to transverse magnetisation will 
be 37% of M0. To calculate T2, results of a series of MR experiments are plotted with 
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the signal intensity against increasing echo time. A curve fit to this data allows T2 to 
be accurately determined.  
 
Figure 2.10: Illustration of T2 measurement in a sample. The remaining signal after a 
number of echo times is shown. A decay curve may then be fitted to these points 
giving the value of T2. 
 
2.2.5 MR Image Generation and Contrast 
The free-induction decay itself is rarely used directly in an image acquisition – an 
‘echo’ is usually created and acquired. As spins begin to dephase at the end of the 
FID, an echo can be generated by bringing dephasing spins back into coherence. 
Building up successive echoes across a volume allows the raw frequency information 
to be obtained and taking the Fourier transform of this data produces the MR image.  
 
There are broadly two subtly different methods of producing an echo and these define 
two basic MR imaging sequences known as gradient-echo and spin-echo. 
 
2.2.5.1 Gradient-echo Imaging 
Gradient echo imaging uses a magnetic field gradient across the sample to rapidly 
dephase spins. Reversing the sign of the gradient causes spins to rephase and form an 
echo. The time taken before creating the echo is known as the echo time (TE). 





Figure 2.11: Basic pulse sequence diagram of a slice-selective gradient-echo 
sequence. Gss=slice selection gradient, GPE=phase encoding gradient, GFE=frequency 
encoding gradient, TE=echo time, TR=repetition time. Adapted from (McRobbie et 
al., 2003). 
 
However, true T2 relaxation is rarely encountered in gradient echo sequences, as the 
transverse relaxation of the remaining magnetisation is susceptible to inhomogeneities 
in the main magnetic field which are not corrected as the gradient refocuses the spins. 
These local differences cause spins to dephase more quickly than would be expected 
in T2-decay, resulting in shorter, composite relaxation known as T2*. This is 
dependent on the extent of the local field inhomogeneities in both the main magnet 
and the sample (%B0) and may be defined by equation 2.5: 
  
  (Eq. 2.5)    
 
It is possible to minimise some of this change and additional ‘shim’ coils cited around 




Figure 2.12: Graph illustrating the effect of magnetic field inhomogeneities on T2 
decay in a sample. These result in faster dephasing and a composite T2* decay. 
 
A common problem with gradient echo-sequences is the build-up of residual 
transverse magnetisation (Epstein et al., 1996), which may lead to image artefacts. 
Additional ‘spoiler’ gradients and RF pulses may be used as part of the pulse 
sequence in order to remove any residual magnetisation. Thus a commonly used 
sequence is so-called RF-spoiled gradient echo. 
 
2.2.5.2 Spin-echo Imaging 
The spin echo imaging sequence gives high SNR images and is less susceptible to 
magnetic field inhomogeneties. Spin-echo imaging uses a 180° refocusing RF pulse to 
create the signal echo, instead of a magnetic field gradient. The 180° has the effect of 
reversing the direction of the dephasing spins, causing them to now rephase. An 
advantage of spin echo is that inhomogeneities in the main B0 field are also corrected 
after the application of the 180° pulse, producing an echo that follows true T2 decay 
and not T2*. 
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Figure 2.13: Pulse sequence diagram of a basic spin-echo sequence. Also shown are 
crusher gradients about the 180° pulse which remove any residual FID prior to 
acquisition due to imperfections in the pulse. Adapted from (McRobbie et al., 2003). 
 
 
2.2.6 k-space and the Fourier Transform 
With the advent of Fourier-imaging through the use of imaging gradients, MRI data is 
acquired in the frequency domain. This may be represented as a 2D or 3D space 
known as k-space. In k-space, the imaging data with each successive phase-encoding 
step is acquired during each phase-encoding line is placed into a row in the k-space 
matrix. After acquiring all k-space data in the 2D plane or 3D volume, performing 
successive Fourier transforms in x, y and (if applicable) z-directions and taking the 




Figure 2.14: Illustration of echo placement into k-space in a 2D image. The 
measured echo during each successive increment of the phase-encoding gradient 
(GPE) is placed in a new k-space line (right), building up the complete range of spatial 
frequency information needed to create an image. Taking the absolute value of the 2D 
Fourier transform of the k-space data will yield a magnitude image. Adapted from 
(McRobbie et al., 2003). 
 
2.2.7 Image Contrast in MRI 
The contrast between structures seen in an MR image is determined by a number of 
factors, namely the density of protons in the tissue (which determines the magnitude 
of M0), tissue relaxation parameters (T1, T2 and T2*) and the choice of MR sequence 
timings. A specific tissue will have a unique combination of these parameters based 
on structure and the local proton environment. To exploit differences between tissues 
one can alter MR scan parameters (such as TR and TE) in the imaging sequence. An 
example is shown in Figure 2.15. 
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Figure 2.15: Example of the effect of sequence parameters on contrast showing the 
difference for two tissues, in this instance varying TE to give T2 or T2* contrast. 
Maximum contrast (S1-S2) is achieved when signal difference is at its highest. From 
this graph it is apparent that Tissue 1 has a longer T2 than Tissue 2. 
 
If the precise values are known for the tissues of interest one can go further and 
mathematically model the signal intensity and relative contrast produced in an image 
in order to determine the optimum for distinguishing two tissues. This is achieved by 
inserting experimental values into a theoretical signal intensity equation for a given 
MR imaging sequence. Contrast may then be determined for a variety of sequence 
parameters, giving the optimum TR and TE. 
 
2.3 Microscopic MRI (!MRI) 
From the initial description of MRI by Lauterbur in the early 1970s, it was conceived 
that the technique could be capable of producing images at near microscopic 
resolutions. This has led to the emergence of the field of microscopic magnetic 
resonance imaging or !MRI – which is typically defined as image acquisition at an 
isotropic voxel resolution of less than 100!m (Benveniste and Blackband, 2006).  
 
The need for a separate term for imaging on this scale arises from the challenges in 
imaging objects at such small voxel sizes. The foremost concern is that that sufficient 
MR signal obtained during imaging this is directly proportional to the voxel volume. 
Thus a 3D dataset with voxel dimensions of 100!m in all directions (termed 100!m 
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isotropic) will have 1/1000 the signal-to-noise ratio (SNR) per unit time of a 1mm 
isotropic dataset.  
 
There are a number of engineering strategies for improving SNR at microscopic 
resolutions. The use of a high field spectrometers (with a field strength >7 Tesla) is 
important as this increases the detectable tissue magnetisation, giving rise to the 
approximately linear relationship between SNR and field strength (Edelstein et al., 
1986). Signal may also be gained through the use of smaller imaging coils, as receiver 
coil sensitivity is inversely proportional to coil diameter. Specialised types of imaging 
coils have also been developed for !MRI use, such as those utilising cryogen cooling 
(Wright et al., 2000) (which reduces coil resistance and improves thermal noise). 
Increasing scan time by combining longer repetition times (which allows more T1 
recovery, boosting signal) and an increased number of signal averages (NSA) will 
also improve SNR. The acquisition bandwidth (BW) – the range of frequencies 
sampled by the receiver during the application of the frequency encoding gradient – 
can also affect SNR. A higher bandwidth will increase the range of frequencies 
sampled, and as noise is constant over the frequency spectrum, more noise will be 
incorporated into an image.  A summary of the relationship between SNR and some 
of these dependencies (excluding T1 and T2) is shown in equation 2.6 (Kale et al., 
2009): 
  (Eq. 2.6)       
 
(where x, y and z represent voxel dimensions, NSA the number of signal 
averages and BW the bandwidth)  
 
It should be noted from that increasing signal averaging alone is a particularly time-
expensive method of increasing SNR. For example, if the voxel size is doubled in all 
directions, the number of averages and thus the time needed will increase by 64-fold. 
Thus one must generally look to the choice and optimisation of the MRI sequence 
parameters and sample preparation to in order to improve SNR. 
 
To produce high-resolution 3D datasets and mitigate potentially long scan times, 
‘fast’ 3D imaging sequences are used in !MRI. Two sequences in particular are 
commonly used: gradient echo, which generally offers T1 contrast with a short TR 
 
SNR " #x#y#z NSA 1BW
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(~30ms) or fast spin-echo offering T2 contrast can acquire multiple echoes per phase-
encoding step. Partial-Fourier techniques may also be used to reduce time (Petiet et 
al., 2008), where a portion (typically ~75%) of k-space data in the two phase 
encoding directions are acquired, reducing the number of TRs needed. While the 
phenomenon of k-space symmetry may be employed to allow final image 
reconstruction, there is loss of SNR due to this undersampling (McRobbie et al., 
2003). 
 
Choice of receiver bandwidth is particularly important in !MRI as this has an impact 
on the resolution of structural detail. The bandwidth of the system should be sufficient 
to resolve the full range of frequencies corresponding to a particular voxel. Too low a 
receiver bandwidth results in blurring and poor edge discrimination. This is a matter 
of balance however, as a higher bandwidth will lead to an increase in noise and 
reduced SNR. The minimum bandwidth needed for a given tissue may be defined in 
terms of its T2*: 
  (Eq. 2.7)   
   
(where N is the number of points in the frequency encoding direction) 
The amounts of data created in !MRI acquisitions can pose challenges during 
reconstruction and analysis, given the use of large matrix arrays (typically 5123 or 
higher) for multiple subjects (leading to datasets of several gigabytes) (Petiet et al., 
2008). However the progressive rise in processing power and storage capacity of 
personal computers, coupled with the introduction of 64-bit architectures has made 
working with larger matrix sizes more practical.  
 
2.4 MR Contrast Agents 
MR contrast agents are compounds that have the ability to alter the intrinsic MRI 
contrast properties of tissue and are used clinically for angiography and enhancing 
areas of pathology such as brain tumours or an area of myocardial infarction in the 
heart (Mathur-De Vré and Lemort, 1995). In recent years these agents have also found 
a use as so-called ‘active-stains’ for ex-vivo tissue (Johnson et al., 2002b). In contrast 
to the engineering and pulse sequence strategies previously discussed that facilitate 
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!MRI, this offers a method of manipulating the MR properties of tissue, further 
boosting the SNR obtainable. 
 
MR contrast agents fall into two categories: positive contrast agents based on 
paramagnetic metals (such as gadolinium or manganese) which generally cause an 
increase in signal; and negative contrast agents, consisting of superparamagetic 
compounds (typically iron oxide based agents) that create signal voids on an MR 
image. The physical mechanisms of these agents are quite different.  
 
2.4.1 Paramagnetic MR Contrast Agents 
Paramagnetic agents act to reduce tissue relaxation times at short distances (Caravan, 
2007) and protons need to be either in direct contact with the complex or close in the 
local environment. Gadolinium-chelate compounds are the most commonly used 
paramagnetic agents and generally provide positive contrast. They reduce both T1 and 
T2 relaxation times but at typical clinical concentrations the T1 effect is most apparent. 
This reduction is due to the compound’s structure: gadolinium has seven unpaired 
electrons in its outer shell. These electrons have a very high magnetic moment 
compared to a proton (~658 times larger) and hence can create strong local effects. In 
the case of T1, strong dipole-dipole interaction leads to a greater number of spin 
transitions in the tissue and thus a shortening of the observed tissue T1. Also at 
relatively high concentrations, the agent will behave as a local inhomogeneity and 
cause higher dephasing of spins and a shortening of T2. 
 
The chelate component of Gd complexes has two functions. It first acts as a protective 
agent for in-vivo use, as gadolinium, in common with other heavy metals, is highly 
toxic. It also reduces the number of water binding sites on the Gd3+ ion, making the 
relaxation effect highly local and primarily dependent on water protons interacting 
with the molecule itself. A common paramagnetic MR contrast agent is the compound 
gadolinium-diethyl-triamine-penta-acetic acid (Gd-DTPA, tradename Magnevist) 
whose structure is shown below. In this instance, the DTPA component in the 
molecule reduces the number of water coordination sites on the Gd3+ ion from 9 to 1.   
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Figure 2.16: The physical structure of the molecule Gd-DTPA, showing a single 
coordinated water molecule in the inner sphere. Adapted from (Caravan, 2007). 
 
There are a number of features of paramagnetic agents that affect their relaxation 
enhancement. An illustration of some of these features and molecular interactions are 
shown in Figure 2.17 below.  
 
Figure 2.17: Types of interaction of water proton interactions with Gd-DTPA and 
molecular parameters that affect relaxation. Such protons may undergo relaxation 
enhancement through the inner sphere, 2nd sphere or outer sphere relaxation 
mechanisms. Molecular parameters shown include: !r= rotation time of the complex, 
!m=residence time of the water molecule in the complex, r=the distance of the proton 
from the paramagnetic ion, T1e=electronic T1 relaxation time, T2e=electronic T2 
relaxation time, S=spin quantum number: 7/2 for Gd3+. Adapted from (Caravan, 
2007). 
 
The relaxation of water molecules surrounding the Gd-chelate is dependent on 
encountering a locally fluctuating magnetic field. A number of characteristics of the 
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agent enable this. First, the properties of electrons in the Gd ion promote relaxation, 
such as the high spin number (S=7/2) and slow electronic relaxation rates (T1e and 
T2e). Second, are properties of the complex that enable interactions with water optimal 
for relaxation. Although there is only one coordination site, the coordinating water is 
in rapid chemical exchange with the surrounding bulk water (106 exchanges per 
second) and this also results in efficient inner sphere relaxation. !m represents this 
residence time of water in the inner sphere, which should be short in order to allow 
the greatest number of water molecules to undergo inner sphere relaxation from the 
surrounding bulk water. Additionally, while not interacting directly with the Gd ion, 
surrounding bulk water molecules may also undergo some relaxation in 2nd sphere and 
outer sphere environments. !r represents the rotation time of the contrast agent 
molecule, which should be relatively slow in order to allow time for immediately 
surrounding water to coordinate in the inner sphere.  
 
An overall measure of the interaction between two species (Gd and water protons) is 
the correlation time (!c) which encompasses some of the parameters discussed (Eq. 
2.8 below), including the water residence time, molecular rotation time and electronic 
T1. Ideally the reciprocal of this quantity should be close to the Larmour frequency in 
order to ensure efficient T1 relaxation.    
 
(Eq. 2.8) 1/!c  = 1/!r + 1/T1e + 1/!m 
 
This study of paramagnetic MR contrast agents was begun fairly early on in the 
development of MR and is formally described in the work of Solomon (Solomon, 
1955) and Bloembergen (Bloembergen, 1957). This has resulted in the construction of 
a simple relationship to determine a measure of the relative efficacy of a contrast 
agent in altering T1 and T2 relaxation times, known as the relaxivity (R), and may be 
defined in relation to T1, T2 or T2* as Eq. 2.9.  
 
  (Eq. 2.9)        
 
(where Ttotal is the observed relaxation time, [CA] is the agent 
concentration and Ttissue is the relaxation time in the absence of agent) 
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From this equation, an effective agent would be expected to produce a high degree of 
relaxation with a small concentration and therefore possess a high relaxivity value. 
This is a characteristic of Gd-based agents. Relaxivity values are specific to a 
particular relaxation mechanism (T1 or T2) and depend on the medium where the 
agent is present. While paramagnetic agents act to reduce both T1 and T2 relaxation 
times, at the concentrations typically used both clinically and active-staining 
applications, the predominant effect is that of an increase in signal due to T1 
reduction. 
 
2.4.2 Superparamagnetic Agents 
While future chapters of this thesis will concentrate on paramagnetic agents, which 
produce local, positive contrast that is most useful in high-resolution imaging studies, 
another major class of compounds – superparamagnetic agents – are also in common 
use.  These are generally composed of crystalline particles of iron oxide (e.g. ferrite, 
Fe3O4). A large ferrite crystal containing a large number of spins can, through 
quantum interactions, result in a very large total spin and thus a very high magnetic 
susceptibility. This phenomenon is known as ferromagnetism and the material’s 
magnetism continues even after removal from the external magnetic field. If small, 
sub-micron, iron oxide particles are used instead of a large crystal, the result is a 
material that exhibits a weaker form of susceptibility known as superparamagnetism 
(termed superparamagnetic iron oxide particles or SPIOs). In contrast to 
ferromagnets, such materials do not remain magnetic after removal from an external 
magnetic field. 
 
As with the paramagnetic agents, high concentrations of iron can be highly toxic in 
biological systems and so for clinical use, particles are coated with a biochemical 
wrapper. One example of an SPIO agent is ferumoxide (tradename Endorem) which 
has a dextran coating to ensure biocompatibility. In contrast to paramagnetic agents, 
these particles result in image hypointensity due to T2 reduction, majority of effects 
from these particles. Behaving like an inhomogeneity in the magnetic field these 
agents are able to produce negative contrast (signal voids) on MR images. A clinical 
use of these agents is in hepatic tumour imaging, as the particles are most easily taken 
up by functioning phagocytic Kuppfer cells of the liver, allowing the delineation of 
tumour cells that do not. A further application in pre-clinical studies has been the use 
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of SPIO agents for stem cell tracking. Cells are able to take up SPIO particles which 
then appear as small hypointensities when introduced into tissue. The movement and 
division of these cells may then be monitored over time to determine their effect in 
regions such as the brain (Panizzo et al., 2009) or the heart (Stuckey et al., 2006). 
2.5 Tissue ‘Active-staining’ for !MRI  
While MRI is usually considered as an in-vivo technique, it has been frequently 
applied to the imaging of post-mortem (Thayyil et al., 2009) and delicate tissue 
samples (Null et al., 2008; Ullmann et al., 2010), where non-invasive examination of 
the intact structure is important and provides a useful adjunct to conventional, 
destructive histology. However, imaging of normal fresh or fixed tissue is constrained 
by the intrinsically long T1 (of the order of seconds) leading to long scan times in 
order to achieve acceptable SNR with high resolution.  
 
An innovation initially described by Johnson et al. (Johnson et al., 2002a) has been 
the use of Gd-based MRI contrast agents as so-called active-stains for tissue. Similar 
to histological staining, the use of the contrast agent enables firstly more rapid !MRI 
of tissues and secondly may modify the MR properties to reveal structural detail. The 
initial use of active staining was for the former, to enable sufficient signal-to-noise for 
!MRI, due to predominant T1 reduction properties of paramagnetic agents as 
previously discussed.  
 
With their predominantly local mechanism of action, which leads to positive contrast 
and increased signal, gadolinium chelates in particular, are the agent of choice for 
active stains in ex-vivo tissue. Given their good relaxivity properties, only small 
quantities are needed: immersing tissue in mM concentrations shortens T1 (typically 
from ~2 sec to <100ms). This causes a great improvement in the signal available due 
to faster recovery of longitudinal magnetisation. !MRI can then be performed with 
greatly reduced scan-times, decreasing from the order of days to hours for a typical 
3D scan.  
 
So far a number of Gd-chelate agents at a variety of concentrations, in combination 
with both spin- and gradient-echo sequences, have been used for active-staining in ex-
vivo mouse imaging. Standardised preparation protocol has yet to be agreed upon for 
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either embryo or brain tissue. The two most commonly used agents are Gd-DTPA and 
gadoteridol (tradename ProHance) used for doping solutions of formaldehyde 
fixatives. While their molecular structures are somewhat different, using different 
chelates, gadoteridol has very similar relaxivity properties to Gd-DTPA in solution. 
The two main approaches employed are either a high concentration of agent (typically 
~45mM) in the initial fixation of tissues (over the first few hours) or immersion with a 
lower concentration (2-8mM) over at least several days. 
 
The consequences of the addition of MR contrast agent to fixative are a dramatic 
reduction and compression of the range of T1s and T2s from normal values (as 
illustrated in Figure 2.18). Thus imaging parameters that are conventionally used in 
the in-vivo setting or in ordinary fixed tissue will not be appropriate may need to be 




Figure 2.18: Examples of compression of T1 and T2 values in 18.5dpc rat foetuses. 
(A) Shows a histogram of T1 values after fixation for 3.5 hours in Bouin’s fixative 
solution doped with increasing concentrations (12, 24 and 45mM) of the Gd contrast 
agent gadoteridol. (B) Histogram of T2 values in a rat foetus after immersion in 
Bouin’s fixative doped with 24mM gadoteridol, after initial, 3.5 and 24 hours 
immersion-fixation. Adapted from (Petiet et al., 2007). 
 
While Gd-based chelates are the predominant agent used for !MRI studies, the use of 
other paramagnetic agents such as manganese chloride, as alternative active-stains are 
also being investigated. MnCl2 becomes Mn2+ in solution and is thought to behave as 
an analogue of Ca2+ in-vivo. A large number of in-vivo MR studies use Mn2+ as a 
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positive contrast agent, as it can lead to signal hyperintensity in tissues where it is 
taken up (Silva et al., 2008) providing an indication of function. Preliminary work in 
ex-vivo mouse brains as an alternative active-stain appears promising, suggesting the 
use of Mn2+ may give specific contrast by binding to tissue in the manner of 
conventional histology stains (Huang et al., 2009), although signal and contrast to 
noise may not be as high as Gd-agents due to the short T2 of Mn-stained tissue.  
 
2.5.1 Applications of MR to Mouse Embryo Phenotyping 
As discussed in the previous chapter, due to the generally low volumes of embryos 
that may be phenotyped with conventional histology and its destructive effects on 
tissue morphology, there is interest in utilising non-invasive imaging methods for 
morphological screening. !MRI is one such imaging method, allowing assessments of 
both embryo development (Petiet et al., 2008) and phenotype (Bamforth et al., 2004; 
Goddeeris et al., 2008).  
 
The use of high-resolution !MRI for cardiovascular phenotyping was initiated in the 
1990s by Smith and colleagues (Smith et al., 1994; Smith et al., 1996), where they 
developed a technique to image embryo vasculature. Individual embryos are dissected 
and perfused through umbilical vessels with an MR contrast agent (bovine serum 
albumin-Gd-DTPA) dissolved in gelatin. Some time after perfusion, the gelatin 
hardens causing the agent to remain in the vessel lumen. A high-resolution 3D MRI 
then enables the visualisation of individual vessels in the embryo similar to an MR 
angiogram. This technique has been successfully used for vascular phenotyping 
studies (Berrios-Otero et al., 2009). A disadvantage of this method is the complexity 
and operator dependency of the embryo preparation, with only a small numbers (1 to 
4) able to be imaged at once.  
 
[Figure removed due to copyright] 
 
Figure 2.19: Maximum intensity projection image of the vasculature of a 16.5dpc 
mouse embryo prepared using the BSA-Gd-DTPA injection technique. Adapted from 
(Berrios-Otero et al., 2009). 
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Later, Jacobs and colleagues produced high resolution MR images of single embryos 
(Dhenain et al., 2001), with the goal of creating 3D anatomical atlases as an advance 
over the 2D histology-based atlases (Kaufman, 1992) commonly used, although this 
involved imaging single embryos with very long scan-times – up to 37 hours per 
embryo (Dhenain et al., 2001). 
  
The use of active staining in embryos, primarily as a method of T1 reduction was 
initiated by Schneider et al. (Schneider et al., 2003b), enabling high-throughput 
embryo phenotyping studies through the use of large volume coils in conjunction with 
a gradient-echo sequence with a short TR (Schneider et al., 2004). 
 
This work has recently been extended by Petiet et al. who developed an immersion-
fixation protocol using Bouin’s fixative doped with gadoteridol, in combination with 
3D spin-echo imaging. The same group went on to produced an annotated database of 
embryonic, neonatal and adult mice imaged at a number of developmental timepoints 
(Petiet et al., 2008) and also to characterise heart phenotypes in mid-gestation 
embryos (Goddeeris et al., 2008). Their methodology has also been used recently for a 
manual volumetric study to determine the effects of embryonic brain development 
after ethanol administration (Parnell et al., 2009). 
 
2.5.2 Embryo Imaging with MR, In-utero 
The studies mentioned above have all been performed in ex-vivo embryos which offer 
the advantages of highly-controlled sample preparation and the imaging of subjects 
with little or no movement, easily achieving sub-100!m image resolutions. However, 
a goal of embryo MRI would be to ultimately develop a high-resolution in-vivo 
imaging, in-utero, in order to perform longitudinal and functional studies. Work on 
this front has slowly progressed over the past decade. 
 
In the in-utero setting there are a number of challenges, particularly that of respiratory 
motion of the mother and movements of individual embryos, which can rapidly 
degrade image quality. Previous work has attempted to use relatively fast T2-
weighted, multi-slice acquisitions (5-9 slices, 0.8-1mm thick, 234x234!m in-plane 
resolution, scan time 4-6.5mins). However this need for a rapid acquisition, to 
minimise the effects of embryo motion typically results in relatively poor spatial 
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resolution due to a limited number of phase-encoding steps and relatively thick image 
slices (Chapon et al., 2002). 
 
[Figure removed due to copyright] 
 
Figure 2.20: In-utero images of 18/19dpc embryos showing visible anatomy. In-plane 
resolution = 234x234!m2 Scale bar = 5mm. Adapted from (Chapon et al., 2002) 
 
More recent studies have used Mn2+ to improve SNR during imaging, as Mn2+ is 
readily taken up by tissues with a high Ca2+ turnover. This leads to signal 
enhancement especially in CNS structures, which in conjunction with retrospective 
respiratory gating to the mother’s breathing, can produce good quality 3D images 
(Deans et al., 2008).  
 
MR-based motion correction techniques such as navigator echoes may also be used to 
characterise and reduce motion (Ordidge et al., 1994). In embryo heart imaging there 
are particular difficulties in obtaining an ECG signals in order to gate the acquisition 
of k-space lines to specific heart phases. Access, the presence of multiple of embryos 
and the maternal heartbeat makes the use of conventional electrode ECG gating 
difficult. A technique called cardiac self-gating, has been used to address this, where a 
small amount of low resolution data is acquired just prior to image acquisition. This 
data can then used to identify the heart movements that relate to the phases of the 
cardiac cycle in a specific embryo. A self-gated sequence and imaging protocol has 
been successfully used to produce 3D images in 17dpc embryo hearts (Nieman et al., 
2009). 
[Figure removed due to copyright] 
 
Figure 2.21: In-vivo black-blood images and volume rendering of a 17dpc embryo 
heart at diastole (left) and systole (right). Images were acquired using a self-gated 
MRI technique.  Adapted from (Nieman et al., 2009) 
 
2.6 Applications of MR to Adult Mouse Brain Phenotyping 
Phenotyping in the adult mouse brain is also a key application of MRI and is able to 
produce excellent contrast between, grey and white matter, and the CSF present in 
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ventricular structures. Conventionally, in-vivo, a number of image weightings (such as 
T1, T2 and Proton Density) are available to generate contrast through the relevant 
intrinsic properties of the three classes (grey matter, white matter and CSF) of brain 
tissues. In addition, tissues may be delineated through other more specialised contrast 
mechanisms such as magnetisation transfer (Natt et al., 2003) and diffusion imaging 
techniques. 
 
Although this thesis focuses on methods of ex-vivo brain imaging, which provides the 
highest spatial resolution and visualisation of the greatest number of structures, an 
important use of MRI is its ability to conduct in-vivo imaging studies. Such studies 
enable the same subjects to be tracked over time, allowing the direct characterisation 
of anatomical or functional change with age or disease. For example, previous work 
in adult mice has used MR to characterise mouse models of neurodegeneration (for 
example, models of Alzheimer’s disease) and the consequences of interventional 
models such as stroke. Changes in the volumes and signal intensity change in tissues 
may be observed. Additionally, neuropathological changes seen in these models may 
have additional MR-contrast that may be used as a biomarker to indicate the presence 
and severity of pathology. For example, in stroke models, infarcted tissue over the 
initial hours post-occlusion, will show a progressive increase in T2, resulting in 
hyperintensity on T2-weighted images. Also amyloid plaques in mouse models of 
Alzheimer’s disease may have an increased iron content leading to a local T2 
reduction and a hypointensity in an image, allowing the plaque to be visualised.    
 
[Figure removed due to copyright] 
 
Figure 2.22: Example 2D multi-slice MR images from individuals in a longitudinal 
study of structural brain changes in the R6/2 transgenic mouse model of Huntington’s 
disease. Imaging was performed from postnatal day 21 to day 84. Potential cortex 
and hippocampal atrophy was seen in transgenic mice and are indicated by white and 
black arrows respectively. Dashed lines indicate structural boundaries identified on 
control brains at P21. Structural labels: 3V=third ventricle, CX=cortex, 
H=hippocampus, LV=lateral ventricles, S=striatum and T=thalamus. Adapted from 
(Zhang et al., 2010a) 
 
! -88- 
[Figure removed due to copyright] 
 
Figure 2.23: Visualisation of amyloid-" plaques in an APP/PS1 transgenic mouse by 
MRI. a&b: T2-weighted in-vivo images of specific numbered plaques identified in a 
typical individual. c&d: similar T2-weighted images in the same animal ex-vivo. e&f, 
g&h: images of the same numbered plaques in a similar histological sections after 
Thioflavin S amyloid, and Prussian blue-diaminobenzidine-enhanced iron stains 
respectively. Adapted from (Wengenack et al., 2008). 
 
However a disadvantage of in-vivo work is a limited scan-time, as an animal can only 
be under anaesthesia for a few hours in each scan session to ensure successful 
recovery, without lasting physiological effects. Also, as with embryo imaging, even 
slight movement may result in blurring of the image. This combination has the effect 
of limiting the achievable resolution to typically 100!m for 3D isotropic acquisitions 
(Bock et al., 2006), or for 2D multi-slice acquisitions, ~30!m in-plane with a 300!m 
slice thickness (Boretius et al., 2009). This relatively coarse resolution, compared to 
ex-vivo studies may affect the sensitivity of in-vivo MRI to detect very subtle 
phenotypic effects. 
 
[Figure removed due to copyright] 
 
Figure 2.24: Illustration of the histological detail in cortical layers obtainable in the 
mouse brain by in-vivo MRI in combination with a specially designed mouse-holder to 
reduce subject motion during acquisition. (30x30!m in-plane resolution, 300!m slice 
thickness). Adapted from (Boretius et al., 2009). 
 
Ex-vivo imaging in contrast, although preventing longitudinal studies, enables high-
resolution imaging as longer imaging times (usually several hours or more) are 
possible, and firm positioning of samples results in very little movement during 
acquisition. The resolutions of acquired images are typically as low as 20!m 
isotropic, thus approaching conventional light microscopy. With such high-resolution 
available, the applications of the technique are generally anatomical, such as MR 
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atlases of single (Johnson et al., 2010) and multiple subjects (Dorr et al., 2008), in 
addition to mutant mouse phenotyping studies (Sawiak et al., 2009a). 
 
[Figure removed due to copyright] 
 
Figure 2.25: Example axial image slices from a ‘canonical’ individual imaged at 
high resolution as part of a mouse brain segmentation and anatomical atlas project. 
(a) Monochrome Nissl stained histology section from a reconstructed 3D brain 
volume. (b) Similar T2* MR image slice from the same brain for comparison (c) 
Overlaid, coloured structure labels as identified from histology and registered to the 
MR image volume. Adapted from (Johnson et al., 2010). 
 
[Figure removed due to copyright] 
 
Figure 2.26: Coronal and sagittal T2-weighted !MR brain images of typical wild-type 
(WT) and transgenic individuals from the R6/2 model of Huntington’s disease. In the 
R6/2 mouse, the lateral ventricles appear enlarged compared to WT, indicating 
neurodegeneration. Images are full 3D volumes with 70!m isotropic resolution. 
Adapted from (Sawiak et al., 2009a). 
 
With such high-resolutions available, one would expect the sensitivity to the detection 
of subtle phenotypic changes in anatomy to be higher than in-vivo imaging. Although 
again, as in the embryo, datasets may be extremely large (e.g. 1 brain consisting of 
approximately 500 coronal slices at 40!m isotropic resolution) making manual 
inspection and volume analysis difficult. Here there is also a need for automated 
methods for automated identification of phenotype and background to the methods for 
the analysis of these large datasets will be introduced in the next chapter. 
 
2.7 Diffusion Tensor Imaging  
Diffusion tensor imaging (DTI) is another MR technique often applied to ex-vivo 
phenotyping studies. It utilises additional imaging gradients to explore the degree and 
direction that water can diffuse in tissue. In the mouse brain, DTI studies have been 
successfully used to investigate brain development (Baloch et al., 2009) and also to 
identify phenotype (Tyszka et al., 2006). The technique is particularly successful in 
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allowing the visualisation of axonal white-matter tracts in the adult brain resulting in 
tractography maps (seen in Figure 2.7 below). However, a key factor limiting the use 
of DTI is the scan time needed to achieve <100!m isotropic datasets (e.g. ~24 hours 
per brain for <50!m resolution) and at least 7 complete image volumes also need to 
be acquired in order to give sufficient directional information to create the diffusion 
tensor map. 
 
[Figure removed due to copyright] 
 
Figure 2.27: Example side (a) and bottom views (b) of white-matter tractography 
seen in  a C57BL/6 mouse brain. Structures are: corpus callosum (red, enlarged in 
(d)), cingulum (cyan), anterior commissure (blue, enlarged in (c)), fimbria (white, 
enlarged in (e)), optic tract (green), and habenular commissure (pink, enlarged in 
(c)). Transparent regions shown for reference: olfactory bulbs (light blue), anterior 
commissure (purple), fimbria (green), hippocampus (yellow), septal nuclei (brown) 
and cortex (dark blue).  (DTI data resolution 43!m isotropic, 6-directions+b0, scan 
time 28 hours). Adapted from (Jiang and Johnson, 2010). 
 
2.6 Conclusion 
In this chapter, the basic principles of MRI were outlined, with a discussion on the 
mechanism of MR contrast agents and their use in !MRI, along with specific 
applications. The datasets produced by !MRI techniques, while detailed, are often 
large, presenting a challenge to an individual observer analysing multiple subjects. In 
the next chapter the use of automated image analysis techniques is discussed, which 
can greatly ease the burden of !MRI study analysis. 
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Chapter 3: 
Image Analysis in Mouse Phenotyping 
 
As seen in previous chapters, the completion of human and mouse genome sequences 
has resulted in a shift of research from genotype to phenotype. This study of mutant 
mice has the potential to make significant advances in the understanding of human 
disease processes, which may lead to new screens and therapies. However, with the 
ambitious scale of current international projects, significant challenges remain in the 
sheer quantity of data that will be acquired for phenotypic analysis of the many 
thousands of mouse lines generated in the coming years. 
 
The previous chapter outlined the role of !MRI techniques in non-invasive mouse 
phenotyping, which offer high-quality 3D images with high signal and contrast-to-
noise, giving typical isotropic resolutions of 20-50!m. However the resulting 3D 
dataset for a single mouse brain or embryo will typically consist of many hundreds of 
image slices. Over a number of subjects and mouse lines this quickly becomes a very 
large quantity of data.  
 
While an individual could visually inspect each dataset, in a similar manner to a 
radiologist giving a report of findings, (comparable to the typical use of histology in 
mouse studies), this restricts the use of the 3D data to a simple description and 
provides limited quantitative information. Thus there is a need for objective, numeric 
measures of phenotypic structural change, which is one role of image analysis. 
 
Additionally, while visual inspection may be a possibility for single or small groups 
of mutant mice, particularly those with obvious structural deformities, the sheer 
quantity of data may make such interpretation time-consuming and labour-intensive 
when many mice are imaged. Thus there is additionally a need for automated methods 
of image analysis to ease this burden. 
 
This chapter will outline some of the basic principles behind image analysis, giving an 
overview of some commonly used manual and more recent, automated methods.  
! -92- 
 
It should be noted that the application of automated methods to the analysis of 
preclinical MRI data is still at a relatively early stage of development with the first 
morphometric studies in the adult mouse reported only a few years ago. Use of such 
analysis in human studies is more established. Examples from both the human and 
mouse brain literature will therefore be described in this chapter. Additionally, the 
analysis of mouse embryo datasets is in the preliminary stages of development 
(Zamyadi et al., 2010), with our contribution (Cleary et al., 2010) discussed later in 
chapter 6.  
 
3.1 Manual Analysis 
The simplest way of analysing data is through a form of manual analysis. At the most 
basic level, this involves visual assessment of images for pathology by an experienced 
observer, similar to the way a radiologist would view and interpret data in the clinical 
setting. In phenotyping studies, the presence or absence of a particular structure may 
be tallied (and noted in a table) to give a measure of the incidence and penetrance of 
the phenotype in that population (such as in (Bamforth et al., 2004)).  
 
A more quantitative approach would be make measurements of structures of interest. 
With 3D imaging volumes, such as those produced by !MRI, one could measure 
volumes of specific of organ structures. Typically these regions are drawn by hand on 
each slice in turn in a dataset, by loading the dataset into an image analysis package 
(one well-known example is ImageJ, a public domain, Java-based image processing 
program) which has specific tools for this purpose. The subsequent regions may then 
be used to generate data on a number of phenotypic parameters, such as shape, 
volume or average signal intensity in the image. While this may be conceptually 
simple, in the case of !MRI datasets, hand drawing of structures in several, often 
complex regions of interest may take many hours and in less-sophisticated programs, 
the task of keeping track of the large number of regions in an animal may not be 
straightforward (a example of a manually segmented mouse embryo is shown below 
in Figure 3.1 (Dhenain et al., 2001)).  
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Figure 3.1: An example of manual segmentation of structures in a 3D !MRI dataset 
of a 13.5dpc mouse embryo. A) Single axial slice of the original MRI dataset, B) 
Outline of manually segmented regions, C) Resulting coloured labels delineating 
structures such as brain (pink), ventricles (light blue) and spinal cord (white). 
Adapted from (Dhenain et al., 2001). 
 
An additional problem with this type of manual regional analysis, particularly in 
larger studies, is the possibility of inconsistencies in the segmentation of structures 
(Riegler et al., 2010) either through errors by a single or multiple observers. 
Structures may be segmented differently by the same observer in the same dataset 
(resulting in so-called intra-observer variability) and or two observers may segment a 
particular structure differently (resulting in inter-observer variability). Regions with a 
small volume or those that are poorly visualised due to low SNR or limited contrast 
boundaries may be particularly affected. 
 
3.2 Semi-automated Segmentation Methods 
Given the time-consuming nature of manual analysis, many image analysis tools now 
offer additional options to assist manual segmentation. For example, by using image 
contrast and regional signal intensity, one may be able to demarcate structures on the 
basis of similar signal intensity between adjacent voxels. Simple algorithms based on 
signal intensity such as flood-filling, may be used to identify regions: starting from a 
selected ‘seed’ voxel and then selecting an area up to a surrounding contrast 
boundary. These are most effective when initiated within an enclosed tissue of interest 
with a relatively homogenous signal intensity range. After building up a series of 2D 
segmentations over a number of slices, a 3D interpolation scheme, such as marching 
cubes, can then generate a 3D reconstruction of the volume. Examples of such 
segmentation and reconstruction are shown in Figure 3.2 below. However, as may be 
seen in the figure, these methods are highly dependent on a well-defined contrast 
boundary surrounding the structure and manual correction is often required to give a 
truly accurate result. 
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Figure 3.2: Examples of a surface and volume rendering based on the selection of an 
area based on MR signal intensity. In A, the approximate exterior surface of mouse 
embryo has been readily segmented by this approach. Similarly, in figure B, the high 
signal intensity of the brain and spinal cord relative to surrounding tissue has 
allowed segmentation of the CNS. While the both embryo and CNS structures are 
selected, in both images there is evidence of the limitations of a simple intensity 
algorithm: in A, a small area at the top of the head of the embryo remains unselected; 
in B, the contours of brain are not well-defined due to erroneous inclusion of 
surrounding voxels with a similar signal intensity. Adapted from (Schneider et al., 
2003c). 
 
3.3 Automated Methods of Analysis 
As seen in the previous section, manual and semi-automated approaches may have 
limitations, particularly in the ability of a single operator to reproducibly delineate a 
large number of anatomical structures in a reasonable amount of time and in the many 
subjects needed for a complete study. Thus a more automated approach to data 
analysis is vital to increase throughput. 
 
The field of human brain research was one of the earliest to adopt computational 
morphometric techniques for identifying anatomical differences in a population. This 
has transformed research in the neuroimaging field, which accordingly has become 
the driving force for development of these automated methods. While initiated in 
human research, these methods are being increasingly applied to MRI datasets of the 
mouse brain (Carroll et al., 2011; Ellegood et al., 2010a; Kovacevi& et al., 2005; 
Lerch et al., 2010).  
 
The following sections aim to provide an overview of some of the automated image 
analysis techniques currently in use in preclinical imaging, going on to give examples 
of current applications, particularly in neuroscience.  
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3.4 The “Atlas”: an Overview 
Automated morphometric techniques for examining imaging data rely largely on 
image processing and statistical techniques but a central theme in their use is the 
notion of an ‘atlas'.  
 
The term has acquired a number of meanings throughout the years in the field of 
image analysis. In its traditional sense it may refer to an anatomical reference work 
mapping structure, typically comprising a high-quality series of images with 
descriptive labels. Alternatively this term has more recently been used to describe a 
(usually digitised) high-quality image of an organ or body structure, such as the brain, 
contained in a fixed conceptual 3D space defined by coordinates that mark key 
reference structures. Furthermore, this atlas may be based on characterisation of 
images from the anatomy of a single individual or a composite of a multiple subjects.  
 
Since the time of Brodmann who produced his seminal work detailing the functional 
brain regions by detailed histological analyses to demarcate cytoarchitecturally 
distinct areas (Brodmann, 1909) there has been a strong desire to create a formal 
taxonomy of brain regions (Zilles and Amunts, 2010). An extension of this is the 
Talairach brain atlas, which was initially created to provide a stereotactic framework 
for neurosurgery.  
 
Conceived by Jean Talairach in the 1960s, the Talairach atlas was the documentation 
of a histological analysis of a 60 year-old female brain (Talairach and Tourneaux, 
1988), identifying specific brain regions in a stereotactic coordinate system, defined 
by a line drawn between anterior and posterior commissures. The atlas was originally 
intended as useful guidance for surgery and surgical planning, as functional regions 
may then be avoided, for example in the surgical approach taken for excision of a 
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Figure 3.3: Coronal section from the Talairach atlas showing an example of its use in 
treatment planning. Coloured and numbered regions show brain structures as 
identified from histology, with numbers corresponding to Brodmann areas. The green 
circle on the right, indicates a hypothetical lesion near the corpus callosum (purple). 
The arrows indicate two possible approaches, the first through Brodmann area 6, the 
second though area 24.  (Adapted from (Talairach and Tourneaux, 1988)) 
 
In the early 1990s, a perceived crisis in the slow development of brain mapping 
techniques lead to a call for new investigational tools, particularly those using the 
emerging field of MRI (Crick and Jones, 1993). This lead to the adaptation of 
Talairach’s work to further the goal of a defined anatomical system for non-invasive 
brain imaging studies. In the wake of these demands, brain atlases using MRI were 
also constructed, resulting in a number that are still in current use, such as those 
developed by the Montreal Neuroimaging Institute (MNI). Their initial datasets had a 
specified coordinate system (MNI coordinates, which while not identical is readily 
converted to Talairach coordinates – seen in Figure 3.4 below) and comprised two 
datasets. The first is a high quality dataset of a single subject, scanned repeatedly and 
averaged and the second is a composite of many subjects and both sexes (Figure 3.4). 
A population atlas is necessary, given the brain is a complex and convoluted structure 
resulting in numerous subtle differences between individuals of both sexes. This 
makes a single subject atlas alone highly subjective in reporting findings and is also 
needed to determine normal anatomical variation. 
  
This use of a common coordinate space for images is an important concept in modern 
neuroscience. It allows the findings of studies to be reported in a common image 
space. For example, regions of activation in functional MRI studies are often reported 
in terms of MNI coordinates so researchers worldwide may then identify the exact 
location on a corresponding histological and multimodal atlases. An ideal scenario in 
preclinical studies would be to emulate this with a standardised reporting structure in 
order to ease interpretation of phenotypic differences identified amongst the many 
groups of researchers worldwide.  
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As has been stated, defining anatomy from a single subject may be misleading due to 
the high degree of natural anatomical variation, especially in the brain. This has led to 
an increase in the use of population brain atlases where variations in the population 





Figure 3.4: Illustration of the correspondence of equivalent images from the 
Talairach Atlas (top), an average image of an atlas comprised of 305 subjects in MNI 
space (middle). Images from both atlases overlaid illustrating the possibility of 
conversion between them. Adapted from (Collins, 1994). 
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3.5 Atlas Space in Preclinical Studies 
As has been seen in the previous sections, atlas space is a volume with a defined 
coordinate system that study datasets will become aligned in. Atlases are particularly 
useful in population studies and they may be used to define several modalities into the 
same space. 
 
Much work in recent years has been towards the goal development of equivalent 
histological, registration and atlas tools for use in preclinical imaging, with a number 
proposals suggested by groups worldwide. For example, most recently Johnson et al. 
proposed a new mouse atlas environment – termed Waxholm space (Johnson et al., 
2010) – as an equivalent to Talairach space for mouse neuroscience studies. This is 
comprised of high-resolution multimodal datasets (~20!m isotropic resolution), 
regional volume segmentations and a registered histological volume, all from the 
same individual brain.    
 
3.5.1 Registration 
In order for these atlases to be produced, image registration techniques are necessary 
to computationally combine images from multiple subjects or modalities. More 
recently improvements in image registration and advances in computing hardware 
have enabled the registration of large !MRI datasets and thus the creation of high 
resolution atlases in the preclinical field. It is registration that also enables the 
automated methods of morphometric image analysis, which will be discussed later in 
this chapter. 
 
Image registration is the technique of spatially transforming an image in order to align 
it exactly with another. In a typical patient study, the goal is usually to align single or 
multimodal images of the same subject. In population studies, such as those 
performed in phenotyping studies, multiple subjects are registered together in order 
for anatomy to be easily compared. This is a more complex problem due to 
anatomical variation in a population. 
 
More formally, registration can be described as an algorithm that computes a 
transform (T) that specifies the mapping needed to align voxels in one image (usually 
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termed the source image) to another (usually called the target image). This is 
illustrated graphically in Figure 3.5 below. 
 
 
Figure 3.5: Schematic illustration of the simplified intended result of image 
registration: computation of an appropriate transform T that best maps the voxels in 
Image A to those in Image B. 
 
Such algorithms are usually iterative, with the process of determining the correct 
transform requiring a series of small changes to the transform used on the source 
image to produce increasingly accurate estimates of alignment until an adequate 
match with the target is reached.  
 
The registration of two individual images is a relatively straightforward process, 
however, the process when registering multiple subjects, although similar, is 
computationally more complex. One such methodology is known as groupwise 
registration and is the approach used in the later chapters of this thesis. This method 
has the advantage of avoiding the use of one target image, which may introduce bias 
into the final result.  
 
In groupwise registration, an average is taken of all images, which becomes the target 
image. After an initial registration is attempted (with all starting images now source 
images), the average is then regenerated and used as the new target. This process 
continues indefinitely until convergence of the transformed datasets – i.e. there is now 
little change in the transformations after each successive iteration. One guide to the 
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quality of groupwise registration is to look at the average of all transformed images in 
the group after registration. This will be initially very blurred (reflecting an average of 
misaligned images) but after successive iterations will become sharper and no longer 
change visually with each iteration, indicating that convergence has been reached. A 
similar, but more objective measure, is to examine the coefficient of variation of 
voxel signal intensity over all voxels in an image between all subjects which will be 
low when images are well aligned.  
 
Four key processes are needed at each stage of the registration process (taken from 
(Crum et al., 2003): 
1.  A similarity or error measure describing the “goodness” of the match 
2.  A transformation model  
3. An interpolation strategy to convert the new image to the defined grid of 
voxels that make up an image. 
4. A way of finding the transformation parameters that maximises the similarity     
measure. 
These processes will be discussed in greater detail in the sections below.  
 
3.5.2 Similarity measures 
In order to identify that a good correspondence has been achieved in the registration 
of one’s images, a similarly measure that indicates the correspondence must be 
calculated.  
 
At a basic level image registration is the activity of maximising similarity between 
two sets of images. One way of achieving this is to maximise the shared information 
between the two. If one were to combine a set of perfectly aligned images it would be 
conceivable that such a combined image would look similar to the source images with 
every structure in precise overlap. Conversely a poorly aligned image will have very 
little overlap. If one were to subtract images, in the first instance there will be very 
little residual ‘information’, in the second there is a great deal. Maximising this 
‘mutual information’ between the source and target images that allows its use as a 
similarity measure. A similarity measure regarded as particularly robust and is often 
used for intra-subject, multimodal registration is known as normalised mutual 
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information (NMI) (Studholme et al., 1999). NMI relies on a concept known as joint 
entropy. In simple terms, this is a quantity that is an expression of the probability of 
finding the same number of voxels with a certain signal intensity range in one image 
as compared to the other. This is calculated from a joint histogram (which plots voxel 
signal intensity in two images against each other for a particular voxel coordinate). 
Intuitively, a focused, near-linear relationship would be expected for two intra-modal 
images that were well-aligned (as voxels for a given (x,y,z) coordinate in both images 
will have the same signal intensity).  
 
3.5.3 Registration: the Transformation Model  
In the creation of a population atlas, there are 3 parts to the registration process, 
involving 2 global registrations: initial spatial alignment using rigid registration and 
affine registration; and finally the third local, non-linear registration. 
 
3.5.3.1 Rigid 
The first part of any registration protocol is rigid registration. The goal of rigid 
registration is to redefine all datasets into a common space and remove any large 
spatial differences. One aspect of the registration procedure is that any initial bias 
between subjects due to alignment is removed before future registration steps that will 
go on to assess size differences. Usually a particular subject is chosen as the target 
image for the registration.  
 
Rigid registration optimises two parameters: rotation and translation (giving 6 degrees 
of freedom) to produce the optimal alignment. 
 
3.5.3.2 Affine 
Affine registration continues the registration process after the spatial normalisation 
achieved with rigid registration. In addition to translation and rotation, shear and 
linear scaling of the datasets are now optimised, resulting in 12 degrees of freedom. 
 
3.5.3.3 Non-linear 
Once the global registration using rigid and affine registration is complete, and any 
large differences between images removed, a non-linear transformation model is then 
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used which registers the images locally (at a voxel level). This has the effect of 
aligning fine structural details in the images together.   
 
Non-linear (also known as non-rigid) registration is the most complex of the 3 
registration stages as deformations across the whole image need to calculated and 
optimised, and as a result is very sensitive to the algorithm being applied. An example 
of a successful algorithm is recent years is that of free form deformation (FFD) 
(Rueckert et al., 1999). 
 
The basis of FFD and similar algorithms is the optimisation of a 3D grid of local 
control points over the image. Manipulating a control point warps voxels in its 
controlled area, allowing local features in the image to be aligned between subjects. 
After making a number of small adjustments to control points across the image, the of 
NMI value between the image and the average is then assessed. This process is then 
repeated until NMI is maximal. 
 
The large number of control points spread over a number of subjects in large MRI 
datasets representing many millions of degrees of freedom.  However, recent 
advances in cluster computing and graphics processing units (GPUs) have finally 
enabled implementations of these algorithms which have reduced the required 
processing times down from many days to a few hours (Modat et al., 2010). 
Importantly, it is from this registration process that parameters will be acquired that 
will be used in subsequent morphometric analyses. Thus, it is vitally important that 
the registration is accurate. A summary of the registration process in creating an 




Figure 3.6: Demonstration of stages during registration of 3 embryos to create an 
atlas. As seen in the top row, embryos are acquired in differing orientations in the 
MRI scanner. First these global differences are corrected using linear, i.e. rigid and 
affine models (orange box, second row). As each stage progresses, the average of all 
embryos becomes progressively sharper, with the non-linear registration allowing the 
most accurate mapping of local anatomy by the 15th iteration and producing the 
sharpest average atlas. 
 
3.5.4 Interpolation 
One problem with image registration is that the calculated transformation, such as in 
the case of a rotation or a scale term will require manipulation of the image in order to 
often calculate at a sub-voxel scale in order to appropriately align the two datasets. 
This causes difficulties in that the resulting transformed image must be represented in 
the defined voxel matrix of the original target image. For example, if a linear rotation 
is applied to an image, it is likely that voxels in the transformed source image will fall 
between existing voxels in the target. Interpolation is then needed to determine the 
value of the new voxel value at this point. A number of schemes are in use, of varying 
complexity such as nearest neighbour (the simplest), linear interpolation, sinc 
functions and splines. The scheme used is dependent on the application, need for 
resulting smoothness and limitations of processing time/complexity.  
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3.5.5 Final Transform and Deformation Field 
After the optimisation of all 3 stages in the registration process, the matrices 
describing each individual’s image voxels and their mapping on to the calculated 
average image are saved in the form of a 3D deformation field. This specifies how 
each voxel in the original image has been to be manipulated in order to map to the 
average atlas of all images.  
 
 
Figure 3.7: Illustration of the deformations calculated in image registration. In the 
leftmost image, the average of a number of mouse embryos after non-linear 
registration is seen. An arbitrary grid has been placed over the average image. In the 
individual image and associated deformation field, the deformations that have been 
calculated by non-linear registration algorithm needed to warp the individual embryo 
image to that of the average atlas of all subjects are shown. 
 
3.6 Applications in MRI:  Image Quality Improvement 
One basic application of image registration is its ability to improve image quality, 
through the combination of multiple images of the same subject. As previously 
discussed, once a coil, preparation protocol and a fixed TR has been chosen, SNR 
improvement in MRI is generally only possible through the averaging of multiple 
image datasets to reduce the effect of noise.  
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Images of a single brain from multiple acquisition sessions have been registered in 
this manner in order to produce a high-quality 3D image for the construction of a 
mouse brain atlas for anatomical use ((Keller et al., 2010), Figure 3.8). This follows 
earlier work in human studies, such as the commonly-used MNI dataset, colin27, 
which is a single subject scanned multiple times and the acquisitions registered in 
order to provide a high-quality anatomical image for structural correlation (Holmes et 
al., 1998). The improvement in image quality with multiple images is shown in Figure 
3.9. 
 
[Figure removed due to copyright] 
 
Figure 3.8: Composite images and segmentation of cerebellar lobules and dorsal 
hippocampus of a mouse brain dataset acquired as part of an MRI anatomical atlas 
project. Images are registered average of 8 separate 3D acquisitions of the same 
mouse brain acquired on a 16 Tesla system. Adapted from (Keller et al., 2010). 
 
[Figure removed due to copyright] 
 
Figure 3.9: Example of the improvement in image quality seen after the use of image 
registration to average multiple MR acquisitions of a human subject. A & B: T1-
weighted Images of an individual after a single multi-slice acquisition at 0.7mm and 
1mm slice thickness respectively. C & D: Corresponding images (0.7mm and 1mm 
slice thickness) after registration and averaging of 27 separate acquisitions. Adapted 
from (Holmes et al., 1998) 
 
3.7 Multiple Subject Atlases and Segmentation-propagation 
Registration of multiple subjects also enables the use of the average atlas image as a 
high-resolution population atlas (Dorr et al., 2008). As this average is also a 
composite of multiple acquisitions, image SNR is greatly increased in the regions 
common to all subjects.  
 
Additionally, as affine and voxelwise mappings are available for all individuals in the 
dataset, segmenting the atlas into regions of interest, allows a measure of the 
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volumetric variation of structures in the population to be readily available. This is 
known as segmentation-propagation. 
 
As has been seen previously, manual quantification of structure volumes is a useful, 
although time-consuming measure of phenotype in MRI data. However the technique 
of segmentation-propagation uses registration to greatly speed up the process. In this 
method, a number of segmentations are drawn on the high-quality average atlas 
(Calmon and Roberts, 2000; Dorr et al., 2008). As the transformation and Jacobian 
values are known which give a 1:1 mapping of regions on the average image and 
equivalent areas on the individual subjects’ datasets, this then allows volumes to be 
measured in all individuals automatically. An example of a comprehensive mouse 
brain atlas comprised of multiple subjects is shown in Figure 3.10 below. This 
consists of 40 C57BL6/J individuals (20 male and 20 female) and 62 segmented 
regions. 
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Figure 3.10: An example of the segmented regions in a C57BL6/J mouse brain atlas 
comprised of 20 males and 20 females. 3D volume rendering image (A), coronal (B), 
sagittal (C), axial (D) and 3D inferior views (E). 
Once an atlas brain has been segmented in this manner, similar datasets from a new 
study may then be registered to it, allowing the reporting of volumes in those new 
datasets and identification of structures. To this end, a number of segmented brain 
atlases are freely available online (Dorr et al., 2008; Johnson et al., 2007; MacKenzie-
Graham et al., 2004). 
 
3.8 Use of the Deformation Field for Morphometric Studies 
While a number of MRI studies have demonstrated gross anatomical changes in 
neuroanatomical mouse models, showing features such as ventricular enlargement, 
indicating atrophy and volume loss is taking place in the brain. Automated imaging 
analysis techniques may go a step further to identify the specific areas elsewhere in 
the brain that are reducing in volume.  
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An early use of deformation fields in human studies has been in the examination of 
local, progressive structural brain changes, for example in the tracking of longitudinal 
changes in patients with Alzheimer’s disease (Figure 3.11, (Fox et al., 2001). 
 
[Figure removed due to copyright] 
 
Figure 3.11: Coronal MRI slices showing regions of relative compression or 
expansion after registration of serial images after an interval of 11 months (control 
subject) and 14 months (patient with Alzheimer's disease). In the patient, the 
expansion of ventricles and contraction of cortical regions may be readily visualized. 
Adapted from (Fox et al., 2001). 
 
3.9 Tensor-based Morphometry 
Going a step further than intrasubject comparison, the deformation fields may be used 
to make comparisons between groups of subjects, on a voxelwise basis. This type of 
statistical morphometric analysis is termed tensor-based morphometry (TBM). 
 
TBM offers unbiased approach, as only the final local deformation field, generated 
automatically by the non-rigid registration process, is typically used for the statistical 
analysis, without any human intervention. A simplified diagram of the process is 




Figure 3.12: Simplified schematic flow diagram of a TBM study comparing two 
groups of embryos. Initially, images from both groups are registered using iterative 
registration, as has been described in previous sections, into an average atlas. 
Deformation fields are saved for each individual. Morphometric information from the 
fields can then be compared between populations in order to look for significant 
structural differences. 
 
Tensor-based morphometry relies on the local deformation field acquired during non-
rigid registration. More specifically, from these a numerical value expressing 
compression or expansion at a particular voxel can be calculated, known as the 
Jacobian determinant (measures of expansion and contraction over the image) as 
calculated by the registration transform. By simple t-testing, the values of the 
Jacobian determinant may then be compared between groups. 
 
More formally: for transform (T1) for a specific point in the image (x,y,z), the 
Jacobian (J1) is the first-order differential.  
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Taking the determinant of J1 (det J1) gives us a scalar quantity that gives a relative 
measure of the total volume expansion or contraction experienced by that voxel. A 
value of <1 indicates contraction of the voxel; >1 indicates. This is graphically 
illustrated in Figure 3.13 below. 
 
 
Figure 3.13: Illustration of the Jacobian determinant (det J) after the application of 
a non-rigid transformation (T) to a 6x6 grid of squares. The relative area inside two 
of the grid squares, before and after transformation, are highlighted in red and blue. 
In the case of the red square post-transformation, there has been an increase in area 
relative to its original size, thus the Jacobian of the red square is >1. Conversely the 
area of the blue square has reduced can be seen to have reduced relative to its 
original size, resulting in corresponding Jacobian value of <1. Modified from 
(Zamayadi, 2010) 
 
Making maps of the Jacobian determinant (commonly referred to as Jacobian maps or 
simply ‘Jacobians’) for each individual gives information about local structural 




3.9.1 Analysis and Presentation of Deformation Data 
In order to interpret the findings of morphometric studies, a method of representing 
the regions of significant findings called statistical parametric maps is employed. A 
piece of software known as Statistical Parametric Mapping (SPM, Functional Imaging 
Laboratory, UCL) is commonly used for this purpose. 
 
In order to analyse imaging datasets, the SPM software package employs a general 
linear model (GLM), which has been successfully used in a large number of previous 
studies. The GLM incorporates a statistical test (such as a conventional t-test), but 
also associated covariates that may change interpretation of the data. For example 
additional variables, sex and age, may have an effect on the Jacobian determinant 
seen in an image voxel, in addition to genetic background.  
 
The general form of the GLM is: 
 
(Eq. 3.1)  Y=XB + U 
 
Where Y is a matrix consisting of Jacobian maps from all averaged individuals in the 
study, X is a design matrix for the study (specifying information such as the 
phenotype or gender of the individual in the corresponding map), B is a matrix 
containing the parameters that are to be estimated and U is a matrix containing error 
or noise data.  
 
After analysis of data, results are then reported pictorially, in the form of a high-
quality image of the average atlas with a coloured overlay consisting of regions that 
are statistically different (volumetrically compressed or expanded) between study 
groups after accounting for covariates. This is termed a statistical parametric map. 
 
As can be envisaged by the need for parametric testing over Jacobian determinants in 
all voxels of an image, a significant issue is that of multiple comparisons. A large 
proportion of these may result in regions of significance at the 5% level due to 
chance. Corrected p-values are therefore often used in statistical maps, typically using 
false discovery rate (FDR (Genovese et al., 2002)) which reduces the number of type I 
errors (the incorrectly rejected null-hypotheses). 
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3.9.2 Use of Morphometric Techniques in Investigating Anatomical Changes 
As the statistical maps are generated over the whole image, the analysis is 
independent of the research question involved, allowing a wide variety of 
applications. In human studies differences in behaviour often manifest in a 
corresponding change in neuroanatomy, and may be detectable on MRI (Nieman et 
al., 2007). In human MR, statistical studies have allowed the identification of subtle 
differences, notably showing an increased hippocampal volume in the brains of 
London taxi drivers (Maguire et al., 2000) compared to control subjects from the 
general population.  
 
As the current preclinical mouse literature is developing, the adult mouse brain was 
the first to be analysed by morphometric techniques. Once a data-processing pipeline 
has become established it is relatively easy to generate experimental paradigms that 
can then be studied. Recent work have produced new insights into differences in the 
adult mouse brain including: sex and strain differences (Chen et al., 2006), 
hemispheric asymmetry (Spring et al., 2010) and phenotyping studies of transgenic 
and knockout mice (Badea et al., 2009; Ellegood et al., 2010a; Lerch et al., 2008). 
 
Indeed, while this approach is often applied to MRI datasets it should be stated that 
these techniques are modality independent and may also be applied to other imaging 
data types such as mouse skull analysis from !CT data (Nieman et al., 2006). 
 
3.9.3 Specific Applications of Morphometric Techniques in Preclinical MRI 
As morphometric methods are able to compare the volumetric and signal intensity 
differences between groups over the many millions of voxels in an image, these 
analyses have the ability to identify small local neuroanatomical differences. 
 
Given the utility of these approaches in clinical studies, this has more recently been 
applied to preclinical studies and has led to novel neurological findings in mouse 
models. For example, recent morphometry studies have shed new light on mouse 
models of Huntington’s disease (HD). While previous studies of HD have utilised 
MRI, they have used gross measures of phenotypic change, such as ventricular, 
striatal and total brain volume, as these structures are easily visualised for manual 
measurements. Using a TBM approach, confirmed by histology, studies by Sawiak et 
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al. (Sawiak et al., 2009a, b) have been able been able identify regions of significant 
volume change in specific striatal regions that may result in the observed ventricular 
enlargement (Figure 3.14 below).  
 
[Figure removed due to copyright] 
 
Figure 3.14: 3D reconstructions of the striatum in the R6/2 model of Huntington’s 
Disease after morphometric analysis.  Coloured regions show the F-score of volume 
areas with significant volume differences between groups with the threshold set at 
p<0.05 (FDR corrected). The 3D striatum is shown superimposed on axial (A) and 
coronal (B) slices from the atlas. Panel C shows the striatum in a 3D ‘glass’ brain. 
Panel D shows magnified views of the left striatum (Str), with significance set at 
p<0.05, p<0.01 and p<0.0025 respectively. Adapted from (Sawiak et al., 2009b) 
 
Recent work has also shown the utility of ex-vivo morphometric studies in 
investigations of memory and learning. In one recent study, where mice were given a 
Morris water maze learning task, TBM was used to identify regions of volume 
expansion in the hippocampus. This indicates that TBM analysis of high-resolution 
anatomical MR images may be sensitive enough to detect neuroanatomical changes 
brought about by learning tasks after only 5 days of training (Lerch et al., 2010). 
 
[Figure removed due to copyright] 
 
Figure 3.15: Representative coronal slices through a mouse brain after a Morris 
water maze-training task in the mouse. After 5 days of training, the statistical 
parametric maps of significant regions after a group ANOVA shows volume increase 
in a number of structures, and particularly in the hippocampus compared to 
untrained controls. Adapted from (Lerch et al., 2010). 
 
3.10 Future Horizons 
As has been seen in the previous sections, the application of automated techniques, 
such as segmentation propagation and tensor-based morphometry to preclinical MRI 
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data, are exciting developments, and have allowed relatively rapid, non-invasive 
phenotyping in the mouse brain. 
 
3.10.1 Mouse Brain 
However although MNI coordinate space has now become the de facto standard for 
the reporting of human MRI studies and the framework for new histological atlases 
(Amunts et al., 2000) there has yet to be a standardised atlas system for the adult 
mouse brain. As shown previously, a number of groups have suggested frameworks 
based on the volume segmentation of single brains (Johnson et al., 2010) with 
histological correlation, while others have performed detailed segmentations of 
average datasets of multiple subjects (Dorr et al., 2008). As mouse phenotyping is an 
international endeavour, a standardised system of reporting and analysis would be 
advantageous. Which atlas becomes the standard will be of some debate in future but 
as with the MNI atlas, a detailed histological correlate (giving a mouse equivalent of 
Talairach) may be the most compelling factor. 
 
3.10.2 Mouse Embryo 
A digital stereotactic framework for analyses of the mouse embryo are very much in 
the preliminary stage, with only two papers demonstrating the feasibility of 
computational techniques to these datasets so far. With the continued interest in the 
study of development and the basis of congenital disease, this unmet need will no 





Optimisation of High-Throughput Cardiac !MRI in 
Ex-vivo Murine Embryos 
4.1 Chapter Outline 
As stated in previous chapters, in recent years MRI has become increasingly used for 
phenotyping mouse embryos, especially in cardiovascular disease models. However, 
there have so far been very few studies that investigate the optimal preparation and 
scanning parameters required for heart imaging using contrast-enhanced !MRI.  
 
This chapter is a study to determine the optimal preparation and scanning parameters 
for gradient-echo imaging of transgenic mice, in order to improve the sensitivity to 
subtle anatomical defects. 
 
4.2 Introduction 
The mouse is a key model for research into human disease and is ideally suited to 
genetic study, as the genome (Mouse Genome Sequencing Consortium et al., 2002) 
and techniques for manipulating its sequence are readily available (Balling, 2001; 
Capecchi, 2001). A number of large-scale programmes are underway to create 
transgenic knockout models for each of the approximately 25,000 mouse genes 
(International Mouse Knockout Consortium et al., 2007). This increasing use of 
genetically modified mice has highlighted the need for techniques to rapidly 
characterise the new morphological phenotypes presented in these models. 
 
Congenital heart defects (CHDs) are a group of conditions amenable to such genetic 
study. They affect over 1% of live births and are responsible for complications 
immediately from birth through to later adult life (Hoffman and Kaplan, 2002). 
Inheritable gene mutations and chromosomal effects are the direct cause of nearly 
20% of CHDs. While the basis of remaining so-called sporadic conditions is 
uncertain, epidemiological studies demonstrate an increased risk of CHDs in siblings 
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and offspring of those affected. This illustrates there is potential genetic involvement 
even in these cases (Bentham and Bhattacharya, 2008). 
 
Modified-mouse embryos are an ideal way of studying these types of disease during 
development. Given the high number of potential mouse variations in the future, 
effective methods of phenotyping embryos are essential. Conventionally this is done 
ex-vivo by microscopic examination with histology, where embryos are dehydrated, 
wax embedded and thinly sectioned (2-8!m) (Kaufman, 1992). This provides high-
resolution 2D data and sections that may also be stained for gene and protein 
expression. Episcopic imaging is a refinement of this process, where autofluorescence 
of each tissue slice can be photographed and combined to generate high-resolution 3D 
volume datasets (1-2!m isotropic resolution) (Weninger et al., 2006; Weninger and 
Mohun, 2002). However these histological approaches are time-consuming and do not 
lend themselves readily to rapid screening as only one embryo may be imaged at a 
time. 
 
A further complication is that a phenotype may be largely unknown (Nolan et al., 
2000) or incompletely penetrant, meaning that a particular genotype does not 
necessarily lead to a phenotypic effect. Therefore relatively large numbers (10s to 
100s) of embryos are sometimes needed to gain a good measure of the prevalence of 
the phenotype in a population (Schneider and Bhattacharya, 2004). Thus a high-
throughput phenotyping technique is essential to meet the demands of modern 
molecular medicine. 
 
Microscopic MRI (!MRI) – high-resolution imaging at an isotropic resolution of 
<100!m (Kim et al., 2009) – is powerful technique allowing assessments of both 
embryo development (Petiet et al., 2008) and  phenotype (Goddeeris et al., 2008). 
High-throughput, !MRI screening can be achieved with multiple mid-gestation 
embryos (up to 32 simultaneously) in a single 12-hour scan at a ~25!m resolution 
(Schneider et al., 2003c; Schneider et al., 2004). Full 3D datasets for all embryos are 
created allowing structures to be visualised relative to one another. In this method, 
embryos are fixed in MRI contrast agent, improving signal to noise and thus image 
quality.  Other methods of whole embryo imaging include microscopic computed 
tomography (!CT) (Holdsworth and Thornton, 2002; Johnson et al., 2006) and optical 
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projection tomography (OPT) (Sharpe, 2003). !CT allows high throughput but suffers 
conventionally from the limited range of linear attenuation coefficients in soft tissue, 
impairing detailed visualisation (Takeda et al., 2000). OPT can provide detailed 
images of gene expression, but requires translucent skin tissue and its use in older 
embryos (>13.5dpc) that are more opaque is limited (Schneider and Bhattacharya, 
2004).  
 
Furthermore, it has been shown that heart development is complete only after this 
stage, with septation occurring by 15.5dpc (Kaufman, 1992; Schneider et al., 2003b).  
 
High throughput MRI screening is a new and improving technique, yet there is limited 
information on the optimal MR and preparation parameters for embryo studies. The 
few previous studies have investigated either qualitative optimisation of MR 
parameters or embryo preparation in isolation (Petiet et al., 2007; Schneider et al., 
2003c). Here described are the results of a combined study, assessing the effect of 
contrast agent concentration, fixation time and MR acquisition parameters for 
imaging the embryo heart. These parameters then used to identify abnormalities in a 
preliminary MRI screen of mouse embryos heterozygous for the gene Chd7, a 
transcription factor implicated in CHARGE syndrome (Bosman et al., 2005) – a group 
of associated congenital abnormalities affecting approximately 1 in 10,000 human 
live births (Blake and Prasad, 2006). The syndrome is characterised by defects in a 
number of organs including the cardiovascular, eye and vestibular systems. The Chd7 
embryos used were created using gene trapping, a method not previously reported for 
this disease model. 
 
4.3 Materials and Methods  
4.3.1 Animal Preparation 
All parts of this study were carried out in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. Successfully plugged pregnant female mice were sacrificed by 
cervical dislocation at 15.5dpc. The embryos were removed from the mother and 
placed in 37°C Hanks (Sigma-Aldrich Company Ltd., Gillingham, UK) solution and 
bled out after cutting the umbilical cord. Care was taken to avoid blood clots in the 
umbilical vessels. The embryos were then immersed in ice-cold 4% paraformaldehyde 
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solution (Sigma-Aldrich Company Ltd., Gillingham, UK), doped with gadolinium-
diethylene triamine pentaacetic acid (Gd-DTPA, [Magnevist], Bayer-Schering, 
Newbury, UK) and placed on a rotator. After a period of time, the embryos were 
removed and embedded in a 1% agarose gel – doped with identical concentration of 
Gd-DTPA to fixation – in a 50ml centrifuge tube. The tube diameter at the widest 
point was 31mm. 
 
For MRI optimisation: Six groups of CD-1 embryos fixed for 3-days (in 2 and 4mM 
Gd-DTPA) or 2-weeks (at 2, 4, 8 and 16mM). Six embryos were used for each 
fixation-time/concentration per tube. 
 
Transgenic screening: 13 transgenic Chd7 embryos (n=5 +/+, n=8 +/-) at 15.5dpc 
were then prepared in an identical fashion to the CD-1 embryos but fixed and 
embedded in media containing 8mM Gd-DTPA (2 week fixation period). The Chd7 
gene in these mice was inactivated using a gene trap method (International Mouse 
Knockout Consortium et al., 2007). Mice were maintained on a C57BL/6 background 
and were backcrossed to this background for at least 5 generations. Any embryo 
subsequently identified with heart abnormalities was wax-embedded and sectioned 
into 10!m axial slices. Heart slices were then stained with haematoxylin and eosin 
(H&E).  
 
4.3.2 MR Acquisition 
Embryos were scanned using a Varian 9.4T VNMRS 20cm horizontal-bore system 
(Varian Inc. Palo Alto, CA, USA), using 40G/cm imaging gradients. A 39mm 
quadrature birdcage coil (RAPID Biomedical GmbH, Würzburg, Germany), was used 
for both volume transmit and receive. Tuning and matching of the coil was performed 
manually; flip angle and shim were automatically calibrated but both parameters were 
checked for consistency between experiments. Sample temperature (measured during 
a full 10-hour 3D gradient-echo scan) was 22.5±1.0°C. 
 
4.3.3 Measurement of Tissue Parameters 
To provide tissue information for the optimisation, T1 and T2* maps were created 
using a single sagittal slice (FOV 27 x 27mm, 2562 matrix size, 0.5mm thickness). For 
T1 mapping, inversion-recovery spin-echo with a global adiabatic pulse was used. T2* 
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mapping was performed with a standard 2D gradient echo sequence with each TE 
acquired as a separate acquisition.  
 
For the 3-day-fixed embryos, parameters were: T1 mapping: 10 TIs, range 20-2700 
ms, TE=11.75ms, TR=5000ms, NSA=2. T2* mapping: 10 TEs, range 20-120ms, 
TR=5000ms, NSA=2 
 
For 2-week data: T1: 13 TIs, range 6-450 ms, NSA=7; T2*: 13 TEs, range 3.5-40ms, 
TR=750-1000ms, NSA=7.  
 
TI and TE spacing was adjusted slightly for each concentration to counter reductions 
in T1 and T2* with contrast agent, especially at higher concentrations. TR was chosen 
to be at least 5x T1. 
 
T1 and T2* maps were created by a pixel-by-pixel, least-squares fit of the resulting 
data using in-house C-programs. Image pixels were assigned a zero value when the 
tissue signal to noise was similar to background, or when the range of TI times 
(optimised for the heart) was inappropriate for the tissue T1, resulting in occasional 
dark pixels in the T1 maps (Figure 4.1). 
 
Given the potential for partial volume in the maps of the chamber lumen (due to small 
heart size), background agarose was used as a surrogate for extracellular/interstitial 
fluid. This assumes that the penetration of the contrast agent in the fluid regions in the 
heart was similar to background at the time of image acquisition. 
 
Proton density mapping (M0) was carried out on the 2-week-fixed embryos, 2mM 
concentration, using a single-slice spin-echo with multiple TE acquisitions 
(TR=1000ms, 10 TEs, range 6-80ms, NSA=2). Signal intensities from heart (n=3) and 
agarose regions of interest were fitted against an exponential to determine the signal 
at TE=0ms. This was used to produce a ratio of M0 between agarose and heart tissue. 
 
Calculation of Linewidth 
Linewidth was calculated from T2* values using (25):   
(Eq 4.1)    
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Relaxivity Calculation  
Tissue-specific relaxivity of Gd-DTPA (R) was determined by fitting mean values of 
T1 and T2* in agarose and heart regions of interest to a linear model, at 2-weeks 
fixation, in accordance with (Stanisz and Henkelman, 2000): 
 
(Eq. 4.2)   
 
4.3.4 Contrast Optimisation by Computer Simulation 
The 2-week-fixed embryos at four Gd-DTPA concentrations were used for contrast 
optimisation between embryo heart and chamber lumen. 
 
To determine contrast between the heart muscle and chamber, the signal equation for 
spoiled-gradient echo imaging (Pelc, 1993) (Eq. 4.3) was used as part of a Matlab 
(Mathworks Inc., Natick, MA, USA) script to calculate theoretical signal. 
 
(Eq. 4.3)    
 
 
$ is the excitation pulse flip angle. T1, T2* values were measured at each 
concentration and inserted into the equation as constants. 7 different TRs, with an 
appropriate number of signal averages (NSA), were trialled. These ranged from 
TR=20ms (with 7 averages) to TR=137ms (1 average). These values gave an overall 
scan time of 10 hours in each case (given a 5123 matrix size). 
 
Assuming "NSA increase in signal-to-noise ratio (SNR) with NSA averages, Eq. 4.3 
can be extended to:  
 
(Eq. 4.4)   
 
 
The noise level was assumed to be constant throughout the acquisition. At these 7 
fixed TRs, CNR and SNR were calculated for heart muscle and chamber over a range 
of TEs (permitted by the system, typically 5-25ms) and flip angles (0-90°) for a fixed 
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bandwidth. The maximum CNR was defined as the greatest SNR difference between 
the two tissues (SNRchamber–SNRheart) occurring over the range of scan parameters. 
 
4.3.5 Volume Imaging 
All embryo volumes were scanned using an RF-spoiled 3D gradient echo sequence. 
Field of view was 27x27x27mm3 with a matrix size of 5123, giving an isotropic 
resolution of 52x52x52!m per voxel. A hard RF pulse (duration 100!s) was used for 
excitation and receiver bandwidth was fixed at 130Hz per pixel. Imaging time in all 
cases was a maximum of 10 hours. 
 
An initial 3-day, 4mM Gd-DTPA dataset was scanned with unoptimised parameters 
(TR=30ms, $=90°, NSA=4, TE=7ms) for general assessment of embryo contrast and 
anatomy. 
 
All concentrations of 2-week fixed embryos were scanned using parameters produced 
after contrast simulation. Embryos at 2mM concentration were additionally scanned 
with parameters – optimised for global embryo contrast – from previous studies in the 
literature (Schneider et al., 2003c) (TR=30ms, TE=10ms, $ =90°, NSA=4) for 
comparison. 
 
4.3.6 Image Processing 
The 5123 3D volume images were reconstructed on the console (VnmrJ v2.3, Varian 
Inc., Palo Alto CA, USA) and converted to Analyze format, using a custom C-
program, for review in ImageJ (National Institutes of Health, Bethesda, MD, USA). 
SNR and CNR were measured in a number of organs by taking the ratio of average 
signal in a whole-organ volume of interest (VOI) and the standard deviation in a 
region of background noise: 
 
(Eq. 4.5)  
 
4.4 Results  
Initially, the effect of Gd-DTPA concentration and fixation time on heart T1 and T2* 
values was assessed. This enabled image contrast simulations to maximise CNR in the 
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embryo heart. The parameters for optimum CNR were then applied to investigate 
heart defects in transgenic Chd7 embryos.  
 
4.4.1 Assessment of Concentration and Fixation Time 
To compare embryos prepared at two Gd-DTPA concentrations (2 and 4mM) and two 
fixation times (3-days and 2-weeks), T1 and T2* were measured in two regions of 
interest – embryo heart tissue and background agarose – from a sagittal-slice through 
three embryos. Figure 4.1 and Table 4.1 show T1 and T2* maps and values for each 
concentration and fixation time from the two regions of interest (heart and agarose). 
 
 
Figure 4.1: Single slice T1 and T2* maps for the two concentrations (2mM & 4mM) 
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Fixation on T1: NS  
Conc. on T1: p<0.0001 
 
Fixation on T2*: NS  
Conc. on T2*: p<0.0001 
Heart ROI T1 (ms) 
 
 

















Fixation on T1: p<0.0001 
Conc. on T1: p<0.0001 
 
Fixation on T2*: NS 
Conc. on T2*: p=0.0002 
 
Table 4.1: Summary of measured parameters in regions of interest (ROIs) in embryo 
T1 and T2* maps  
 
4.4.1.1 Effect of fixation time: 
The length of fixation time affected heart tissue by reducing T1 at both concentrations. 
For example, at 2mM T1 reduced from 172ms at 3-days to 136ms at 2-weeks 
(p<0.0001). A reduction was also seen in T2* in the heart for the 2mM groups, 
although this was less than the change in T1. No significant T2* change was detected 
between the 4mM heart groups (3-days and 2-weeks). Agarose T1 did not 
significantly change with fixation time, which is expected as agarose preparation was 
independent of embryo fixation, using fixed Gd-DTPA concentrations. Figure 4.2 
shows a comparison of 3-day and 2-week fixed embryos at 4mM concentration. The 
contrast between heart and chamber is clearly improved (Figure 4.2b), as the signal 
intensity increased in the chamber at 2 weeks (chamber:background signal intensity 
ratio 3-day = 0.58; 2-weeks = 0.96), due to the penetration of Gd-DTPA into the 








(a)        (b) 
 
Figure 4.2: (a): Axial slice through a 4mM embryo fixed for 3-days.  
Arrows indicate heart chamber (c) and background agarose (b). (Signal intensity 
ratio (chamber:background) 0.58) 
(b): Axial slice through a 4mM embryo fixed for 2-weeks. Arrows indicate heart 
chamber (c) and background agarose (b). (Signal intensity ratio 0.96) 
 
4.4.1.2 Effect of Gd-DTPA concentration 
In the heart, there was a significant reduction in T1 with increasing concentration; for 
example, reducing from 172ms (2mM) to 98ms (4mM) (p<0.0001) for the 3-day 
fixation period. The decrease in T2* was also significant. 
 
It was observed that both concentration and fixation time have an impact on heart T1. 
Although the effect of fixation time was less (21% T1 reduction) than for 
concentration (43% reduction), it does have a noticeable effect on resulting gradient-
echo images in embryos at the same concentration. Further optimisation continued 
using the 2 week fixation time, in the light of the improvements seen in contrast agent 
penetration. 
 
4.4.2 Tissue Parameter Measurements at 2-week Fixation 
Subsequently, the T1 and T2* for tissues at all four different concentrations of Gd-
DTPA with 2-week fixation were measured, to provide input values for the later 
contrast simulation. Table 4.2 shows a summary of T1 and T2* values for each 
concentration in the two regions of interest (agarose, heart). With the addition of 
higher Gd-DTPA concentrations there was still a significant decrease in T1 with 
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concentration: in the heart, mean T1 reduced from 136.2 (2mM) to 16.7ms (16mM) 
(p<0.0001). T2* reduction was also significant (p<0.0001) and notably by 8 and 
16mM, values had become particularly short (heart 8mM: 6.3ms, 16mM: 3.6ms). The 
corresponding linewidths – calculated from T2* values – increased with 
concentration. In the heart, the linewidth increased from 22Hz (at 2mM) to 97Hz (at 
16mM). 
 
Table 4.2: Summary of measured embryo tissue parameters for four different Gd-
DTPA concentrations at 2-week fixation. 
 
 
4.4.2.1 Relaxivity Calculation 
Using the measured T1 and T2* values to investigate relaxivity at 2-weeks (shown in 
Figure 4.3), it was noted that R1-relaxivity in the heart (3.8 mM-1s-1) was similar to 
agarose (3.9 mM-1s-1). However there was a larger difference in the R2* constant 
(heart: 15.9 mM-1s-1, agarose: 5.9 mM-1s-1) suggesting that T2* will decrease more 
rapidly in heart tissue than in agarose.  
 
Tissue Type 
(mean ±1SD, n=3) 
2mM 4mM 8mM 16mM 
Agarose T1 (ms) 
T2* (ms) 













Heart ROI T1 (ms) 
T2* (ms) 







34.9 ±0.5  
6.3 ±0.8 
57 
16.7 ±0.5  
3.6 ±0.3 
97 
One-way ANOVA for concentration effect: p<0.0001 for all tissues 
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Figure 4.3: Effect of Gd-DTPA concentration on R1 and R2* in agarose and heart 
ROIs. Agarose R1/R2*-Relaxivity: 3.9±0.5/5.9±0.2; Heart: 3.8±0.7/15.9±0.4 mM-1s-1 
 
4.4.2.2 Estimation of Proton Density (M0) 
To estimate proton density, the lowest concentration embryos (2mM) were scanned 
with multiple echo times and fitted to find signal intensity at TE=0ms for regions of 
interest in the heart tissue and agarose. The mean ratio of M0 values from the fit 
tissues (agarose:heart) was 1. 
 
4.4.2.3 Scan Parameter Determination 
After measuring the tissue parameters (T1, T2*) for the 2-week data, these values were 
input into the Matlab program to yield the estimated scan parameters giving 
maximum contrast for each concentration. The results are summarised in Table 4.3. 
 
Concentration Optimum-Contrast Parameters 
2mM TE=22ms, TR=28ms, $=39°, NSA=5  
 
4mM TE=16ms, TR=28ms, $=52°, NSA=5 
 
8mM TE=9ms, TR=20ms, $=60°, NSA=7 
 
16mM TE=6ms, TR=20ms, $=74°, NSA=7 





4.4.3 Assessment of High-Resolution Embryo Images 
For each concentration, 3D gradient echo datasets were created using estimated 
parameters from the simulation. SNR and CNR were measured in heart, chamber and 























11.2 ±1.1 16.2 ±2.2 15.9 4.7 ±1.1 5.1 ±1.1 
TE=10ms, TR=30ms      
#=90°, NSA=4      
2mM 14.1 ±1.4 28.0 ±0.7 28.3 14.2 ±1.4 13.9 ±1.1 
[Shim LW=45Hz]      
TE=22ms, TR=28ms      
#=39°, NSA=5      
4mM 14.6 ±0.9 34.7 ±2.1 35.0 20.4 ±0.9 20.0 ±2.0 
[Shim LW=55Hz]      
TE=16ms, TR=28ms      
#=52°, NSA=5      
8mM  (2-tailed t-test: NS difference)   
[Shim LW=77Hz] 23.2 ±1.0 50.3 ±1.4 48.6 25.5 ±1.0 27.1 ±1.6 
TE=9ms, TR=20ms      
#=60°, NSA=7      
16mM      
[Shim LW=135Hz] 23.0 ±1.5 59.2 ±2.7 60.1 37.0 ±1.5 36.1 ±2.3 
TE=6ms, TR=20ms      
#=74°, NSA=7      
Table 4.4: Summary of SNR and CNR values in volumes of interest (VOIs) over 
whole-embryos for the 4 Gd-DTPA concentrations at 2-weeks fixation.1-way ANOVA 
of SNR and CNR change with concentration, for each VOI: p<0.0001 
 
There is a marked SNR difference between the 2mM images at initial starting values 
(Schneider et al., 2003b) and optimised scan parameters – best illustrated by the 
signal intensity increase seen in Figure 4.4. The image using optimised parameters at 
2mM shows improved heart and chamber SNR (heart SNR: 11 to 14 p<0.003, 
chamber: 16 to 28 p<0.0001). Fluid/tissue contrast is also superior in the optimised 




Figure 4.4: 2mM embryos. Left: scanned with initial parameters found in the 
literature (TE=10ms, TR=30ms, #=90°, NSA=4); right: with optimum contrast 
parameters produced by simulation (TE=22ms, TR=28ms, #=39°, NSA=5). Images 
identically scaled. 
 
As seen in Table 4.4 and Figure 4.5, increasing Gd-DTPA concentration initially 
leads to a rise in SNR in the heart, with SNR increasing from 14 (2mM) to 23 (8mM) 
(p<0.0001). A signal increase is also seen in the chamber: 2mM SNR: 28, 16mM 
SNR: 59 (p<0.0001). SNR at 2mM using initial globally-optimised parameters (2 g 
opt/2mM* in Figure 4.5) (Schneider et al., 2003b) was measured for comparison and 
found to be 11 (heart) and 16 (chamber). 
 
However, a plateau can be seen (Figure 4.5) where mean heart SNR does not increase 
after 8mM (8mM mean 23.2; 16mM: 23.0). By 16mM, shim linewidth has also 
become high (135Hz, previously 77Hz at 8mM) indicating a shortening in global T2*. 
Therefore 8mM appears to be the optimum concentration, with a balance of good 
contrast in the heart and improved resolution and SNR. This is also shown in the 





Figure 4.5: SNR values of whole-embryo organ volumes at calculated optimum MR 
parameters for each concentration. 2 (g opt) represents SNR measurements on the 
2mM data using globally-optimised parameters. Below: comparison of identically 
scaled images of an axial section through an embryo at optimum MR parameters. A 
scan at global-optimum parameters (2mM*) is included for comparison. Overall SNR 
can be seen to increase with increasing Gd-concentration. 
 
This is supported by Figure 4.6, which shows the excellent signal and contrast to 
noise in resulting images at 8mM (heart SNR: 23, CNR heart-chamber: 27). At this 




Figure 4.6: Example images from an 8mM 3D gradient-echo dataset at optimum 
parameters. Excellent contrast over the whole embryos can be observed (a) as well as 
heart chambers (b). (ra=right atrium, la=left atrium, lv=left ventricle, rv=right 
ventricle) 
 
4.4.4 Validation of Simulations 
In order to compare the signal predictions made by the simulation to experimental 
data, linear regression was performed to examine the relationship between measured 
SNR and simulated values. SNR was measured in heart and agarose VOIs in the 
gradient-echo data sets that corresponded to region-volumes in slices used for the 
initial T1 and T2* measurements. 
 
As seen in Figure 4.7, there is excellent agreement between simulated and measured 
SNR values in both the agarose (r2=0.998) and heart (r2=0.993) regions of interest, 
indicating that the simulation is adequately predicting signal intensity values for tissue 
and thus also for contrast optimisation. 
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Figure 4.7: Graphs comparing the simulated and experimental values. (a) Regression 
plot of experimental heart data against simulated signal values (r2 =0.993). (b) 
Regression plot of experimental agarose data against simulated signal values 
(r2=0.998) 
 
4.4.5 Transgenic Screen 
Using this optimum preparation (8mM Gd-DTPA, 2-weeks fixation) and MR scan 
parameters, 13 embryos (Chd7+/+ or +/-) were then screened for heart defects. Of the 8 
embryos heterozygous for Chd7, 1 was identified as having a ventricular septal defect 
(VSD). This is illustrated in Figure 4.8a and b where hearts from both hetero- and 
homozygote are shown. There is a clear difference between the ventricle septal walls 
– patent in the heterozygous embryo. This was later confirmed by H&E sectioning of 











(a)       (b)         (c) 
 
Figure 4.8: Images of Chd7 wild-type and mutant embryo hearts. (a) Detail of normal 
heart in a wild-type littermate. (b) Detail of a ventricular septal defect in an embryo 
heterozygous for the Chd7 gene. (c) Subsequent axial H&E section, from the same 
animal, confirming the defect. 
  
4.5 Discussion 
This study presents the results of an optimisation with the aim of improving detection 
of heart and vascular defects in high-throughput MRI embryo screens.  
 
In the initial part of this study the effects of Gd-DTPA concentration and fixation time 
on T1 and T2* values of the embryo heart were assessed, to determine the best 
preparation method for imaging. To date, there has been very limited work 
investigating the effect of MRI contrast agent concentration and fixation time on 
mouse embryo imaging. Work by Schneider et al. reported an initial investigation of 
embryo contrast at 2mM by altering MR scanning parameters (Schneider et al., 
2003c) to perform non organ-specific contrast optimisation. A study by Petiet and 
colleagues (Petiet et al., 2007) in 18.5dpc rat embryos, demonstrated the impact of 
contrast agent concentration and fixation time on tissue T1, using the Gd contrast agent 
gadoteridol (an agent with slightly reduced T1-relaxivity than Gd-DTPA but a higher 
viscosity (Bellin, 2006; Tweedle, 1997)). Four concentrations – 0, 12, 24 & 46mM 
(assuming a standard 0.5M solution) – and two timepoints (3.5 & 24 hours) were 
reported. After 3.5 hours fixation, mean whole-embryo T1 varied from 1570ms 
(0mM) to 266 (12mM), 115 (24mM) and 74ms (46mM) respectively, demonstrating a 
reduction in T1 as concentration increases. Increasing fixation time also showed a 
reduction in T1 (24mM concentration), where T1 decreased from 3140ms (fresh) to 
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14ms (24 hours). In addition, T2 also reduced with an increase in fixation time. The 
authors conclude that a 3-6 hour fixation was optimum in terms of T1 and T2 
reduction, deciding on a 5 hour fixation time at 24mM. 
 
In the study it was also observed that there was a decrease in T1 with increasing 
concentration and with fixation time. The fixation time dependency was probably due 
to changes in skin permeability with gestational age (Petiet et al., 2007).  It is known 
that skin stratification occurs by 14dpc, and development of full barrier-function at 
16dpc (Hardman et al., 1998). Thus 15.5dpc embryos are likely to have impeded 
movement of Gd-DTPA into body tissues which may account for our findings. 
 
Short TR sequences can be used to minimise scan times in high resolution embryo 
datasets and active staining methods thus rely on shortening T1 to recover tissue SNR 
(Johnson et al., 2002b). From our results, ignoring any T2* effects, increasing fixation 
time and Gd-DTPA concentration would contribute to an increase in SNR per unit 
time and therefore benefit acquisition. In the heart, limited change was seen in T2* for 
either concentration when fixation time was increased from 3 days to 2 weeks 
indicating that there is no effect of T2*-signal loss at the longer fixation time. 
 
In the study by Petiet (Petiet et al., 2007), the intention was to have an initial high 
concentration of agent that could reduce tissue T1 to the desired level (<100ms) in a 
short fixation time. Given the effect seen in the heart, where the Gd-DTPA has less 
penetration (T1 values are elevated compared to heart tissue at 3 days but have 
reduced by 2-weeks), a 2 week fixation time was chosen to continue the optimisation. 
At two weeks, concentration of Gd-DTPA and thus T1 in the whole embryo will have 
tended toward equilibrium with its surroundings. In addition, if repeat imaging is 
needed, then more stable T1 and T2* values in the embryo increases the likelihood that 
optimised scanning parameters will remain valid in the future. 
 
Calculated from the 2-week multiple concentration data, R1-relaxivity in the heart (3.8 
mM-1s-1) was similar to agarose (3.9mM-1s-1, in-line with a previously recorded value 
of 3.9 mM-1s-1for Gd-DTPA saline solutions at 8.45T (Donahue et al., 1994)). R2*-
relaxivity in the heart, however, was >2.5 times higher than agarose (15.9 vs. 5.9 mM-
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1s-1) illustrating that Gd-DTPA has a particular impact on reducing tissue T2* 
regardless of concentration. 
 
The final part of the study was to determine the optimum parameters in the heart for 
maximum contrast between heart wall and chambers. A range of possible MR 
parameters, to identify the maximum signal difference were investigated, using an 
approach commonly used to optimise flip angle for gradient echo imaging (Pelc, 
1993). It was noted that there was no unique set of parameters for any one 
concentration and the calculated parameters varied markedly between concentrations. 
One question that was specifically addressed was whether an increase in TR would be 
more beneficial for SNR as opposed to increasing the number of averages. It was 
found that increased averaging with short TRs (relative to T1) was favoured, with 5 
averages/28ms TR (2 and 4mM concentrations) and 7 averages/20ms TR (8 and 
16mM) giving the highest contrast to noise. Although an odd number of averages 
could compromise some of the benefits of pulse sequence phase cycling (Kingsley, 
1995), this may be outweighed by the need for the highest contrast to noise per unit 
time obtainable, especially at such small voxel sizes.  
 
Thus an advantage of higher Gd-DTPA concentration, which reduces T1 further, is 
that TR may be reduced, allowing a shorter acquisition time or the opportunity to 
increase signal averages. While this approach also has the potential to reduce signal 
due to T2* decay, our measurements show that heart and chamber SNRs consistently 
increased from 2 to 8mM concentrations.  For these concentrations the benefits of a 
shorter T1 on signal outweighed T2* losses. At 16mM, the short tissue T2* measured 
(~3ms) was probably responsible for the lack of change seen in heart SNR compared 
to 8mM, as well as impaired resolution of structure. 
 
In the embryo heart, SNR improved with the optimised scan parameters resulting in a 
marked increase in contrast between heart wall and chamber (heart SNR increased 
from 11 to 14; chamber SNR from 16 to 28). Subsequent Gd-DTPA concentrations 
also showed improvements in organ SNR and heart-chamber contrast above that of 
2mM up to the 16mM concentration. While a contrast improvement was seen at 
16mM, this was mostly due to an increase in chamber signal alone – mean heart SNR 
remained similar to 8mM. 
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 When scanning each concentration at simulation-derived optimum MR settings, 
measured global shim linewidth increased with Gd-DTPA concentration (2mM: 
45Hz, 4mM: 55Hz) reaching a maximum at 16mM (135Hz). This reinforces the 
notion that global T2* is particularly short at 16mM. As this linewidth exceeds the 
bandwidth of 130Hz per pixel, there would be concern about susceptibility effects and 
blurring due to the wide point spread function (Callaghan et al., 1994; Choi et al., 
1997), affecting image discrimination and contrast over the whole embryo. The 
chosen 8mM concentration had a linewidth of 77Hz, well within bandwidth. This 
trend was also shown by the calculated maximum linewidths in the heart specifically, 
where the value increased markedly with concentration. The combination of these 
factors led us to determine that 8mM, when imaged at the optimal parameters, showed 
the greatest balance of heart contrast, image resolution and overall embryo SNR for 
phenotyping. 
 
There was no difference between the SNRs of agarose and heart chamber in 8mM 
optimum images. This indicates that the composition of the 1% agarose background 
was similar enough to the heart chamber at 2-weeks to be used as a surrogate when 
making T1 and T2* measurements. This is supported by a previous study suggesting 
that for Gd-DTPA solutions with a small macromolecule content, T1-relaxivity should 
remain similar(Stanisz and Henkelman, 2000). 
 
Our method of contrast optimisation was also validated, as linear fits of simulated to 
measured signal intensity values showed excellent agreement with experimental data 
(Figure 4.7). 
 
It is understood that tissue parameters are affected by magnetic field strength, with a 
longer T1 and shorter T2 as field increases (Bottomley et al., 1984). A recent in vivo 
rat brain study (de Graaf et al., 2006) compared relaxation times in a number of brain 
regions at three field strengths (4.0, 9.4 and 11.7T). Although significant T1 
increase/T2 reduction was seen as field strength increased, the change in tissue 
parameters was less dramatic between 9.4 and 11.7T (e.g. mean cortex T1 1948 vs. 
2073ms) compared to 4.0 and 9.4T (1285 vs. 1948ms). As our embryos are contrast-
enhanced, the measured T1 and T2* are dominated by the relaxation characteristics of 
the Gd-DTPA. Previous work (Donahue et al., 1994) with Gd-DTPA saline solutions 
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(at field strengths of 1.0, 4.7 and 8.45T) showed that for T1, Gd-DTPA relaxivity was 
not significantly different between 4.7 and 8.45T (4.02 vs. 3.87mM-1s-1). These 
studies indicate that, given the dominant effect of the contrast agent, our optimised 
scan parameters may be broadly applicable, particularly to the higher field strengths 
generally used for !MRI. 
 
From our measurements of chamber SNR with Gd-DTPA concentration, there is the 
suggestion that vascular signal can be emphasised with progressively higher amounts 
of Gd-DTPA and/or longer echo-times if structural anatomy is not specifically 
desired. This parallels the early attempts at vascular phenotyping by Smith and 
colleagues (Smith et al., 1994), where a solution of BSA-Gd-DTPA was directly 
injected into embryo vasculature, producing MRA-like images of the vascular tree.  
 
Using the optimal preparation for improved SNR and contrast, an initial screen of 13 
Chd7+/+ and +/- embryos for heart defects was performed, using 8mM Gd-DTPA with 
2-weeks fixation and corresponding MR scan parameters. With this relatively simple 
preparation and single acquisition of the multiple embryos, a ventricular septal defect 
was easily identified in a heterozygote (see Figure 4.8b) and later verified by 
histology (Figure 4.8c). This confirms that the gene trap generated Chd7 mutant 
produces a heart phenotype, consistent with expected findings (Bosman et al., 2005) 




In this chapter optimised preparation and scan parameters for heart imaging in 
15.5dpc mouse embryos were presented. Fixation for 2-weeks provides a gain in SNR 
due to T1 reduction, as does increasing Gd-DTPA contrast agent concentration. It was 
found that the best balance of heart CNR and muscle SNR was achieved at 8mM. 
Using gradient-echo simulations with measured T1 and T2* values, the optimum 
scanning parameters were determined and verified. These parameters were then used 
to identify a heart defect in Chd7+/- mice. This optimisation should allow better 
determination of heart and vascular anatomy in a variety of transgenic embryos, 
enabling greater sensitivity in detection of defects.  
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Chapter 5: 
Magnetic Resonance Virtual Histology for Embryos: 
3D Atlases for Automated High-throughput 
Phenotyping  
5.1 Chapter Outline 
The previous chapter outlined an optimised preparation and scanning protocol for the 
enhanced SNR and CNR to enable cardiac phenotyping in mid-gestation mouse 
embryos. In this chapter, this work is extended to show that the protocol may also be 
successfully applied to the visualisation and examination of CNS phenotypes, using 
the Hesx1 model of septo-optic dysplasia as an example. 
 
While !MRI phenotyping is possible through the examination and segmentation of 
images by an experienced observer, this can become time-consuming and labour-
intensive. This chapter further expands previous work, resulting in a novel application 
of image registration and atlas techniques in order to produce an automated, high 
throughput method of analysing phenotypic differences between mice with differing 
genetic backgrounds.   
 
This work was a collaboration with Marc Modat, UCL Centre for Medical Image 
Computing, who developed and modified the non-linear registration software for use 
with large embryo datasets. Additionally, histological sectioning and staining of 
embryos was performed by Sujatha Jayakody and Sandra De Castro, of the Neural 
Development Unit UCL Institute of Child Health.   
 
5.2 Introduction 
In the wake of the first draft of the full mouse genome sequence (Mouse Genome 
Sequencing Consortium, 2002), large-scale mutagenesis programmes are underway 
(International Mouse Knockout Consortium, 2007) that will produce mice with gene 
knockouts for each of the approximately 25,000 genes in the mouse genome. Analysis 
of these mice in coming years will give new insights into the genetic basis of human 
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disease, as novel genes are identified that impact upon mammalian physiology and 
morphology. Mouse embryos in particular may be studied to determine the role of 
genes on development and congenital abnormalities. With an increasing number of 
new mutants, effective methods of identifying novel phenotypes in these embryos will 
be crucial.  
 
Current phenotyping of embryo morphology is generally achieved by histological 
examination using microscopy. Specimens are dehydrated, wax embedded and thinly 
sectioned (2-8!m) (Kaufman, 1992), providing high resolution 2D data and tissue 
sections that may also be stained for gene and protein expression. Episcopic imaging 
is a development of this process, where autofluorescence of each tissue slice can be 
photographed and combined to generate high resolution 3D volume datasets (1-2!m 
isotropic resolution) (Weninger and Mohun, 2002). However these histological 
approaches are time-consuming, introduce distortions into final 3D image due to the 
sectioning process and do not readily enable rapid screening as only one embryo may 
be imaged at a time. 
  
MRI is now an established method for non-invasive embryo imaging, beginning with 
the early work of Smith and colleagues (Smith et al., 1994). High-resolution 3D 
datasets with isotropic resolutions of down to 12!m are created (Smith et al., 1996) 
with excellent soft tissue contrast, allowing the visualisation and segmentation of 
individual organ structures (Dhenain et al., 2001). MRI is also capable of high-
throughput screening of multiple ex-vivo embryos (up to 32 in a single overnight 
scan) with the combination of a large volume imaging coil (Schneider et al., 2004) 
and fixation in an MR contrast agent (Cleary et al., 2009). Diffusion-tensor imaging 
(DTI) – an alternative MRI technique – has also been used to investigate the structure 
of embryo CNS by exploring the degree and direction water is able to diffuse along 
neuronal axons (Zhang et al., 2003). Although this technique is ideal for investigating 
white matter, it is impractical for high-throughput imaging, as many hours are needed 
to generate connectivity maps in a single brain. 
 
Other imaging methods such as optical projection tomography (OPT) and micro-
computed tomography (µCT) are also able to non-destructively produce 3D datasets. 
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OPT can create images of embryos that combine both anatomical structure and gene 
expression with conventional fluorophores, at high resolution (5-10µm) (Johnson et 
al., 2006; Sharpe, 2004). However the technique requires embryos which are partially 
transparent thereby making its use challenging in older subjects (>13.5 days post 
coitum, dpc) (Schneider and Bhattacharya, 2004). µCT is also capable of acquiring 
high-resolution datasets (typically less than 27µm) in a short scan-time (~2 hours) 
(Johnson et al., 2006). Although conventionally µCT has difficulty in distinguishing 
soft tissues, which have inherently low contrast due to a narrow range of CT numbers 
(Holdsworth and Thornton, 2002), the use of CT contrast agents as tissue stains, such 
as osmium tetroxide (Johnson et al., 2006) and potassium triiodide (Degenhardt et al., 
2010), have improved its ability to discriminate tissues. µCT is also particularly suited 
to skeletal studies, as it can produce excellent images of dense radiopaque structures 
such as bone (Oest et al., 2008). 
  
Despite the availability of these advanced imaging techniques, any embryo dataset 
must still be manually assessed through inspection by a trained observer. As high-
throughput analysis is increasingly demanded, conventional visual assessment for 
abnormalities is likely to become labour-intensive and insensitive. 
  
Advanced computational techniques such as segmentation-propagation and voxel-
based morphometry (VBM) have been used to investigate populations in both clinical 
and adult mouse MRI studies (Ashburner and Friston, 2000; Calmon and Roberts, 
2000; Lerch et al., 2008; Sawiak et al., 2009b). These methods enable anatomical 
differences between groups to be identified with little manual intervention or visual 
assessment. Integral to these techniques is the use of an atlas, a spatial average image 
of the whole population (Ashburner and Friston, 2000; Calmon and Roberts, 2000) 
created by finely warping individual subject images together to locally align 
anatomical features. Segmentation-propagation is a quantitative method for making 
volumetric measurements. After segmenting a volume of interest on the atlas image, 
such as the brain or heart, differences may then be identified between groups in the 
population by propagating the segmented volume to all individuals, thus providing the 
group mean and standard deviation from a single volume of interest on the atlas 
image. However, while average images of registered wild-type embryos have been 
reported previously (Zamyadi, 2008), there has so far been no application of atlas 
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methods for phenotypic assessment. It is envisaged that a combination of multiple 
whole-embryo imaging with image processing techniques would allow the creation of 
an average embryo atlas from a population and enable automated phenotypic 
comparisons between transgenic and wild-type littermates. 
 
In this study there were three stages to the investigation of the embryo atlas. This 
started with addressing the lack of brain tissue contrast on MR images. Initially a 
contrast enhanced MR technique was developed to produce structural detail in the 
embryo CNS. This was assessed in Hesx1-/- and Hesx1I26T/I26T mice, models of septo-
optic dysplasia (SOD) (Dattani et al., 1998; Sajedi et al., 2008). These models 
typically give rise to a dysmorphic pituitary gland. However, the small size of the 
gland and its protected location often results in preparation artefacts and damage 
during histological sectioning. Thus a non-invasive approach may facilitate 
phenotyping morphology in this region. Combining the contrast enhanced protocol 
with computational methods, an MRI atlas was generated for a population of CD-1 
embryos and compared against histology. Finally, this enabled the use of a 
segmentation-propagation technique to assess brain and cardiac phenotypic 
differences between CD-1, C57BL/6 strains and Chd7+/- knockout mice (a model of 
the condition CHARGE syndrome) (Bosman et al., 2005; Randall et al., 2009) based 
on a novel population atlas. 
 
5.3 Materials and Methods 
5.3.1 Animal Preparation 
All parts of this study were carried out in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. Pregnant female mice were sacrificed by cervical dislocation. 
Embryos were then dissected from the mother and transferred to warm Hanks 
solution. Their umbilical cords were cut and the embryos were allowed to bleed out 
into the solution. The embryos were then fixed in a solution of 4% formaldehyde and 
Magnevist MR contrast (Gadolinium-DTPA, Bayer-Schering Pharma, Newbury, UK) 
and left on a rotator. The embryos were removed and embedded in a 50ml centrifuge 
tube using 1% agarose gel doped with an identical concentration of Magnevist to 
initial fixation. After comparing Gd-DTPA concentrations (2, 4, 8 & 16mM) in 
groups of CD-1 embryos over two fixation durations (three days and two weeks), it 
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was determined that fixing embryos with 8mM Gd-DTPA for at least two weeks 
produced the greatest SNR and brain contrast without major susceptibility artefacts. 
Three groups of mice were imaged at 15.5dpc: outbred CD-1 mice from an 
established colony at UCL, and Chd7 wild-type and heterozygous gene trap mice 




Embryos were imaged on a Varian VNMRS 9.4 Tesla MRI system (Varian Inc., Palo 
Alto CA, USA) using a 33mm quadrature birdcage volume coil (RAPID Biomedical 
GmbH, Würzburg, Germany). Maps of T1 and T2* in tissue were created using a 
single sagittal slice field of view=27x27 mm2, 2562 matrix size, 0.5 mm thickness). 
For 3D imaging a gradient-echo sequence was used, TR=20 ms, 7 averages, flip 
angle=60°. Field of view=27x27x27 mm3, matrix size=5123, zero-filled to 10243 on 
the console to a voxel-size of 26x26x26 µm3. Echo-time (TE) was 9 ms for 15.5dpc 
embryos; 5 ms for 18.5dpc embryos to enable better visualisation of the bone 
structures of the cranial floor.  
 
5.3.3 Image Registration 
Embryos were first semi-automatically extracted from the dataset and group-wise 
registration, using global and local transformations, was performed to create an 
average image atlas. The obtained deformation parameters from each individual to the 
template were then used to propagate the different regions of interest to each embryo. 
 
5.3.3.1 Digital Extraction 
The embryos were extracted from the acquisition volumes using simple operators 
such as Gaussian smoothing, thresholding and mathematical morphology (erosion, 
dilation and selection of connected components).  
 
5.3.3.2 Registration and Atlas Average Creation 
The intensity ranges of the embryos were first normalised prior to registration. One 
embryo was selected and taken as the reference, with all further processing performed 
in its image-space. The others were first spatially normalised using a rigid registration 
algorithm consisting of 6 global degrees of freedom (DOF): 3 translation and 3 
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rotation parameters, in order to correct the differing orientations of each embryo in the 
acquired images. All resulting images were then averaged into a new blurry reference 
image. This initial registration step, due to the rigid transformation, did not affect the 
geometry of the embryos. Thus the average image was not biased toward the selected 
embryo’s geometry. The embryos were then aligned using affine registration (12 
global DOF: 3 translations, 3 rotations, 3 scales and 3 shears) to the previously 
created average image. Rigid and affine registration was performed using a block-
matching technique (Ourselin et al., 2001). 5 iterations were performed using the 
affine algorithm. After each iteration the resulting average image was updated (an 
example of the result after affine registration is shown in Figure 5.5A). A non-linear 
registration algorithm, Free-Form Deformation (FFD) (Rueckert et al., 1999) was then 
used to locally align the embryos to the reference average image. Control point 
positions were optimised in order to locally deform each image to the target reference 
image. The degree of alignment was evaluated using Normalised Mutual Information 
(NMI) (Studholme et al., 1999). 18 iterations of non-linear registration were 
performed, using a coarse-to-fine approach where the control point spacing was 
gradually reduced to 5 voxels width (130 !m) overlaid on the full resolution images. 
After each non-linear registration step, it was ensured the average image was 
geometrically in the middle of all input images by the subtraction of the mean total 
displacement from each deformation field before resampling the embryo images to 
produce the average atlas. All non-linear registration steps were performed using a 
parallel implementation (Modat et al., 2010) of the FFD algorithm on a computing 
cluster, which allowed them to run concurrently within each step. A cluster with 
approximately 1000 CPU cores was used. 
 
5.3.4 Volume Segmentation, Rendering and Propagation 
Regions of interest were semi-automatically segmented and rendered using Amira 
visualisation software (v5.2.2, Visage Imaging Inc., Andover MA, USA). As the 
result of the group-wise registration consists of an atlas average image and a set of 
deformation fields, there is direct spatial correspondence between every voxel in the 
average image and their corresponding positions in each single embryo. Using this set 
of deformation fields, segmented regions of interest were propagated from the atlas 
into the original image space of each embryo. 
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5.3.5 Signal-to-Noise Measurements 
Signal-to-noise (SNR) in raw image data was calculated by taking the mean signal in 
a volume of interest and dividing by the standard deviation of the signal in a region of 
background noise.  
 
5.3.6 Statistical Analysis 
Analysis of volume data was performed in Prism v5.00 (GraphPad Software, San 
Diego CA USA) using one-way ANOVA with Tukey testing for multiple 
comparisons (propagated volumes) and the Kruskal-Wallis test with Dunn’s test for 
multiple comparisons (normalised volume data). 
 
5.4 Results 
5.4.1 Micro-MRI for the Investigation of Embryo Brain Anatomy in 3D 
15.5dpc CD-1 embryos were fixed in 4% formaldehyde solution (Sigma-Aldrich 
Company Ltd., Gillingham, UK) with a gadolinium-chelate contrast agent (Gd-
DTPA) and imaged at 52!m resolution, interpolated to 26!m by zero-filling. 
Obtaining tissue contrast, particularly in brain structures is often difficult in embryo 
imaging. Images of the embryo CNS acquired from specimens fixed in four contrast 
agent concentrations (2 to 16mM) and two fixation durations (three days and two 
weeks) were evaluated to determine optimal preparation. Two weeks fixation resulted 
in better penetration of the agent into brain structures compared to 3 days, as 
determined by reduced tissue T1 (e.g. 179 to 80ms, 4mM). It was determined that 
embryos fixed in 8mM Gd-DTPA for two weeks, produced images with the highest 
brain contrast-to-noise (CNR=8.0, 8mM vs. CNR=5.7, 4mM, between external 
capsule and basal ganglia regions), without major artefacts. Images also showed 
excellent tissue contrast throughout the entire embryo.  White-matter tracts and 
developing layers of the cortex were clearly visualised (Figure 5.1), which was due to 
the selection of MRI parameters; a relatively long 9ms echo time compared to the 6ms 
T2* of the CNS (mean T1=38ms) giving T2*-weighted images.  Using this imaging 
protocol, multiple subjects may then be imaged (up to 40; using a 35mm diameter 
volume imaging coil, with a 60mm z-profile) in a single 10-hour overnight scan with 





Figure 5.1: Sagittal section through an example 3D embryo dataset showing CNS 
structures in the brain. Structures of the cortex can be seen, including cortical plate 
(CP), ventricular (VZ), intermediate (IZ) and marginal zones (MZ) (blue labels). Also 
thalamus (Th.), hypothalamus (H/t) and ventricular septum (Sep.). 
 
Following this preliminary investigation, the imaging protocol was applied to a 
phenotyping study of 18.5dpc embryo mice (Hesx1-/-, Hesx1I26T/I26T and wild-type) for 
CNS and pituitary defects. Hesx1-deficient embryos showed hypoplasia of the left 
olfactory bulb and telencephalic vesicles (Figure 5.2). Eyes were absent with no sign 
of optic nerve development.  Close examination revealed an apparent hyperplasia of 
the pituitary gland with an outgrowth of closely associated mucosal tissue, which has 
not been previously described (Dattani et al., 1998) (Figure 5.2A) in Hesx1-/- mutants. 
Tissue contrast was readily apparent between both parts of the gland in wild-type 
embryos, which enabled segmentation of the individual lobes (Figure 5.2B). The 
Hesx1I26T/I26T embryo showed milder forebrain defects with normal corpus callosum 
and olfactory bulbs, but eyes were also absent. This particular specimen showed a 
distinct phenotype in which the anterior and posterior pituitary lobes could not be 
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identified, but there was a tissue mass invading the oropharyngeal cavity. Although 
ectopic oral pituitary tissue has been inferred from histological analysis, it has not 
been shown so evidently as in Figure 5.2B. The mid-coronal MRI shows an obvious 
cranial shift of the left anterior hypothalamic area as a result of the malformation of 
the pituitary gland (bottom of Figure 5.2A, red arrow).  These MR findings were all 
confirmed on subsequent histology (Figure 5.2A). 
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Figure 5.2: Images of Hesx1 mutant and wild-type embryos. (A) Sagittal and coronal MR images of 18.5dpc wild-type, Hesx1-/- and Hesx1I26T/I26T 
18.5dpc mice at the levels showing greatest changes in structure. Similar histology views from the same embryo are also shown. The pituitary gland is 
also visibly enlarged and penetrates the oropharyngeal cavity (Hesx1-/- sagittal view, middle-left). In the Hesx1I26T/I26T mutant, in addition to an 
enlarged pituitary gland, structures of the left hypothalamic area can be seen to be upwardly shifted (red arrow). (B) 3D volume rendering of whole-
brain and pituitary structures. In the Hesx1-/- mutant, the gland is visibly dysmorphic and enlarged compared to wild-type, with a large amount of 
associated mucosal soft tissue posterior. The rendering also shows an underdeveloped left olfactory bulb (white arrows). The gland in the Hesx1I26T/I26T 
mutant (bottom) is highly dysmorphic compared to wild-type. 
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5.4.2 Generation of an MRI Embryo Population Atlas 
Conventionally, embryo atlases use single subjects at a given developmental 
timepoint to illustrate representative anatomy. In this study an average atlas of a 
population of mid-gestation embryos was generated. Using computational methods 
combining 3-stages of image registration – rigid, affine and non-linear registration –6 
CD-1 embryos were warped into a single average image.  
 
Figure 5.3 demonstrates that the atlas reinforces structures common to all, whilst 
reducing the effect of imaging or preparation artefacts present in individual embryos. 
Combining images from multiple subjects also increases image signal-to-noise. 
Comparing our images to histology, it was observed that hypointense regions on the 
MR images, enhanced in the composite atlas, correlate well to large fibre structures in 
the developing CNS such as internal (Figure 5.3, blue triangles) and external capsule 
(Figure 5.3, red arrows). It is notable that the anatomical detail has been preserved 
during atlas formation and SNR is improved and as such, the atlas is ideally suited to 
a host of image processing techniques such as brain volume segmentation-
propagation, which will be explored in the following section. 
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Figure 5.3: Similar axial and sagittal images comparing single embryo, atlas and 
equivalent histology sections. Even with six embryos, there is a noticeable 
improvement in signal-to-noise. Structural details common to all embryos appear 
enhanced in the atlas image and correspond well to histology, such as internal (blue 
triangles) and external capsule (red arrows). 
 
5.4.3 Unsupervised Generation of Quantitative Tissue Volumes in a Whole 
Population 
Figure 5.4 shows the steps in the segmentation-propagation process of an MRI 
embryo atlas. This allows regional segmentation from a single average image to be 
mapped onto the original individuals for calculation of tissue volumes. The utility of 
the atlas segmentation in automatically identifying volume differences between two 
groups of mice with differing backgrounds: outbred CD-1 (n=6) and C57BL/6 mice 
(n=13) was examined. The C57BL/6 mice were further subdivided into wild-types 
and Chd7+/- gene trap mice (n=5 and n=8 respectively).  
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Figure 5.4: Schematic diagram outlining the segmentation-propagation process. 
Following the initial non-linear registration of all images in the study population, an 
average atlas is created. The transforms used to warp the images to create the 
average image are recorded at all points in 3D across the dataset. Applying the 
inverse transform to regions segmented on the atlas allows volumes of structures to 
be measured in individual subjects. A similar method has been used previously for 
volume measurements in adult mouse brains (Bock et al., 2006). 
 
First, an MRI atlas of these 19 individuals was created using the registration 
techniques described previously. The improvement in the average image after 18 




Figure 5.5: Overview of average images produced during the registration process: 
(A) average image of the 19-embryo dataset after global alignment (affine 
registration). (B) Final average image after multiple iterations of the local 
deformation algorithm. The sharpness of the non-linear registration result as seen in 
image (B) indicates good alignment of structure. 
 
 
The resulting average atlas was then manually segmented (Figure 5.6) into left 
olfactory bulb (coloured green), pituitary (yellow), mesencephalic vesicle (blue), 
whole-brain (purple) and whole-body (tan) volumes. Heart ventricles (red) were also 
segmented for comparison. Volumes from the atlas segmentation were then 




Figure 5.6: 3D volume rendering of the atlas of 19 subjects indicating the volumes of 
interest drawn for segmentation-propagation volume measurement. 
 
As shown in Figure 5.7, there was good anatomical agreement between the areas 
segmented on the atlas with resulting propagation on the original individual dataset. 
Furthermore, propagated volumes compared favourably against manually 
segmentation from 6 CD-1 embryos. Using the established Dice similarity measure of 
spatial agreement (Dice, 1945) (where a value of 1 represents full spatial overlap and 
0 is none) there was a mean correspondence between manual and propagated whole-
brain volumes of 0.95±<0.01.  The propagated volumes measured in the three groups 




Figure 5.7: Similar sagittal slices through our 19 embryo atlas (left) and a single 
CD-1 embryo (right) illustrating the good correspondence of segmented regions 
propagated from the atlas to individual datasets. (Red: heart ventricles, yellow: 


















Whole Body 388 6.9 322 10.6 312 4.7 
Whole Brain  45.7 2.6 42.5 6.2 39.2 4.3 
Olfactory Bulb 0.3 6.2 0.3 15.4 0.2 15.1 
Vesicle 0.2 11.0 0.2 38.1 0.2 47.7 
Pituitary 0.1 7.3 0.1 13.3 0.1 8.8 
Heart 
Ventricles 2.4 12.8 2.2 14.3 2.0 7.4 
Table 5.1: Summary of propagated volumes for our three groups of embryos. 
 
Analysing the propagated volumes, significant differences were found in the absolute 
overall brain volume between the three groups (p<0.05, Figure 5.8B), with the 
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smallest mean brain volume (39.2mm3) observed in the Chd7+/- mice. Significant 
differences were found between CD-1 and Chd7 wild-type embryos in propagated 
volumes of the whole embryo and olfactory bulb (0.323 vs. 0.258 mm3, p<0.05, 
Figure 5.8B & C). 
 
In an attempt to account for developmental differences between embryos the data was 
also normalised to embryo body volume. After normalisation, significant differences 
were observed between strains in brain and pituitary volumes (both p<0.01, Figure 
5.8D & E). 
 
 
Figure 5.8: (A)-(C): Graphs showing propagated volume differences in brain and 
pituitary regions between groups. (D)-(E): Graphs showing volume differences in 




The main findings of this study were: i) development of embryo-specific MR methods 
and contrast agent protocols enabled high-resolution structural imaging with enhanced 
anatomical detail in the CNS; ii) using these methods, the structural consequences in 
Hesx1-/- and Hesx1I26T/I26T mouse mutants were identified; iii) a composite whole-
embryo atlas using computational methods was generated with excellent anatomical 
tissue contrast, and finally iv) a novel application is presented of a technique to 
generate a composite atlas from three groups of embryos, allowing automated high-
throughput investigation of phenotype, through volume analysis by segmentation-
propagation. 
 
5.5.1 Phenotyping the Developing Brain Using MRI  
This study demonstrates that through our preparation of 15.5dpc embryos, which 
combines fixation in a relatively high concentration of MR contrast agent (8mM) and 
sufficient fixation time (>2 weeks) enabling the agent to fully penetrate into the CNS, 
one is able to visualise small brain structures. Image signal-to-noise is high, as brain 
T1 is now short and uniform across the brain (reduced to ~38ms).  
 
Previous embryo MRI phenotyping studies have largely concentrated on the heart 
(Fischer et al., 2007; Petiet et al., 2008; Schneider et al., 2003b), although some have 
investigated gross changes in the developing brain and other organs (Schneider et al., 
2003a). The images acquired in these cases have generally been optimised to give 
high overall signal from tissue, resulting in proton density (Jacobs et al., 1999) or 
predominantly T1-weighted MR images (Petiet et al., 2007; Schneider et al., 2003c). 
Although the use of the gadolinium-chelate active-stains improves signal-to-noise, the 
narrow range of tissue T1s (Petiet et al., 2007) after staining limits the scope for T1-
weighted contrast, producing a generally uniform appearance of the embryo brain. 
Given the short T1 of our embryos, the brain contrast observed in our images was 
unlikely to be due to the chosen MR repetition time (TR). It is likely that the short T2* 
observed in the embryos (~6ms) enabled CNS tissue contrast to be generated through 




Typically MRI methods are able to produce images with the greatest degree of 
intrinsic CNS contrast (white-grey matter) when axons are fully myelinated (Miot-
Noirault et al., 1997). In the developing embryo, while distinct myelinated brain 
structures are beginning to form, contrast on MR images is generally limited, as T1 
and T2 differences are small in these young brains (Mori et al., 2001), making 
visualisation of brain structures difficult. Some of this structure has been seen without 
contrast enhancement, as part of a wider DTI study (Mori et al., 2001). However our 
technique allows a reduced scan time together with higher resolution (10 hours for up 
to 40 whole embryos at 52!m isotropic compared to 13 hours for a single extracted 
brain), indicating that high throughput is possible while still maintaining good brain 
tissue contrast. 
  
Beyond preparation optimisation, further improvements in SNR could be made with 
the adoption of multiple solenoid imaging coils as opposed to the single, large volume 
coil used in this study. A recent investigation showed a greater than threefold increase 
in SNR is achievable but this typically requires a large number of receive channels 
(16), which are currently uncommon on most preclinical MR systems (Zhang et al., 
2010b).  
 
Our methods were used to phenotype Hesx1 embryos, which demonstrated novel 
phenotypic defects showing hyperplasia of the pituitary gland and closely associated 
mucosal tissue penetrating into the oropharyngeal cavity. The presence of pituitary 
tissue in this area may also explain the perinatal lethality observed in these embryos 
(Dattani et al., 1998), as the pups suffer from respiratory difficulties. Furthermore, a 
previously unrecognised cranial shift in the anterior hypothalamus was also observed. 
Symptoms such as obesity and circadian rhythm defects are often associated with 
human SOD (Rivkees, 2003), which suggest a hypothalamic contribution to the 
disease. Our findings in the mouse model provide supporting evidence for this 
hypothesis. 
 
5.5.2 Population Atlases for Anatomical use 
In this study, multiple embryo MRI and image registration were combined to produce 
an MRI atlas that allows a number of white matter and other structures to be readily 
identified. Previous MRI-based anatomical studies of the embryo (Jacobs et al., 1999; 
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Petiet et al., 2008) have consisted of single subjects that are imaged at a particular 
timepoint. This single subject may not represent the true population average due to 
normal variations in development and may also have been affected by the preparation 
and the imaging process. An averaged dataset thus reduces the contribution of 
preparation and imaging effects from individual images not common to the whole 
population. Previously, wild-type population atlases have concentrated on 
characterising the adult mouse brain (Dorr et al., 2008; Kovacevi" et al., 2005; Ma et 
al., 2005), as anatomical structures are fully developed by this stage and subjects have 
consistent intrinsic MRI tissue contrast.  
 
The fidelity of the atlasing process in the developing mouse embryo can be seen in the 
quality of both CD-1 and 3-group average images, indicating good performance of the 
algorithm in identifying anatomical correspondence between subjects. The image 
sharpness of a resulting atlas has been shown to be a good indicator of the accuracy of 
registration (Robbins et al., 2004). It was also noted that in a number of organs other 
than the brain there was also good registration and enhancement in the average atlas, 
such as the liver, heart and great vessels. 
 
Having an efficient registration algorithm is essential for registration of large datasets 
such as presented here. Our non-linear registration algorithm – fast-Free-Form 
Deformation (F3D) (Modat et al., 2010) – is a new, parallel and scalable 
implementation of the well-known Free-Form Deformation (FFD) algorithm 
(Rueckert et al., 1999). Improvements to the registration optimisation process 
decreases computation time, thus allowing more iterations to be run. For example, 
registration of a single embryo dataset with ~57 million voxels, represents an 
optimisation problem with 3 million degrees of freedom. With our algorithm this may 
be completed in 1 to 2 hours on a standard computer compared to a much longer 
processing time (many hours to days) with the original FFD implementation. Our 
method is therefore well-suited to the needs of high-throughput screens, where speed 
without compromising accuracy and the ability to register large numbers of images is 
an important consideration.  
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Phenotyping of the CNS in prenatal mice by MRI has been mostly restricted to those 
with gross developmental abnormalities, such as a study of Cited2-/- mutants which 
displayed severe exencephaly (Schneider et al., 2003a). In that study, a small number 
of mutant embryos (n=4) were imaged. The findings of this chapter suggest that high-
throughput MRI could now be expanded to visualise and identify more subtle CNS 
defects through the combination of enhanced MRI contrast and atlasing methods. 
 
5.5.3 Automatic Volume Measurements in an Embryo Study 
A mixed average population atlas was used to make regional volume measurements 
from a single segmentation in the embryo. Previous work on volumetric 
measurements in the adult mouse brain has allowed the characterisation of wild type 
brains (Dorr et al., 2008; Kovacevi" et al., 2005) and also volume differences between 
mouse strains (Chen et al., 2006), but has not been performed in the embryo. After 
segmenting five volumes of interest on a mixed atlas of three groups of embryos, 
significant differences between CD-1 and Chd7 wild-type embryos were identified in 
propagated olfactory bulb and body volume. This was attributed to phenotypic 
differences between CD-1 and C57BL/6 strains at this stage of development, with 
CD-1s being generally larger. A significant difference between propagated brain 
volumes of Chd7 wild-type and Chd7+/- mice was also noted, indicating that Chd7 
may be implicated in the process of overall brain development. This would be 
consistent with recent histological findings of impaired olfactory bulb development 
(Layman et al., 2009) and previous descriptions of hearing and ear defects (Bosman et 
al., 2005). After normalising the propagated volumes to whole-body volumes, 
significant strain differences were seen in whole-brain and pituitary gland volumes. 
 
Both propagated volumes and those normalised to whole-body volumes were 
presented in this study. Normalisation of data may reduce the effect of non-gene 
related differences, such as variation in growth-rate, which could affect overall size 
and thus organ volumes. Both volumes are presented, as normalisation also has the 
potential to mask phenotypic effects, and as yet there is no accepted standard mode of 
data presentation. The ability to rapidly generate accurate volumetric data from an 
imaging modality such as MRI in the embryo is new and further work is required to 
fully assess the need for data normalisation in phenotypic analysis. 
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Given the brain volume differences identified between wild-type and the 
heterozygous Chd7 embryos (a mean volume difference of ~8%) one hypothesises 
that this sensitivity would be sufficient when screening the homozygous mutant 
embryos generally produced by the ENU mutagenesis programmes, which would be 
expected to exhibit more severe phenotypes. 
 
Our methods could also be used to address mutations with variable expressivity, 
where a phenotype may be present in one embryo but not others. By comparing 
embryos on an individual basis to an atlas of wild-types, and performing 




In this chapter, an average atlas generated from high-throughput multi-embryo MRI 
datasets was presented. The results demonstrated that anatomy is conserved in wild-
type CD-1 embryos, enabling the creation of an average embryo atlas that has 
effectively enhanced anatomical detail. Volumetric analysis of three groups of 
embryos using segmentation-propagation found significant brain volume differences 
between CD-1, Chd7+/- knockout and wild-type. Significant differences were 
observed in whole-body and olfactory bulb volumes between CD-1 and Chd7 wild-
types (C57BL/6 background). Normalising propagated volumes to whole-body, 
significant strain differences were also seen in whole-brain and pituitary gland 
volumes. 
 
As there is no limit to the number of embryos that may be registered, this technique 
opens the possibility for quantitative analyses of very large numbers (100s) of 
embryos with increased statistical power. One hopes this represents a first step 
towards combining high-throughput MR embryo imaging with high throughput 







Structural Correlates of Active-Staining Following 
Magnetic Resonance Microscopy in the Mouse Brain  
6.1 Chapter Overview 
Chapter 4 described the development of an optimised preparation and scan protocol 
for high-throughput phenotyping of the mouse embryo. In this chapter, this work is 
extended by examining optimal preparation and MR parameters to produce detailed 
images of the adult mouse brain. After optimising the preparation of ex-vivo in-situ 
brains for !MRI, enhanced delineation of subtle structures such as in the thalamus 
and hippocampus is demonstrated. Detailed histological comparisons of these 
structures with those seen on MRI are then performed. 
 
This work was produced in collaboration with Dr. Frances Wiseman, UCL Institute of 
Neurology, who culled and provided the animals used and Prof. Sebastian Brandner, 
UCL Institute of Neurology, who performed histological sectioning and staining. 
 
6.2 Introduction 
An ever-increasing number of mice are being created through genetic manipulation to 
advance the goal of translational neuroscience to produce and identify mouse models 
of human conditions. In order to investigate and validate these mouse models, detailed 
studies must be undertaken of the mouse brain. Phenotyping the brain 
morphologically conventionally relies on examination of cellular and anatomical 
structures by histology. While this method is ideal to visualise physiological or 
pathological changes on a cellular and architectural level, tissue processing artefacts 
and shrinkage affect the reliability of 3D volumetric assessments. Effective methods 
for rapid, non-invasive phenotyping are thus needed for the analysis of mouse 
mutants. 
 
In recent years these efforts have been advanced by the increasing use of microscopic 
MRI (!MRI) to characterise brain phenotypes of novel mouse mutants. MRI offers a 
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number of advantages over traditional histological sectioning, namely its ability to 
produce non-invasive datasets, which allow the accurate calculation of volumes 
without distortion. Morphometric techniques may then be used to allow the 
identification of novel phenotypes. Work in this field has lead to the creation of non-
invasive mouse brain atlases (Dorr et al., 2008; Ma et al., 2005) and has generated 
new insights into models such as Huntingdon’s disease and age-related 
neurodegeneration (Lerch et al., 2008; Sawiak et al., 2009b; Wetzel et al., 2008). 
 
!MRI produces high resolution datasets of ex-vivo tissue with isotropic resolutions of 
less than 100!m (typically between 21.5-70!m in most brain studies (Badea et al., 
2007b; Sawiak et al., 2009a)). This can be technically challenging, with each voxel 
representing a tissue volume of <1nL, conventionally requiring long scan times to 
obtain sufficient signal-to-noise (SNR). The innovation of tissue active staining, 
where gadolinium-chelate MR contrast agents are used during the fixation process to 
shorten T1 relaxation, has enabled the acquisition of high SNR 3D datasets with 
greatly reduced scan times (Johnson et al., 2002a).  
 
The appearance of !MR images acquired in this manner is sensitive to preparation 
and scan parameters including the contrast agent, fixation concentration and pulse-
sequence used (Cleary et al., 2009). It has been recently shown that the use of higher 
contrast agent concentrations (>5mM Gd-DTPA) as part of the fixation of mouse 
brains excised from the skull (ex-situ), in combination with a 3D gradient-echo 
sequence, can produce images with high contrast, delineating a number of brain 
structures seen on conventional histology (Huang et al., 2009; Kim et al., 2009). 
 
The combination of a high contrast agent concentration with in-situ preparation may 
produce enhanced neuroanatomical contrast and allow more detailed and sensitive 
morphometric atlases, with clearer delineation of regions of phenotypic change. 
Resulting volume measurements and morphometric analysis may also be less affected 
by preparation than ex-situ brains (Badea et al., 2007a).  However, there is little data 
in the literature comparing ex- and in-situ brains by MRI. Furthermore, the timecourse 
for optimal fixation of in-situ brains with an MR contrast agent is unknown and a 
direct histological correlation of brain structures enhanced through gradient-echo 
imaging together with active-staining has not been performed. 
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The specific aims of this study were to investigate enhanced tissue contrast using an 
active-stain !MRI preparation and optimised scanning protocol (Cleary et al., 2009) 
for imaging adult mouse brains.  Specifically the effect of active-staining on perfused- 
and simple immersion-fixed ex-situ brains was assessed and the in-situ MR tissue 
characteristics over a period of 9 weeks were monitored. Furthermore, this study 
sought to identify the optimal imaging parameters to enable rapid imaging of in-situ 
brains in 3 hours with a standard imaging coil. In particular contrast-enhanced brain 
structures were assessed via a direct comparison with tissue histology, which may 
give insights into the cellular distribution and mechanism of MR active-staining. 
 
6.3 Materials and Methods  
6.3.1 Animal Preparation:  
All parts of this study were carried out in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. Wild-type mice (n=8) (O'Doherty et al., 2005) were taken 
from a colony maintained by mating Tc1 females to F1 (129S8 x C57BL/6) males. 
The mice were culled by an overdose of sodium pentobarbitone administered by 
injection. 
! 
Ex-situ Brain Study:  In order to investigate the preparation of excised brains the 
effects of perfusion-fixation were compared to simple immersion-fixation. 2 of 4 mice 
were given an initial saline flush (15-20ml of normal saline at a flow rate of 
3ml/minute introduced via a needle in the left ventricle) and then perfusion-fixed with 
50ml of 4% buffered formol-saline (Pioneer Research Chemicals, Colchester, UK) 
with 8mM Gd-DTPA (Magnevist, Bayer-Schering Pharma, Newbury, UK) at a flow 
rate of 3ml/minute; the remaining 2 mice were simply culled. All 4 brains were then 
carefully extracted from the skull and post-fixed in 4% buffered formol-saline (with 
8mM Gd-DTPA) at 4°C. 
  
In-situ Study: For in-situ brain MRI, 4 mice were perfusion-fixed as previously 
described with 2 fixed using formol-saline perfusate alone and 2 with formol-saline 
with 8mM Gd-DTPA. After this, mice were decapitated and skin, muscle, lower jaw, 
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tongue, nasal bones and zygomatic arches removed, with the remaining intact skulls 
post-fixed in 4% buffered formol-saline (with 8mM Gd-DTPA) at 4°C. 
 
6.3.2 Imaging: 
All imaging was performed on a Varian 9.4T DirectDrive VNMRS system (Varian 
Inc., Palo Alto CA, USA) with a 26mm quadrature birdcage coil (RAPID Biomedical 
GmbH, Würzburg, Germany). Samples were removed from fixative and excess 
solution carefully blotted with a paper towel. They were then immersed in Fomblin 
perfluoropolyether (type PFS-1, Solvay Solexis S.p.A., Bollate, Italy) in 20ml plastic 
syringes and immobilised with surgical gauze. Samples were allowed to equilibrate 
for at least 2 hours at room temperature prior to imaging. Air bubbles in samples were 
minimised by the equilibration time and gentle agitation of the syringe. 
 
6.3.2.1 Ex-situ Study 
T1, T2* and 3D gradient-echo images of the 4 ex-situ brains were obtained after 7 days 
fixation. 1 immersion fixed and 1 perfusion-fixed brain were then reimaged after 2 
weeks fixation and further T1, T2* and 3D gradient-echo images obtained. Parameters: 
Single sagittal slice (0.5mm thick), matrix=128x64, FOV=18x9mm, NSA=4, TR was 
at least 5xT1. T1: Inversion-recovery spin echo, 17 TIs (range 6-400ms), TE=10ms; 
T2*: Gradient echo, FA=90°, 11 TEs (2.9-14ms). 3D RF-spoiled gradient-echo 
imaging: FOV=18x18x9mm, TR=20ms, FA=60°, NSA=6, matrix=256x256x128, 
TE=9 or matrix=450x450x225, TE=6ms. 
 
6.3.2.2 In-situ Study 
4 Wild-type Tc1 skulls were fixed and imaged over a 5 week period. T1 and T2* maps 
were obtained at each time point. Parameters: Single sagittal slice (0.5mm thick), 
matrix=128x85 (reconstructed on the console to 128x128), FOV=19.5x13mm, 
NSA=4. TR was at least 5xT1. T1: Inversion-recovery spin echo, 13 TIs (range 
appropriate for estimated T1), TE=10ms; T2*: Gradient echo, FA=90°, 8 TEs (range 
appropriate for estimated T2*). 40!m isotropic, structural 3D gradient-echo images at 
unoptimised parameters were also obtained (FOV=20.48x13.04x13.04mm, matrix 
size=512x326x326, TE/TR/FA=6ms/20ms/60°, NSA=2 or 6). Measured tissue 
parameter values were input into a Matlab program (The Mathworks Inc., Natick MA, 
USA) employing the theoretical equation for spoiled gradient echo signal (Eq. 6.1) to 
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determine the approximate optimal scan parameters for maximal cortex-corpus 
callosum contrast in a 3 hour scan-time, as described previously (Cleary et al., 2009). 
 
(Eq. 6.1)  
   
The effect of echo time on brain contrast was also investigated experimentally by 
repeated imaging of one brain at 5 weeks fixation with 5 different echo-times (3.8-
7ms). 
 
6.3.3 Delineation of Anatomy on MRI and Histological Correlation 
4 additional perfusion-fixed in-situ brains were then imaged using our final protocol 
after 9 weeks fixation (males, ages 18-21 weeks) in 4% buffered formol-saline (with 
8mM Gd-DTPA), using an RF-spoiled gradient-echo sequence. Optimised 3D GE 
scan parameters: FOV=20.48x13.04x13.04mm, matrix size=512x326x326, 
TE/TR/FA/NSA=4ms/17ms/52°/6.  
 
One brain was carefully extracted from the skull, dehydrated using graded alcohols 
and xylene, embedded in paraffin, cut into 3-!m sagittal sections and processed for 
haematoxylin-eosin (H&E) and Luxol Nissl staining. Antibodies or antisera against 
the following antigens were used: GFAP (DAKO Z0334), MAP-2 (Chemicon 
MAB3418), Neurofilament 200 (Sigma N5389); Myelin basic protein (SMI94). All 
immunostaining was carried out using the automated Ventana Benchmark or 
Discovery (Ventana Medical Systems) automated staining apparatus following the 
manufacturer’s guidelines, using biotinylated secondary antibodies and a horseradish 
peroxidase-conjugated streptavidin complex and diaminobenzidine as a chromogen. 
Slides were photographed with a SIS Megaview 3.2 megapixel digital camera 
mounted on a ZEISS Axioskop. 
 
6.3.4 Image Processing 
T1 and T2* maps were created by a pixel-by-pixel, least-squares fit of the resulting 
data using in-house C-programs. The inverse of these were also calculated, using 
ImageJ (National Institutes of Health, Bethesda MD, USA), producing corresponding 
maps of R1 and R2*.   Statistical analysis of map values was performed in Prism v5.00 
(GraphPad Software, San Diego CA, USA). 3D volume images were reconstructed 
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and converted to Analyze format using custom Matlab code and reviewed in ImageJ. 
SNR and CNR was measured in a number of brain regions by taking the ratio of 
average and signal differences in whole-structure volumes and the standard deviation 
in a region of background noise (Eq. 6.2): 
 
(Eq. 6.2)   
 
Visualisation of brain structures was performed in Amira software (v5.2.2, Visage 
Imaging Inc., Andover MA, USA). 
  
6.4 Results 
6.4.1 Ex-situ Study: Comparison of Immersion and Perfusion-fixed Brains at 
Two Fixation Durations.  
After 7 days immersion in contrast-fixative, there was no significant difference in T1 
and T2* values between the immersion and perfusion-fixed brains (p>0.40 in all 




T1 and T2* measurements were repeated at 2 weeks (Figure 6.1). A similar change 
was observed in whole-brain T1 (perfusion: 33.2 to 31.4 and immersion: 35.1 to 31.7) 
and T2* (perfusion: 3.7 to 3.5 and immersion: 3.5 to 3.2) between 7 days and 2 weeks 
(Figure 6.1).  
 
 Perfusion Fixation (n=2)  Immersion Fixation (n=2) 
Region of 
Interest  
Cortex Cerebellum Whole-brain  Cortex Cerebellum Whole-brain 
        
T1 (ms) 32.2±0.4 31.8±0 33.2±0.2  33.1±1.3 28.2±6.2 34.2±1.3 
T2* (ms) 4.4±0.6 5.1±0.8 3.7±<0.1  4.4±0.2 5.2±0.2 3.8±0.3 
Table 6.1: Table showing T1 and T2* values in brains after 7 days immersion only or 
with initial perfusion-fixation (mean values ± SD). 
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Figure 6.1: T1 and T2* maps showing similar sagittal slices and mean, whole-brain 
T1 and T2* values through representative immersion and perfusion-fixed brains after 
7 days and 2 weeks. 
 
It was noted that the immersion-fixed brains had sustained some additional cortical 
damage during the extraction process when compared to the perfusion-fixed brain 
(Figure 6.2). Furthermore, cortical vessels, although present in both immersion and 
fixed brains, were more apparent in the perfusion-fixed brains, otherwise the brains 
from the two methods appeared similar.  This comparison indicates that the use of 
simpler immersion-fixation method, where the brain is removed directly from the 
skull without perfusion-fixation, would facilitate magnetic resonance microscopy 




Figure 6.2: Representative slices through 3D volumes of brains imaged after 2 weeks 
fixation (40!m isotropic resolution). 
 
6.4.2 In-situ Study 
Given that varying degrees of cerebellar and cortical damage was apparent in all 
brains imaged, the feasibility of contrast-enhanced imaging with the brain in-situ was 
explored. Initially it was investigated whether the addition of 8mM Gd-DTPA in the 
initial perfusate would improve the rate of T1 reduction over perfusion fixation and 
immersion fixation alone. After measurement of T1 and T2* values in each group after 
1 week fixation, it was apparent that there was no significant difference (p>0.65) in T1 
data: therefore all brains were pooled in subsequent analysis. MR parameters were 
measured over 1, 2, 3, and 5 weeks. Table 6.2 demonstrates that T2* values were 
found to reach a minimum at 3 weeks immersion (mean thalamus-midbrain=2.9ms, 
cortex=3.8ms).  In contrast, T1 values continued to reduce after 3 weeks, approaching 
uniformity across the brain by the 5 week timepoint (mean thalamus-midbrain 
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region=48±3 ms, cortex=43±2ms, Table 6.2). Figure 6.3 illustrates the corresponding 
regional R1 changes occurring over 5 weeks.  It was observed that a greater 
immersion time lead to a lower T1 (e.g. whole-brain T1: 1 week 109±53 vs. 5 weeks 
44±2ms, p<0.05, Table 6.2) and also reduced the magnitude of T1 difference between 
cortical and midbrain-thalamus structures deep in the centre of the brain (e.g. mean 
difference at 1 week=15ms vs. 5 weeks=5ms, Table 6.2).  
 
 
An increase in the conspicuity of white matter structures (such as fibres of the internal 
capsule) was observed on 3D images with increasing immersion time (Figure 6.3). 
 









      
Immersion 
Duration  
     
1 week 113±32 99±23  6.1±1.5 6.3±1.1 
2 weeks 67±5 55±4  3.4±0.2 4.3±0.3 
3 weeks 61±7 49±3  2.9±0.2 3.6±0.3 
5 weeks 48±2 42±2  3.2±0.2 4.0±0.1 
Table 6.2: Table showing T1 and T2* values within cortical and central thalamus-
midbrain regions of interest over 5 weeks fixation. 
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Figure 6.3: Comparison of representative R1 maps and similar volume slices from the 
same in-situ brain over 5 weeks fixation. As seen in R1 maps (top) a greater amount of 
time is required for values in the centre of the brain to equilibrate with more cortical 
regions. Although a modest SNR enhancement may be seen in 3D gradient-echo 
images after successive weeks (bottom), there is a noticeable improvement in the 
quality of structural delineation, particularly in the hippocampus (blue-arrows) and 
white matter structures (e.g. internal capsule, red arrows; mammilothalamic tract, 
yellow arrows). (Images identically scaled) 
 
6.4.3 Scan Parameter Optimisation 
From calculations using mean T1 across the whole-brain at 5 weeks immersion, it was 
determined that parameters of TR=17ms, NSA=6, at the whole-brain Ernst angle 
(47°) would produce the highest SNR (assuming constant noise), in a 3 hour scan 
time.  From the T2* data at 1 week the ratio of M0 in the corpus callosum relative to 
cortex in the 4 brains was estimated to be 0.96±0.01. Using these estimates and T2* 
values from maps at 5 weeks, it was calculated that a TE of approximately ~3.4ms 
would give optimal cortex/corpus callosum contrast. To ascertain the optimal TE at 5 
weeks experimentally, repeated high-resolution scans of a single brain from our 
dataset were performed, with the calculated TR, NSA and flip angle above. Figure 6.4 
shows the effect of varying TE from 3.8ms (the minimum permitted by the system at 
100kHz bandwidth) to 7ms. Although SNR in all structures was highest at TE=3.8ms 
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(whole-brain SNR=31.5), cortex-corpus callosum CNR appeared to be maximal at 
TE=4ms (CNR=7.5, whole-brain SNR=30.3). Interestingly white-grey matter CNR in 
the cerebellum peaked slightly later at a TE=5ms (CNR=22.4). 
 
 
Figure 6.4: Representative sagittal slice (A) and measured SNR (B) and CNR (C) 
from 3D volume data of a brain imaged after 5 weeks fixation at five different echo 
times. 
 
As indicated in Figure 6.5, it was noted that increasing echo time appeared to enhance 
the delineation of more subtle structures, such as cortical layers and the layer of 
Purkinje cells in the cerebellum, indicating a T2* dependency to this contrast. Opting 
for a balance of high SNR and high grey-white matter CNR, final parameters of 





Figure 6.5: Enlarged sections of cerebellar lobe and cortex showing their 
appearance at TE=3.8 and 7 ms. Red arrows appear to correlate to the Purkinje 
layer of the cerebellum and appear to become more defined at a longer TE, as does 
the visibility of cortical layers. (Images identically scaled) 
 
6.4.4 Brain MR Parameters at 9 weeks 
After identifying the need for a long immersion duration to enable full penetration of 
contrast agent, the above optimised parameters (FA=52°, appropriate for these T1s) 
were applied to a further 4 in-situ brains after 9 weeks immersion, acquiring T1 and 
T2* maps and high-resolution 3D volumes. Compared to 5 week data, while R2* 
values remained similar in both cortical and thalamus-midbrain regions to our 
previous brains (Figure 6.6B), R1 showed a more marked increase (Figure 6.6A), with 
the corresponding whole-brain T1 measured as 35±2ms compared to 44±2ms of 
previous brains at 5 weeks.  As seen in a corresponding R1 map of a sagittal slice 
through an example brain (bottom right, Figure 6.6), values have a narrow distribution 
across the brain (SD of T1 values over whole-brain ROI=3.8±0.1ms, n=4) indicating 
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that 9 weeks immersion may be more suitable. Whole-brain SNR was comparable to 
previous 5 week data and measured to be ~30.  
 
Figure 6.6: Graph showing the timecourse of R1 (A) and R2* change (B) with 
immersion time in fixative+Gd-DTPA solution, incorporating values from the 
previous 5 week study and 9 week brains indicating a minima has been reached. 
Representative R1 maps from 5 and 9 week brains shown for illustration (C). 
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6.4.5 Structural Correlates of Active-Staining in the Brain  
The resulting gradient echo images acquired at the selected parameters 
(TE/TR/FA/NSA=4ms/17ms/52° Ernst angle/6 averages), after 9 weeks in contrast-
fixative, demonstrated excellent contrast, enabling the delineation of a number of 
structures in the cortex, hippocampus, olfactory bulb and cerebellum (Figure 6.7, 
sagittal image). In the hippocampus, individual layers were clearly visible such as a 
bright granular cell layer of the dentate gyrus, as well as bright region of the stratum 
lucidum and dark layer in the region of CA3 (Figure 6.7, coronal view A, blue panel). 
Individual nuclei were also visible, including medial and lateral habenular nuclei and 
a number of thalamic nuclei (Figure 6.7, coronal view A, green panel).  White-matter 
tracts were easily visualised, appearing with strong negative contrast on gradient-echo 




Figure 6.7: Sagittal and corresponding coronal views through a brain fixed for 9 
weeks and imaged at optimised parameters. Sagittal view (top) shows the principal 
anatomical structures seen. Coronal view (A) shows hippocampal anatomy visible 
(blue panel) and visible nuclei (green panel). Coronal view (B) shows visible white-
matter tracts. 
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Sagittal MR images were compared to histology where a good correlation was 
observed between a number of white matter structures defined on a neurofilament 
stained section and equivalent dark areas on a similar MR image (Figure 6.8A). 
Structures such as the anterior commissure, superior colliculus commissure and 
fasciculus retroflexus were easily visualised. 
 
In the cerebellum, (Figure 6.8B) structures on MR correlated well to those seen on 
histology, such as the bright outer molecular layer, consisting of mostly Purkinje cell 
dendrites (seen on calbindin section, Figure 6.8B), a bright granular cell layer and 
dark Purkinje cell layer (evenly-spaced, large Purkinje cells visible in all sections, 
Figure 6.8B) and axonal fibre tracts (Figure 6.8B, neurofilament section). While MR 
signal intensity was high in both molecular and granular layers, the granular layer 
appeared to be slightly hypointense. 
  
In the olfactory bulb (Figure 6.8C) the main features of mitral, glomerular and 
external plexiform layers were easily identified in MR images, with these regions 
correlating well to all stains. Sublayers in the granular cell layer, seen on H&E and 
calbindin sections (Figure 6.8C), were not readily apparent on MR with images best 




Figure 6.8: (A) Representative sagittal sections through MRI and a similar neurofilament histology section in the same brain, showing visible white-
matter anatomy. (B) Detail through the cerebellum showing the correspondence of structures between histology and MRI such as the granular, 
molecular and Purkinje layers and axonal fibre tracts. (C) Detail through the olfactory bulb showing layers identified on similar histology sections 
from the same brain. 
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As hippocampal anatomy was especially well defined on MRI, identification of the 
source of the regional MR contrast was sought by histological comparison. In addition 
to standard histological stains, the data was also compared to a standard Timm stained 
section – an established method of visualising the presence of intracellular Zn2+ that 
characterises hippocampal mossy fibres (Haug et al., 1971). Figure 6.9A shows a 
comparison of hippocampal structures with a similar axial Timm section from a 
C57BL/6 mouse (Crusio et al., 1986). A conspicuous area of hypointensity in the 
stratum pyramidale region of CA3 (orange arrows, Figure 6.9A and B) was observed, 
which correlated with unmyelinated mossy fibres synapsing with pyramidal cells 
(Figure 6.9A(iv) and 9B, Timm and calbindin sections respectively).  Previously, it 
was observed that hypointensity was associated with myelinated white matter 
structures (Figure 6.8A), which is not the case in the stratum pyramidale. An area of 
myelinated fibres in the dentate gyrus molecular layer (Figure 6.9B, blue arrows) did 
not result in a hypointensity on MRI. Closely associated and lateral to the stratum 
pyramidale (concave aspect; red arrows) are the suprapyramidal mossy fibres 
(running in the stratum lucidum) a region of unmyelinated axonal fibres (Figure 6.9A 
and B, Timm and calbindin sections) that appeared as an area of hyperintensity within 
CA3. The granular layer of the dentate gyrus (green arrows, Figure 6.9A) was clearly 
visible as a region of hyperintensity that correlated to a dense area of closely packed 




Figure 6.9: (A) Hippocampal view (ii) from an axial MRI slice (i) compared with a representative section from a C57BL/6 mouse hippocampus stained 
with Timm silver sulphide stain (iv), showing regions of high ionic zinc concentration, a feature of hippocampal mossy fibres. Red arrows indicate 
correspondence with mossy-fibre bundles, orange with pyramidal cells, green with the granular layer of the dentate gyrus. (Timm section adapted from 
(Crusio et al., 1986)) (B) Sagittal view of hippocampal anatomy from a brain fixed for 9 weeks compared with H&E, calbindin and myelin basic protein 
(MBP) stained sections. Dark regions on MR (orange arrows) appear to correlate with heterogeneous regions containing mossy fibres and pyramidal 
cells. Corpus callosum (white arrows) indicated for comparison. Blue arrows in the MBP section indicate a diffuse region of myelinated fibres in the 
molecular layer of the dentate gyrus. 
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6.5 Discussion 
After an initial study of ex-situ brains which showed a high degree of extraction 
damage, subsequent investigation demonstrated that in-situ brains prepared in a 
solution of 8mM Gd-DTPA and imaged with gradient-echo sequence produced high-
resolution (40!m isotropic), high SNR images, with a 3-hour scan time. Additionally, 
structures delineated on MR were shown to directly correlate to those defined on 
histology, such as major white matter tracts and layers of the olfactory bulb and 
hippocampus. This comparison has then enabled us to assess the effects of tissue 
microstructure on MR contrast of actively-stained tissue. 
 
6.5.1 Ex-situ Brain Imaging 
Ex-situ brain imaging with a gradient-echo sequence has been reported previously 
(Huang et al., 2009; Kim et al., 2009) and our ex-situ brains show T1 and T2* values 
are in line with those studies (T1"30ms, T2"7ms, 10mM Gd-DTPA, after 4 days 
immersion in contrast-fixative (Kim et al., 2009)) displaying similar image contrast. 
Additionally our study has shown that these values remain relatively unchanged even 
after extending the immersion time to two weeks (e.g. mean T1 perfusion-fixed went 
from 33 to 31ms) to leave more time for Gd-DTPA penetration. It was demonstrated 
that brains need not be perfusion-fixed and that simple immersion-fixation produced 
equivalent image quality, thus enabling magnetic resonance histology in laboratories 
where perfusion-fixation is not readily available. Imaging of extracted, ex-situ brain 
tissue does have some advantages, in that smaller RF coils can be used, improving 
SNR and a smaller field of view may improve imaging-time (Kim et al., 2009). 
However the tissue damage observed in our ex-situ brains may compromise their use 
for automated and quantitative morphometric analyses where accurate anatomical 
volumes and morphology are essential for sensitivity. 
 
6.5.2 In-situ Brain Optimisation 
Given the effect of damage in ex-situ imaging later parts of this study focussed on in-
situ brain preparation and MR methods optimisation to produce detailed images of the 
mouse brain. It was demonstrated that full penetration of Gd-DTPA into brain tissue, 
as assessed by R1 values in the cortex and basal ganglia, had equilibrated across the 
brain by 9 weeks. Indicating that a much greater immersion time is required than in 
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the ex-situ brain in order to produce the maximal increase in SNR, and thus image 
quality, across the brain. 
 
Currently there is no standard protocol for in-situ brain preparation and scan 
parameters, with a number of approaches in current use. A T2-weighted 3D fast spin-
echo sequence (FSE) with brains fixed in 2mM gadoteridol (a non-ionic macrocyclic 
Gd-chelate) for at least 7 days (Tyszka et al., 2006) is able to produce T2-weighted 
images of multiple in-situ brains with a 32!m resolution in a 11.3 hour scan, and has 
been successfully used for morphometric phenotyping (Ellegood et al., 2010a) and 
atlasing (Dorr et al., 2008) studies. While this can offer good T2-weighted images 
with an improved imaging time, the use of an FSE sequence can lead to image 
blurring and a loss of structural definition (Mulkern et al., 1990). 
   
Partial-Fourier spin-echo has also been successfully used for in-situ phenotyping 
studies giving T1-weighted images with 21.5!m resolution in a ~2 hour scan time 
(Badea et al., 2007b). Sharief and Johnson developed an innovative multi-echo T2 
sequence (Sharief and Johnson, 2006) where reconstructed images combine data from 
a number of echo times. This has the effect of improving contrast, especially in T2-
dependent structures such as in the cortex and brain nuclei. In both these imaging 
protocols, brains are initially perfusion-fixed with a high concentration (50mM – 
assuming a standard 0.5M clinical solution) of gadoteridol and fixed overnight 10% 
formalin prior to imaging.  
 
Our results indicate that, in the in-situ brain, such short immersion periods may not be 
sufficient to give maximal T1 reduction (and thus SNR gain) over the whole brain. If 
one assumes that a T1 of ~31 ms (2-week ex-situ data) is a likely minima for values 
after Gd immersion, this level is nearly achieved after 9 weeks (whole-brain T1 
~35ms). The need for such an increase in immersion time compared to ex-situ brains 
for Gd penetration is most likely due to the presence of intact meningeal layers and 
limited entry points for fixative into the skull (e.g. through the foramen magnum and 
orbits) resulting in a greatly reduced exposed brain tissue surface-area.  
 
Although a virtue of gradient-echo imaging is a short TR and thus reduced acquisition 
time, this makes it sensitive to T1 differences. The heterogeneity seen in R1 maps, 
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corresponding to higher T1 values in more central structures compared to cortical and 
cerebellar regions, will thus limit T1 recovery, causing signal reduction in these 
portions of the brain. As the majority of these regions, such as basal ganglia and 
midbrain contain white-matter fibres, there is likely to be an intrinsically lower signal 
due to the lower T2 of myelinated structures (Counsell et al., 2003). Thus it is 
important to ensure there is adequate agent penetration to ensure full T1 recovery in 
these regions. Although TR could be increased to compensate, in chapter 4 it was 
shown that increased signal averaging is generally preferable to small TR increases to 
boost SNR (Cleary et al., 2009) and is thus not ideal when imaging with a fixed scan 
time. The benefits of allowing a greater degree of T1 reduction are readily seen in our 
gradient-echo images taken over 5 weeks (Figure 6.5), in which structures of the 
hippocampus and white matter tracts are more conspicuous by the last 5 week 
timepoint. 
 
Although active-staining primarily acts to reduce tissue T1 due to administration of 
contrast agent (Johnson et al., 2002b; Petiet et al., 2007) there is also a corresponding 
reduction in T2 (Cleary et al., 2010; Petiet et al., 2007). This may also be exploited to 
produce image contrast using much shorter TEs than in normal tissue. 
  
In our method, the use of a relatively high contrast agent concentration, leads to a 
large mean reduction and compression of the whole range of normal tissue T2 values. 
For example, as T2* is now ~3.8ms as measured in the cortex (in-vivo T2"45ms at 
9.4T (Uematsu et al., 2007)), our chosen echo-time of 4 ms results in T2*-weighting 
in that region, allowing cortical layers to be visualised. Similarly, increased T2*-
weighting, improves visualisation of the Purkinje layer of the cerebellum. Thus an 
8mM Gd-DTPA concentration with a gradient-echo sequence with a relatively short 
TE and TR combines the potential of a short scan time and a high number of signal 
averages and an optimal T2* weighting to reveal tissue contrast.  
 
The contrast observed in our gradient echo images may be explained by a 
combination of intrinsic tissue MR relaxation and effect of contrast agent 
concentration. For example, myelinated white matter is known to have a lower T2 
than grey matter, due to higher bound water content (Counsell et al., 2003), giving a 
characteristically darker signal on MR images in-vivo, which was also observed in the 
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data.  This is probably best explained by the contrast agent reducing T2 values but still 
preserving T2 differences between tissues, which can be exploited by the correct MR 
parameters. Yet it has also been suggested that distribution of agent itself may be 
enhancing contrast, particularly in non-myelinated structures (Huang et al., 2009). 
Although this is unlikely to account for our observed white matter contrast: using R1 
maps as an indication of contrast agent concentration, the lack of regional contrast in 
maps at 9 weeks does not suggest a selective regional distribution of contrast agent, 
where higher concentration of contrast agent would be expected to result in area of 
increased R1.    
 
Interestingly, negative contrast was also observed in classically unmyelinated regions 
of the hippocampus that did not appear to depend on the presence of even small traces 
of myelin (as seen in our MBP-stained section, Figure 6.9B, blue arrows).  Previous 
work in the ex-situ mouse brain has suggested that ~23% of brain volume is 
inaccessible to the Gd-DTPA indicating the agent is not distributed uniformly at a 
cellular level (Huang et al., 2009).  The present study reinforces this view, as the dark 
appearance of these unmyelinated regions are likely to be due to increased local Gd-
DTPA distribution and MR susceptibility at a local level. Thus the choice of a 
gradient echo sequence is ideally suited to detection of such regions, especially those 
with subtle T2* differences. 
 
Both intrinsic contrast and susceptibility could explain the subtly different appearance 
of molecular and granular layers of the cerebellum on MR. Although the granular 
layer contains a great number of densely packed cells, as seen on the neurofilament 
stain, there are still a large number of axonal fibres passing through this region. This 
could result in the observed hypointensity either through intrinsic relaxation 
mechanisms where the presence of such myelinated tracts, with a lower T2*, leads to 
a partial volume effect with a slight loss in signal, or the regional cytoarchitecture, 
comprising a mixture of cell bodies and axons, could affect local Gd-DTPA 
distribution, causing a susceptibility effect.  
 
Similarly an enhancement of the layer of Purkinje cells was observed with increasing 
echo time. This layer also contains a mixture of large Purkinje cells surrounded by 
basket cell axons. However a large T2* dependence on contrast in this region was 
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observed, indicating that susceptibility effects through structural heterogeneity play a 
greater role, probably due to distribution of contrast agent.  
 
In the olfactory bulb, the observed contrast delineated the mitral and glomerular but 
not granular layers. In previous in-vivo high-resolution T2-weighted images (Boretius 
et al., 2009) all of these regions were observed including granular layers. It is 
conceivable that the more complex cytoarchitecture of both glomerular and mitral 
layers may explain this observation. Glomeruli are relatively large structures that 
consist of a number of nerve synapses, surrounded by glial cells (Kosaka et al., 1998); 
also mitral cells have axonal fibres that contribute to the olfactory tract (Shepherd et 
al., 2007). In contrast, granule cells possess only dendritic processes and are without 
axons (Price and Powell, 1970). This more complex structure may lead to greater 
susceptibility effects in the presence of contrast agent in these regions.  
 
Comparisons with previous diffusion-weighted (Shepherd et al., 2006) and in-vivo 
work (Boretius et al., 2009) may offer some explanation for the enhanced contrast 
seen in the hippocampus. The area of the stratum lucidum has been seen as 
hyperintense on diffusion images in the rat (Shepherd et al., 2006) indicating a region 
of restricted diffusion that may affect the access of Gd-DTPA to the region and thus 
maintain a longer T2* than surrounding tissue. Similarly, the dense packing of 
granular cells in the dentate gyrus may prevent infiltration of contrast into the region 
and also maintain a long T2* resulting in its bright appearance. 
 
Previous work (Benveniste et al., 2000) has shown contrast enhancement in the 
hippocampus on subsequent ex-vivo images monitored over a period of 2 to 50 hours 
after initial in-vivo perfusion-fixation with Gd-DTPA. Images acquired at 2 hours post 
fixation showed a general increase in signal over the whole hippocampus, but the 
granular layer of the dentate gyrus appeared particularly hyperintense. The stratum 
pyramidale was visible as a dark band. Over subsequent timepoints, while signal 
enhancement over the whole hippocampus appeared to be maintained, the conspicuity 
of both granular layer and stratum pyramidale was greatly reduced. This evolution of 
contrast was attributed to the vascular nature of this region, with intravascular 
retention and extravasation of contrast agent leading to the appearance of reduced and 
increased signal respectively. The initial enhancement seen in the granular layer may 
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indicate that the hippocampus is compartmentalised, possessing regions accessible to 
contrast agent to a greater or lesser degree. High-resolution in-vivo imaging, without 
contrast, has also demonstrated delineation of hippocampal structures in T2-weighted 
images, including the stratum pyramidale, and granular and polymorphic layers of the 
dentate gyrus (Boretius et al., 2009). In images with strong weighting (TE=82ms), 
contrast in these regions was markedly different to that of ours as both dentate gyrus 
and stratum pyramidale appeared hypointense, with the stratum pyramidale visible as 
a continuous line from CA3 to CA1. Also the granular layer of the dentate gyrus was 
not easily distinguished from the polymorphic layer. These findings suggest that in 
certain structures local accumulation of contrast agent can contribute to MR 
appearance more than intrinsic tissue T2* contrast. This suggests the exciting 
possibility that targeting such regions could provide the basis for the investigation of 
novel MR microscopy stains. 
 
While the presence of contrast agent is likely to contribute most to changes in tissue 
parameters, an additional consideration is tissue fixation. Aldehyde fixatives cause the 
cross-linking of proteins (Fraenkel-Conrat and Olcott, 1948), reducing water mobility, 
resulting in a reduction of tissue MR relaxation times (Dawe et al., 2009). A study in 
the rat cortical slice model (Shepherd et al., 2009) found T1 reduced 21% after >10 
days fixation, although an 81% T2 reduction could be reversed after washing out the 
fixative by immersion in PBS. Timecourse studies in fixed human brain have also 
shown a progressive decreases in T1 and T2, with T1 change occurring fastest over the 
initial 1-2 weeks and a slower decline after 5 weeks (Tovi and Ericsson, 1992). Grey 
and white matter T1 (Pfefferbaum et al., 2004) and T2 values (Blamire et al., 1999) 
also tend to converge with a longer fixation time. There are, however, few studies in 
the literature assessing the effect of fixation on the use of Gd-chelates. Work in 
Xenopus oocytes (Purea and Webb, 2006) indicates that fixation may alter cell 
membrane structure, enabling the entry of contrast into the cytoplasm. However, 
further experiments are needed to examine the role of fixation on contrast in active-
stained !MRI of the mouse brain.  
 
The time needed for the penetration of agent in our methodology may be a 
disadvantage, as histological techniques, especially in light of developments in 
automatic sectioning systems, can provide more detailed information in a similar 
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The findings of this chapter show that active-stained !MRI can provide detailed 
anatomical images of the in-situ mouse brain with high resolution and signal-to-noise. 
Additionally, a variety of stains were used to identify and compare the MRI 
appearance of brain structures to those defined by histology. Combining this data has 
highlighted possible mechanisms for the enhanced contrast in these regions, surmising 
that contrast depends on both preserved, intrinsic T2* differences as well as regions 
delineated by distribution of active-stain due to tissue microstructure. This 
methodology could enable greater sensitivity for the phenotypic characterisation in 
mutant mouse models and enhance regions of the mouse brain that may be targeted in 




Contrast-enhanced !MRI for High-throughput 
Phenotyping, as Applied to the Tc1 Model of Down 
Syndrome  
 
7.1 Chapter Outline 
The preceding chapter demonstrated an optimised preparation and scanning protocol 
for the adult mouse brain. This chapter goes further in applying this protocol to enable 
a tensor-based morphometry analysis of the Tc1 model of Down syndrome, 
identifying novel phenotypes. 
 
This work was produced in collaboration with Benjamin Sinclair (CABI/CMIC UCL), 
who developed and validated the software tools used for the high-throughput TBM 
analysis of this data. Also Dr. Frances Wiseman (UCL Institute of Neurology) who 
culled and provided the animals used.  
 
7.2 Introduction 
Neurological disease models are a major application of gene-targeted and transgenic 
mouse technologies. In recent years, there has been a dramatic increase in the 
production of novel mutant mice in order to develop new and improved models of 
human conditions. 
 
A particular application of transgenic methods has been to the human condition Down 
syndrome (DS). In human patients, this condition results in a non-disjunction 
germline transmission of all or part of an additional copy of chromosome 21 (Hsa21), 
giving a theoretical 50% increase in gene dosage. The condition is the most common 
chromosomal disorder of newborns, with a typical incidence of 1 in 700 live births. 
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The condition affects a number of organ systems but congenital heart defects, 
neurological and craniofacial malformations are the most common. The structural 
consequences of brain anatomy in DS typically include an overall smaller brain-
volume and reduced cerebellar size (Beacher et al., 2010). In older subjects 
ventricular enlargement may be common as part of the early-onset dementia 
associated with DS.  
 
Although there are instances of transmission of part of Hsa21, 95% of DS affected 
individuals carry a complete copy of chromosome 21. Although the smallest of 
human chromosomes, Hsa21 still houses a large number of genes. Initial estimates put 
the total at ~230 (Hattori et al., 2000), although recent advances in the detection of 
non-protein coding RNA put this figure as high as ~400 (Gardiner and Costa, 2006). 
 
With such a large number of genes, the effect of this increased dosage is wide-
ranging. The additional copy of Hsa21 results in elevated expression of many of the 
genes encoded on this chromosome, with varying expression levels in different 
tissues. The increased dosage of Hsa21 genes, and the dosage imbalance between 
Hsa21 and non-Hsa21 genes has been proposed to cause the phenotypic alterations 
that characterise DS. 
 
Hsa21 is syntenic to three regions of the mouse genome. Most of the genes on Hsa21 
have homologous genes on mouse chromosome 16 (Mmu16), but two smaller gene 
rich regions have synteny on Mmu10 and Mmu17. The majority of mouse models 
used for DS research are either trisomic for large regions of Mmu16, 10, 17 or are 
transgenic animals used to investigate overexpression of a single gene, such as 
DYRK1A.  
 
With the use of a number of mutants to model DS, spanning from single genes to the 
length of Hsa21, the key genes that control the condition are slowly beginning to be 
identified. This characterisation of Hsa21 should enable the discovery of new 
pharmacological targets and one day even allow the possibility of DNA-based 
therapies for the condition. 
 
! -187- 
A model of DS that has been of great interest in recent years has been the 
transchromosomic (Tc1) mouse, produced as part of efforts beginning in the late 
1980s, culminating in an initial characterisation reported in 2005 (Hernandez et al., 
1999; O'Doherty et al., 2005). In this model a near complete form of Hsa21 is 
introduced into the mouse, with the aim of examining the effects in the mouse but 
using human genetic material to offer a more translational model of the condition. 
This also opens the possibility to monitor the effects of future drug treatments in 
specifically modulating the human gene and protein expression in an animal model. 
While preliminary measurements of skull morphology, and cerebellar neuronal 
density have been made in its initial characterisation (O'Doherty et al., 2005), so far 
no examination of whole-brain anatomy in the Tc1 model has been performed. 
  
Other DS mouse models trisomic for mouse syntenic regions to chromosome 21 have 
demonstrated altered brain morphometry and reduced cerebellar volume (Aldridge et 
al., 2007) and also ventricular enlargement (Ishihara et al., 2010).  
 
Brain phenotyping in the mouse is still heavily reliant on conventional histological 
methods – typically sectioning and microscopic examination. While histology can 
offer high-resolution datasets that can provide cellular and molecular information 
using staining techniques such as immunohistochemistry, volumetric morphologic 
assessment is difficult due to the effects of processing and tissue destruction. It is also 
a very slow process, often requiring a day or more to section a single brain. This low 
throughput reduces the utility of histology in providing the screening and analysis 
needed for high-volume phenotyping studies.  
 
Microscopic MRI (!MRI) is an established, non-invasive method that can produce 
high-resolution 3D datasets of the mouse brain. Additionally, the digital nature of 
these datasets allow the use of observer independent, automated analysis techniques 
such as voxel and tensor-based morphometry (VBM and TBM respectively) 
(Ashburner and Friston, 2000). These are now standard tools for the groupwise 
analysis of human brain studies and are increasingly used in preclinical imaging 
studies (Badea et al., 2007a; Lerch et al., 2008; Sawiak et al., 2009b). A challenge has 
been the adaptation of existing software tools for the mouse brain, particularly in the 
complex non-linear image registration that underpins the use of TBM and VBM 
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techniques. Clinical studies often use multislice imaging sequences, with a relatively 
coarse resolution and slice-thickness. Such scans are fast, well-suited to in-vivo 
studies and result in a relatively small data size (order of ~megabytes). In the mouse 
brain there is the possibility of high-resolution (~10s of !m), overnight ex-vivo 
acquisitions which can lead to datasets of >100s of megabytes per brain. Only 
relatively recently, with the development of novel registration implementations that 
utilise parallel processing (on graphics processing units and computing clusters), have 
these large datasets been able to be processed and registered in a reasonable amount 
of time (typically several hours) (Modat et al., 2010).  
 
In this study, a novel, high-resolution !MRI preparation and scanning protocol was 
used (Cleary et al., 2011) to perform an initial investigation of the Tc1 model of DS. 
Detailed visual inspection of subjects and automated computational techniques for 
analysis of the mouse brain (developed by Benjamin Sinclair, CABI/CMIC, UCL) 
were then combined. These automated approaches may be divided into: 
 
1. ‘Global phenotyping’, in which a single quantity is measured by which to compare 
mutant mice to healthy controls, in our case brain size and total intracranial volume 
(TIV). 
 
2. ‘Voxel-wise phenotyping’, in which at each region of the brain, as defined by the 
voxels of a representative atlas, a quantitative measure of the degree of anatomical 
compression and expansion during image registration (known as the Jacobian 
determinant) is calculated. Comparison (at each voxel) between groups, yields regions 
of significant differences between mutants and healthy controls localised to specific 
regions of the brain. 
 
In the mouse phenotyping field there is currently no agreed standard for the analysis 
and presentation of voxel-wise data. As a result there are several ways the data may 
be evaluated. In this study, phenotypic differences based on absolute voxel-wise 
volume difference and also after normalisation to account for global brain size 
differences are presented. This normalised analysis may be achieved: (i) numerically, 
by the omission of the global scaling factor calculated during affine registration, 
instead relying on local non-linear Jacobian determinant alone or (ii) statistically, 
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based on the use of an anatomical measure (total brain volume) as a covariate for each 
individual brain. Both these approaches are presented and compared here. 
 
7.3 Materials and Methods 
7.3.1 Animal Preparation 
All parts of this study were carried out in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. Mice were bred and provided by Elizabeth Fisher, Frances 
Wiseman and Victor Tybulewicz at the Department of Neurodegenerative Disease, 
UCL Institute of Neurology. The imaging cohort consisted of 28 male (14 Hsa21+ 
transchromosomic, 14 Hsa21- littermate controls, 129S8 x C57BL/6 background) 
aged between 18-21 weeks, were culled with an overdose of sodium pentobarbitone 
and perfusion-fixed with 4% buffered formol-saline (with 8mM Gd-DTPA). They 
were then left for 9 weeks in 4% buffered formol-saline (with 8mM Gd-DTPA). 
 
Samples were removed from fixative and excess solution carefully blotted with a 
paper towel, and were immersed in Fomblin perfluoropolyether (type PFS-1, Solvay 
Solexis S.p.A., Bollate, Italy) in 20ml plastic syringes and immobilised with surgical 
gauze. Samples were allowed to equilibrate for at least 2 hours at room temperature 
prior to imaging. Air bubbles in samples were minimised by equilibration and gentle 
agitation of the syringe. 
 
7.3.2 Imaging 
Mouse brains were imaged in a randomised order using a Varian 9.4T VNMRS 
system using a 3D spoiled-gradient echo (3D GE) sequence. Optimised 3D GE scan 
parameters: FOV=20.48x13.04x13.04mm, matrix size=512x326x326, 
TE/TR/FA/NSA=4ms/17ms/52°/6, resulting in a scan-time of 3 hours per brain. 
 
7.3.3 Image Processing and Registration 
Raw k-space data was taken from the scanner and Fourier transformed using a custom 
Matlab script at acquired resolution, giving an isotropic voxel size of 40x40x40!m, 
and saved in Analyze format. While MRI receiver gain was standardised for all 
acquisitions, to minimise variations in signal intensity, the intensity range of all 
images were normalized using the histogram equalisation function in a Matlab script. 
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As part of the creation of the average atlas for of the population, one image was 
chosen as the target and initial rigid and affine registration was performed using an 
iterative block-matching algorithm (Ourselin et al., 2001). Finally, non-linear 
registration was performed using a fast, parallel implementation (Modat et al., 2010) 
of the free-form deformation algorithm (Rueckert et al., 1999). 
   
A coarse-to-fine approach was used for the non-linear registration, where the control 
point spacing was gradually reduced to a width of 5 voxels (200µm) overlaid on the 
full resolution datasets. Constraints to the algorithm were used such that image 
folding, indicated by the presence of negative Jacobian determinant values in the 
deformation fields, was minimised. 10 iterations of the algorithm in total were used to 
warp images until adequate convergence, as assessed by the visual inspection of the 
sharpness of aligned brain anatomy in the average atlas image. 
 
The final average image was then used in combination with an expectation-
maximisation (EM) approach (Van Leemput et al., 1999) to segment the atlas into 
grey, white matter and intracranial fluid in order to enable more detailed analysis of 
total intracranial volume (TIV) and whole-brain volume. Segmentation was carried 
out using the inbuilt EM algorithm of SPM5 (Functional Imaging Laboratory, UCL) 
and the spmmouse toolkit (Sawiak, 2009), which includes prior probability maps for 
the mouse brain.  
 
7.3.4 TBM Analysis 
Tensor-based morphometry was used to identify regions of significant compression or 
expansion in images from the Jacobian determinant of the deformation field, where a 
value >1 indicates an expansion of that region was required in order to align the 
structure with the average image; <1 indicates a contraction was required. 
Deformation maps calculated after both affine and non-linear registration were used 
in subsequent analysis. 
 
Maps of the Jacobian determinant from the deformation fields in each 
transchromosomic and wild-type brain dataset were then subjected to groupwise 
comparisons using the general linear model (GLM) of SPM (Functional Imaging 
Laboratory, UCL). This resulted in statistical parametric maps of t-values for both 
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expansion and contraction after multiple two-tailed t-tests. Maps were corrected using 
the false discovery rate (FDR) method (Genovese et al., 2002) and thresholded at a p-
value of <0.05, which was taken as significant. 
 
7.3.5 Weight Measurement Study 
A separate group of 37 Tc1 animals (15 Hsa21+, 22 Hsa21-) was also monitored over 
time in order to assess the difference in body weight of these animals from 8 to 20 
weeks. This was used as an indicator of overall animal size. 
   
7.4 Results 
7.4.1 Visual Inspection 
After visual inspection of initial data it was observed that the lateral ventricles were 
enlarged in 11 Hsa21+ subjects, along with disruption of the choroid plexus. Figure 
7.1 shows examples of typical wild-type and Hsa21+ individuals. An absent corpus 
callosum was also identified in 1 individual (Figure 7.2). 
 
Figure 7.1: Visual comparison of similar coronal slices from example wild-type and 
Hsa21+ individuals from our acquired dataset. In the Hsa21+ individual, loss of the 




Figure 7.2: Representative coronal slices through one Hsa21+ individual presenting 
with an absent corpus callosum, blue arrows indicate the residual portions of white-
matter that have failed to cross the midline. 
 
 
7.4.2 Automated Analysis 
7.4.2.1 Atlas Creation 
Our datasets were found to be suitable for non-rigid registration, with the average 
image retaining small anatomical details such as tract and commissural structures and 
individual regions of the hippocampus. This successful application of the F3D 
algorithm to our datasets is clearly demonstrated in the quality of the resulting 




Figure 7.3: Coronal, axial and sagittal views from our average atlas of all 28 subjects in the study. The conspicuity of anatomical features, such 




7.4.2.2 Global Volume Differences: 
After segmentation and categorisation of brain structures using EM, global volume 
differences were examined. Hsa21+ mice were found to have larger mean brain 
volume than wild-type subjects (mean difference 14%, p<1x10-7). A larger 
corresponding total intracranial volume (TIV, the total of: grey + white matter + 
intracranial fluid) (17%, p<1x10-6) was also observed. 
 
Figure 7.4: Graphs showing (a) the EM-segmented total intracranial volume (TIV) 
and (b) segmented grey and white matter tissue volumes of both wild-type and 





7.4.3 Voxel-wise TBM Analysis: 
7.4.3.1 Analysis Based on the Total Affine and Non-linear Jacobian Determinant 
  
Figure 7.5 shows regions significantly larger and smaller in Tc1 mice based on total 
volume change over the voxels in each brain. This provides information on regions 
with an absolute volume difference between groups. As seen in the majority of 
representative slices, most mid-coronal regions of the brain were significantly larger 
in Tc1 mice (blue areas Figure 7.5). However a number of cerebellar regions, such as 
lobule 9 and parafloccular lobules, the forceps major of the corpus callosum, and a 
large portion of the olfactory bulbs did not show a significant difference between 
groups. Interestingly, some small bone regions near the inner ear and regions of the 




Figure 7.5: Montage of volume changes identified in 16 representative slices through 
the average atlas dataset. Coloured regions show areas of significant volume 
difference overlaid in our cohort of 28 Tc1 mice comparing the pixel-by-pixel, total 
volume change between groups (global affine + local registration). Blue indicates 
regions larger in Hsa21+ mice; red indicates areas smaller. Labelled structures 
indicate regions identified in the analysis, including those absent from blue areas (no 
significant difference) and small regions of global volume decrease in Tc1 mice 
(p<0.05, FDR corrected). 
 
7.4.3.2 Analysis of Normalised Data  
Given the large global change observed in section 7.4.3.1 above, it is useful to 
examine differences between the groups after correcting for this change, enabling a 
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regional or proportional volume assessment. Data is presented from two methods for 
achieving this below.  
 
7.4.3.2.1 Analysis of the Non-linear Registration Jacobian Determinant Only 
Figure 7.6 shows regions significantly larger and smaller in Tc1 mice based on 
changes in the Jacobian determinant calculated during the non-linear registration 
process only and without the affine scaling.  
 
Significant areas of reduced proportional volume were observed in the regions of the 
cingulum, hippocampal CA1 and the forceps major of the corpus callosum. Also in 
multiple cerebellar regions, including posterior lobes, ansiform lobules and 
paraflocculae. Also thalamic nuclei, olfactory bulbs and cortices of the inferior 
colliculi. Conversely, a number of regions were found to be larger in Hsa21+ mice, 
including: lateral ventricles, amygdala, hypothalamus, reticular and trigeminal nuclei, 





Figure 7.6: Representative caudal to rostral views showing regions of significant 
change after correcting for global volume changes from the affine registration. 
Regions coloured red indicates local volumes are significantly smaller in the Tc1 
mice in these regions, blue regions larger (FDR corrected, p<0.05). 
 
7.4.3.2.2 Total Brain Volume as a Covariate 
Correction of data for a large global effect by including the total brain volume (the 
sum of grey and white matter segmentation) as a covariate in the statistical analysis 
(Figure 7.7) was also attempted. 
  
By this method, a number of regions were found to be larger in the Hsa21 animals, 
including: the deep grey of the superior colliculus, and pontine tegmental and reticular 
nuclei. 
! -199- 
Conversely regions found to be smaller included: the vermis of lobule 7, small areas 
of the ansiform lobule, lobule 2, trigeminal nerves and small regions corresponding to 
bone above the inner ear. These are labelled in Figure 7.7 below. 
 
Figure 7.7: Montage of volume changes identified in 16 representative slices 
throughout the dataset. Colourmaps indicate regions of significant volumetric 
changes in the Tc1 mouse brain with correction for total brain volume by its inclusion 
as a covariate in the groupwise analysis. Blue indicates regions significantly larger in 
Tc1 mice; red smaller (FDR corrected, p<0.05). 
 
7.4.4 Weight Measurements 
In order to ascertain if overall body size correlated with brain volume, the weights of 
an additional cohort of 37 animals (15 Hsa21+, 22 controls) were measured from 8 to 
20 weeks of age, at 4 weekly intervals. While the mean weight of Tc1 mice was 
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significantly less at 12 and 16 weeks (p<0.05), by 20 weeks (similar to the age of 
mice used in the imaging study) no significant difference in weights was observed 
(Figure 7.8).   
 
 
Figure 7.8: Graph showing the weights of an additional cohort of Tc1 mice (n=37), 
followed over a 20 week period (* indicates p<0.05). 
 
7.5 Discussion 
This study has phenotyped the Tc1 model of Down syndrome using !MRI for the first 
time. Both global brain changes and more subtle phenotypic differences between 
groups have been identified through a combination of visual inspection of the data 
and tensor-based morphometry methods. 
 
From a methods point of view, it was shown that the image contrast seen in gradient-
echo !MRI images is reproducible in a large number of subjects and the anatomical 
detail visible aids in the identification of fine regions of structural difference. This 
should enable the broad applicability of the technique to mouse phenotyping studies. 
 
Our contrast-enhanced methodology, in combination with a further novel 
implementation of the well-known free-form deformation algorithm (Modat et al., 
2010), enabled the creation of a high quality average atlas. This indicates that our 
imaging and tissue preparation protocol is a good foundation for the application of 
morphometric analysis techniques.  
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The high quality of the atlas, which retains regional detail in fine brain structures, 
indicates that the contrast-enhanced !MRI methodology (Cleary et al., 2011) is 
compatible with non-linear registration. The ability of a non-linear registration 
algorithm to correctly detect and align anatomy in the underlying datasets is a 
fundamentally important to the generation of an accurate deformation. Additionally, 
the enhanced signal to noise seen after averaging of all 28 subjects, may also help 
more precisely delineate the regions of significant difference between groups, when 
significant regions are overlaid on to this image. 
 
Ventricular enlargement was seen in 11 Hsa21+ mice, which may indicate a 
neurodegenerative process in the brain. Recent work in Ts1Cje and Ts2Cje models of 
DS (models with partial trisomy of mouse chromosome 16) has also shown 
ventricular enlargement (Ishihara et al., 2010). The individual identified with a corpus 
callosum deficiency was probably due to mouse background, as absent corpus 
callosum is often seen in 129 mice (Hof et al., 2000). In the subsequent TBM 
analysis, blue regions of significant expansion appeared to overlap the lateral ventricle 
regions in our analysis based on the non-linear Jacobian determinant only.  
 
A continual issue in the presentation of phenotyping studies as discussed in the 
preceding chapter is the use of normalised data. Given widespread volume increases 
observed in the Hsa21+, more subtle effects of, for example, the relative distribution 
of structure volumes may be being masked.  
 
The results show that brains of Hsa21+ mice were significantly larger than those of the 
wild-type. The assessment of body weight measurements suggests that the brain 
volume increase observed is not explained by a generally large overall size difference 
in the Hsa21+ mice. This appears to be due to an underlying genetic mechanism 
causing brain hypertrophy. A reduced brain volume would be the expected feature, as 
seen in clinical studies (Pinter et al., 2001). However, brain enlargement has 
previously been shown in an MRI investigation of a YAC transgenic model of DS 
(YAC152f7) (Sebrié et al., 2008) which has small gene complement (PIGP, TTC3, 
DSCR9, DSCR3, DYRK1A) compared to those in the Tc1 model. In that study, the 
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authors suggest that the increased DYRK1A copy-number was probably responsible 
for the observed increase in brain volume. 
 
In the analysis, the data was corrected by either removing the contribution of the 
affine registration scale factor (which in effect normalises the data by average skull 
volume) or through statistical methods by covariating with measured total brain 
volume. While both approaches produced somewhat similar regions of significance, 
the maps derived from covariated brain volumes showed greatly reduced regions of 
significance compared to affine normalised data. This could be due to the fact that the 
affine registration is aligning all skull structures, including extracranial structures, 
bone and brain structures. Whereas the covariate analysis is correcting for brain 
volume only. Therefore both sets of data are presented in this chapter. 
 
The non-linear, non-affine TBM maps, with larger regions of significance, appear to 
more strongly reflect previous findings in the Tc1 model. Previous histology 
(O'Doherty et al., 2005) found significant reduction in the granular neuron density in 
4 regions of the cerebellum, (16% mean reduction in density, p<0.003), including 
specific samples from lobule 8 in each subject (also 16% mean reduction, p<0.03) In 
TBM maps based on local non-linear volume changes, it was observed that a 
proportional reduction in volume in a number of cerebellar regions, including lobule 
8. 
 
Facial dysmorphia is a common finding in clinical cases of DS and indeed 
craniofacial changes have been observed previously in the Tc1 mouse through skull 
measurements using micro-computed tomography (O'Doherty et al., 2005). A 
significant region of volume reduction was observed in the trigeminal nerve. 
Differences in facial anatomy may be a cause of this, given its function in providing 
sensory innervation to the face and whiskers. A change in facial morphology may 
have a corresponding effect on the degree and development of this innervation. 
Similarly, regions of significant volume change were noted near the inner ear and in 
the inferior colliculus, indicating possible effects on the auditory system.  
 
A reduced proportional volume was also seen in the CA1 region of the hippocampus 
as well as a number of thalamic nuclei.  
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Previous behavioural studies have demonstrated both motor (Galante et al., 2009) and 
memory deficits (Morice et al., 2008) in Tc1 mice, supportive of our regional 
findings. However, further work may be needed to directly confirm the precise 
sensory, motor and memory changes in these animals suggested by our imaging 
findings. 
 
Due to time limitations in this study additional histology was unable to be performed 
to confirm the TBM analysis. In particular, it may have determined the precise nature 
of the increased brain volume, particularly if this is an increase in neuronal density 
and if so, whether this represents an increase in all or only specific cell types.  
 
Additionally, the regions identified significant on the basis of the non-linear Jacobian 
determinants would warrant further investigation to confirm a histological change in 
that region. However a possible confounding factor in this instance is the global size 
increase observed in the mouse brains, which may make visualisation of histological 
changes specifically seen in the normalised regions difficult.  
 
While this may be an issue, a recent study successfully identified subtle cerebellar 
changes in a mouse model of fragile X syndrome through TBM-guided histology 
(Ellegood et al., 2010b). The affine-normalised regions identified in that study were 
smaller than those presented here and differences in cell populations were still 
identified by subsequent GFAP, NeuN, VGAT, and VGLUT1 immunohistochemistry. 
 
However there may be some drawbacks to the technique. One disadvantage is the 
application of groupwise statistics to a mosaic model of a condition, where a variable 
number of constituent cells in the mouse will contain an Hsa21 chromosome.  In 
simple terms, this has the potential effect of giving a broad range of phenotype and it 
remains to be seen if atlas based analysis will be superior to individual assessment in 
this scenario. In this model, previous fluorescent in-situ hybridisation studies, 
demonstrated that ~60-70% of brain nuclei appear to be Hsa21+ (O'Doherty et al., 
2005). However this number may vary between animals and could potentially vary 
between cell populations.  
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Similarly, a situation where a gene is incompletely penetrant may result in a small 
number of individuals demonstrating a phenotype. These individuals will then be 
averaged into their category and the effect masked by the groupwise analysis. This 
may indicate that manual methods such as visual inspection and the analysis of 
outliers still have a role to play in the phenotyping of certain mouse models. 
 
As seen previously, despite the size of brain datasets (~400MB per individual), and 
sheer quantity of data (512 axial slices), our findings demonstrate that tensor-based 
morphometry is a powerful method to automatically assess the differences in local 
brain anatomy across two populations. 
 
7.6 Conclusion 
In this study, the Tc1 model has been phenotyped for the first time using contrast-
enhanced gradient echo !MRI and tensor-based morphometry. The image contrast 
seen in the !MRI images is reproducible in a large number of subjects, producing a 
high-quality average atlas after non-linear registration, suggesting the broad 
applicability of the technique to general brain phenotyping studies. Visual inspection 
identified lateral ventricle enlargement in a number of the transchromosomic animals. 
Global segmentation showed that Hsa21+ mice had a significantly larger mean total 
brain volumes (17%), with subsequent voxel-wise analysis on the total Jacobian 
determinant showing this increase is localised across the majority of brain structures. 
After normalisation of the data, voxel-wise analysis showed significant proportional 
volume reductions in the cerebellum, trigeminal nerves, inner ear regions, 
hippocampal CA1 and a number of trigeminal nuclei. Our findings demonstrate that 
tensor-based morphometry is a powerful method to automatically assess the 




Chapter 8:  
General Discussion 
The challenge of phenotyping future numbers of modified mouse lines will require 
robust, large-scale methods for morphological assessments. This thesis demonstrates 
the utility of an imaging-based approach, integrating both high-throughput imaging 
and analysis. The use of contrast-enhanced high-resolution !MRI for the investigation 
of mutant mice in both the embryo and adult mouse brain was explored, which 
resulted in improved image quality, enabling the delineation of subtle structural 
features. Additionally, these imaging correlates were compared to histology. This 
work was extended through the application of automated analysis to this imaging, 
employing registration techniques such as segmentation-propagation and tensor-based 
morphometry to successfully identify novel phenotypes. 
 
In chapter 4, the use of an MRI contrast agent (Gd-DTPA) as a tissue active stain for 
imaging the embryo heart and cardiovascular system was investigated. Optimising 
preparation and scan parameters for heart imaging in 15.5dpc mouse embryos. It was 
found that fixation for 2-weeks provided a gain in SNR due to T1 reduction, as does 
increasing Gd-DPTA contrast agent concentration. Additionally, it was found that the 
best balance of heart CNR and muscle SNR was achieved at 8mM. Using gradient-
echo simulations with measured T1 and T2* values, the optimum scanning parameters 
were determined and verified. This combination produced a heart-chamber CNR of 
approximately five times that of previous literature parameters, highlighting the need 
for preparation and pulse sequence optimisation. These parameters were then used to 
identify a heart defect in Chd7+/- mice. This optimisation should allow better 
determination of heart and vascular anatomy in a variety of transgenic embryos, 
enabling greater sensitivity in detection of defects.  
 
Chapter 5 addressed the need for automated image analysis for high-throughput 
phenotyping of the embryo CNS. The use of individual 3D embryo MRI histology, 
identified new pituitary phenotypes in Hesx1 mutant mice, previously difficult to 
confirm due to the minute size of the gland, which is often destroyed during 
histological sectioning. Use of embryo atlasing techniques for anatomical studies as 
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the resulting average image is a representation of the true population with high SNR. 
Subsequently, registration techniques were used to produce a whole-body embryo 
atlas from 6 CD-1 embryos, creating an average image with greatly enhanced 
anatomical detail, particularly in CNS structures. This methodology enabled 
unsupervised assessment of morphological differences between CD-1 embryos and 
Chd7 knockout mice, and using a new atlas generated from these three groups, 
quantitative organ volumes were automatically measured. A difference in mean brain 
volumes between Chd7+/+ and Chd7+/- mice and differences in whole-body, olfactory 
and normalised pituitary gland volumes between CD-1 and Chd7+/+ mice (C57BL/6 
background) were demonstrated. This work demonstrates the feasibility of combining 
high-throughput embryo MRI with automated analysis techniques to distinguish novel 
mouse phenotypes. As there is no limit to the number of embryos that may be 
registered, the technique opens the possibility for quantitative analyses of very large 
numbers (100s) of embryos with increased statistical power.  
 
Chapter 6 investigated the structural correlates of the MRI agent Gd-DTPA, together 
with the optimal preparation and scan parameters for contrast-enhanced gradient-echo 
imaging of the adult mouse brain. It was observed that perfuse-fixation of the brain 
offered no advantage over the simpler preparation of immersion fixation. However, 
given that damage was observed in all ex-situ brains, further work focussed on in-situ 
brain imaging. Optimal fixation time for in-situ brains was much longer than in ex-situ 
studies, requiring approximately 9 weeks fixation before reaching similar T1 values 
across the brain. From these data, estimates of MR parameters for the optimal cortex-
corpus callosum contrast were determined. In-situ brains, fixed for 9 weeks with 8mM 
Gd-DTPA and scanned with calculated parameters 
(TE/TR/FA/Averages=4ms/17ms/52°/6 averages), produced images with high SNR 
(~30) and detailed anatomical differentiation. Correlating brain structures directly to 
histology, our MR images delineated detailed cytoarchitecture in the cortex, 
cerebellum, olfactory bulb and hippocampus. Neurofilament staining demonstrated 
that regions of negative MR contrast strongly correlated to myelinated white-matter 
structures. Many sub-regions were able to be identified, particularly within the 
hippocampus, such as the unmyelinated mossy fibres (stratum lucidum) and their 
region of synapse in the stratum pyramidale, together with the granular layer of the 
! -207- 
dentate gyrus, an area of densely packed cell bodies, which was clearly visible as a 
region of hyperintensity.  This suggests that cellular structure influences the site-
specific distribution of the MR contrast agent, resulting in local variations in T2*, 
which leads to enhance tissue discrimination. Our results show that !MRI with a 
relatively high contrast agent concentration (8mM Gd-DTPA) is able to produce high-
quality images that delineate a large number of anatomical features as confirmed by 
histology. Our findings provide insights into the cellular distribution and mechanism 
of MR active-staining, which enable interpretation of magnetic resonance microscopy 
brain data and highlight cellular structure for investigation of disease processes. 
 
These results show that active-stained !MRI can provide detailed anatomical images 
of the in-situ mouse brain with high resolution and signal-to-noise. Additionally, a 
variety of stains were used to identify and compare the MRI appearance of brain 
structures to those defined by histology. Combining this data highlighted possible 
mechanisms for the enhanced contrast in these regions, surmising that contrast 
depends on both preserved, intrinsic T2* differences as well as regions delineated by 
distribution of active-stain due to tissue microstructure. This methodology could 
enable greater sensitivity for the phenotypic characterisation in mutant mouse models 
and enhance regions of the mouse brain that may be targeted in future transgenic 
studies. 
 
Chapter 7 presented a study to phenotype the Tc1 model for the first time using 
contrast-enhanced gradient echo !MRI and tensor-based morphometry. It was shown 
through this study, that the image contrast seen in our !MRI images is reproducible in 
a large number of subjects. Similar to the work in the embryo (chapter 6), it was found 
that applying registration methods to the data resulted in a high-quality average atlas 
of the subjects in our study population, indicating our datasets were amenable to non-
linear registration. This suggests the broad applicability of the technique to general 
brain phenotyping studies. Visual inspection identified lateral ventricle enlargement in 
a number of transchromosomic animals. Global segmentation showed that Hsa21+ 
mice had a significantly larger mean total brain volumes (17%), with subsequent 
voxel-wise analysis on the total Jacobian determinant showing this increase is 
localised across the majority of brain structures. After normalisation of the data, 
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voxel-wise analysis showed significant proportional volume reductions in the 
cerebellum, trigeminal nerves, inner ear regions, hippocampal CA1 and a number of 
trigeminal nuclei. This study demonstrates that tensor-based morphometry is a 
powerful method to automatically assess the differences in local brain anatomy 
between two populations and has identified phenotypic features not easily assessed by 
visual inspection. 
  
Although this investigation successfully identified group differences, the Tc1 model 
challenges our current analysis, where there variability in the number of constituent 
cells containing Hsa21. Further work would seek to refine these methods such as 
through an integrated approach to the analysis of outliers, which may indicate more 
extreme phenotypes.  
 
Future directions in the field would aim to develop both MR imaging and analysis. In 
terms of imaging, as we have seen in our work, the use of paramagnetic contrast 
agents in conjunction with gradient-echo imaging has produced images with excellent 
contrast and high resolution. However the precise mechanism and distribution of these 
agents have yet to be explored. As an adjunct to conventional MR image weightings, a 
technique such as a susceptibility imaging (Shmueli et al., 2009) may demonstrate a 
further !MRI contrast mechanism and give clues as to the nature of a contrast agent’s 
distribution. Also an investigation of novel contrast agents, based on other 
paramagnetic ions and/or chelates may be able to produce alternative contrast in a 
similar manner to histological stains. 
  
In terms of analysis, as we have discussed previously, standardisation of atlas space in 
a manner similar to Talairach coordinates (such as in Johnson et al., 2010) is 
extremely desirable given the international nature of current phenotyping efforts. 
While we have used the GLM to perform a group analysis, its role in the investigation 
of outliers should be examined further. Additionally, hypothesis-generation 
techniques, such as independent component analysis, may have a role, most likely in 
initial screening. The TBM methodology used in this work could also be expanded to 
include analysis of the underlying directional vector data that gives rise to the Jacobian 
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determinants. This may allow further insight into the spatial origin of regions of 
deformational change and enable more intricate studies of brain shape. 
 
8.1 Final Conclusion 
The burgeoning use of genetically modified mouse models in both the laboratory and 
large-scale mutagenesis programmes will require novel rapid methodologies for the 
morphological phenotyping of new mouse lines. This thesis has demonstrated the 
development of both imaging and analysis techniques, applicable to both embryo and 
adult mouse data. It is hoped that !MRI in combination with computational analysis 
will have an increasing role in easing the burden of the identification and 
characterisation of novel mouse phenotypes in the future. 
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Appendices 
The following appendices introduce two preliminary mouse embryo studies 
supplementary to the main body of this thesis.  
 
Appendix 1: Overview 
In this appendix, a further application of the contrast enhanced embryo imaging 
protocol is presented, characterising the cardiovascular phenotype of a novel double 
knockout model of congenital heart disease – Chd7+/-Tbx1+/- mice. Tbx1 is a gene 
implicated in the condition DiGeorge syndrome – a condition characterised by aortic 
arch defects. The possible effect on the gross anatomy of the heart due to interactions 
between these genes is unclear. This was a preliminary study to examine the 
phenotype of mice heterozygous for the genes Chd7 and Tbx1, for the first time with 
!MRI. 
 
Appendix 2: Overview 
The introduction to this thesis mentions the use of diffusion tensor imaging (DTI) in 
providing a non-invasive characterisation of tissue microstructure, particularly in the 
brain. While there have been some previous studies utilising DTI in the 
characterisation of the mouse embryo, these have been restricted to studies of the 
embryo head only, with a low number of diffusion directions. In Appendix 2, a novel, 
contrast enhanced method is described that enables the whole-body phenotyping of 




Phenotyping a Novel Double-heterozygous Model 
of Congenital Heart Disease Using micro-MRI 
 
This work was presented at the meeting of the Society for Cardiovascular Magnetic 
Resonance, Phoenix AZ 2010. 
 
A.1 Introduction 
CHARGE and DiGeorge syndromes are conditions with incidences of 1 in 10,000 and 
1in 4000 and are strongly associated with haploinsufficiency of specific genes (CHD7 
and TBX1). Both conditions are characterised by cardiovascular defects. Knockout 
mouse models are an important tool for the identification and characterisation of 
genes implicated in congenital heart conditions. Micro-MRI is an emerging technique 
for high resolution cardiac phenotyping in a reduced time compared to conventional 
histology, enabling the acquisition of 3D images of multiple embryos in a single scan 
(Cleary et al., 2009). 
 
A.2 Purpose 
Given the phenotypic overlap of these conditions this investigation sought to examine 
the effect on cardiac morphology in double-heterozygous mouse embryos (Chd7+/-




Study Design: 18 embryos (1 wild-type, 7 Chd7+/-, 2 Tbx1+/- and 8 Chd7+/-Tbx1+/-) 
were imaged and examined for cardiac abnormalities. Embryo Preparation: 16.5dpc 
embryos were fixed for at least 2 weeks in a solution of 4% formaldehyde-PBS with 
8mM Gd-DTPA (Bayer-Schering AG) and then embedded in 1% agarose gel (doped 
with 8mM Gd-DTPA) in 50ml centrifuge tubes.  
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Imaging: Performed on a Varian 9.4T VNMRS system with 33mm quadrature 
birdcage coil (RAPID Biomedical GmbH), using a 3D gradient echo sequence 
(TE/TR/FA/NSA=9/20/60/7, FOV=27x27x27mm3, voxel size=52x52x52!m3). 
  
Image analysis: Datasets were zero-filled to 26x26x26!m3 and reviewed in Amira 
(v5.2, Visage Imaging Inc.). 
 
Histology: Embryos identified with abnormal hearts by MRI, were then histologically 
examined by H&E staining. 
 
A.4 Results 
Of the 18 embryos scanned for MR analysis, abnormal (thin or patent) ventricular 
septa (VSDs) were identified in 6 embryos. Of these, 1 was a Chd7+/- heterozygote (an 
incidence of 1/7 in this study, see Figure A.1).  
 
 
Figure A.1 Axial sections through example embryo datasets showing the presence of 
ventricular septal defects (indicated by red triangles) in both Chd7+/- embryos and 
double Chd7+/-Tbx1+/- heterozygotes. 
 
VSDs were seen in 5/8 Chd7+/-Tbx1+/- embryos (Figure A.2a). In one double 
heterozygote an interrupted aortic arch was also observed, in addition to a VSD, 
which was readily seen by MRI (Figure A.2b). 
! -213- 
 
Figure A.2 (a) Volume rendering of a heart of a Chd7+/-Tbx1+/- double heterozygous 
embryo. (RA: right atrium, RV: right ventricle, LA: left atrium, LV: left ventricle) A 
clear ventricular septal defect can be seen between left and right ventricles. (b) 
Volume rendering of the same embryo showing great vessel structures only. An 
interrupted aortic arch was identified in this embryo (arrow). 
 
A.5 Conclusion 
Using micro-MRI, cardiac abnormalities were successfully identified in genetically-
modified embryos. A single Chd7+/- embryo was found to have an abnormal 
ventricular septum. A relatively high incidence of VSDs was observed in Chd7+/-
Tbx1+/- compared to Chd7+/- mice, indicating possible interaction of these two genes. 
An interrupted aortic arch was identified in one Chd7+/-Tbx1+/- embryo. All abnormal 
findings were later confirmed by histology, which indicates that micro-MRI is an 




Contrast-enhanced Micro-diffusion Tensor 
Imaging for Mouse Embryo Phenotyping 
 
This work was presented at the meeting of the British Chapter of the International 
Society for Magnetic Resonance in Medicine, Nottingham 2010, and was a joint 
project between myself and Bernard Siow (CABI/CMIC, UCL). Mouse embryos were 
provided by Nicholas Greene (UCL Institute of Child Health). 
 
B.1 Introduction  
Mouse embryos are widely used as models for the study of human congenital 
abnormalities such as spina bifida, which is one of the most common birth defects. 
Morphological phenotyping of these embryos is still heavily reliant on histological 
sectioning: a destructive process that is time-consuming and operator dependent. 
Diffusion-tensor imaging (DTI) is a powerful technique that can explore tissue 
structure non-invasively, providing microstructural information such as the direction 
of tissue fibres. DTI techniques are particularly useful where traditional anatomical 
MR contrast is limited, such as in the developing foetal brain (Mori et al., 2001). In 
the mouse embryo, DTI can characterise brain development (Mori et al., 2001) as well 
as examine phenotype in mutant animals (Zhang et al., 2003). However, these studies 
have imaged only the brain in mid-gestation embryos, with a modest number of 
diffusion directions (typically 6) and long acquisition times (~10 hours). Gadolinium 
chelates, such as Gd-DTPA, are commonly used in the fixation of embryos for MR 
microscopy, to reduce T1 and boost SNR (Cleary et al., 2009). While the use of Gd-
DTPA is common in anatomical embryo imaging, its use has been limited in embryo 
DTI studies (Aggarwal et al., 2010). This study describes the development of a 
contrast-enhanced technique for whole-body DTI of mid-gestation embryos, 
comparing embryo preparation, pulse sequences and resolution. Subsequently, this 
methodology was applied to investigate the phenotype of the splotch mouse model of 
spina bifida, which carries a mutation in the gene Pax3 (Greene et al., 2009) a 
transcription factor implicated in the condition. 
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B.2 Methods  
15.5dpc embryos (C57BL/6 background), were dissected from the mother and fixed 
for 2 weeks in a solution of 4% formal-PBS doped with 2mM Gd-DTPA. Later they 
were moved to a solution of PBS+2mM Gd-DTPA for at least 2 weeks. Imaging was 
performed on a Varian VNMRS system using a 26mm volume coil (RAPID 
Biomedical GmbH) and 3D spin-echo (3D-SE) and fast-spin-echo (3D-FSE) diffusion 
sequences (diffusion parameters: G=50G/cm, "=3.5ms, #=8ms, 42 directions+6 b0 
images), with parameters chosen to maintain sample temperature during the 
acquisition: SE: TR=500ms, TE=15.3ms, b$1550s/mm2; FSE: TR=500ms, 
TE1=14.75ms, ESP=5.75ms, ETL=4, b$1660s/mm2. Voxel size: 100x100x100!m3 
and 75x75x75!m3 isotropic. 3D-SE T1 and T2 map data were also acquired. Sample 
temperature was 19±1°C. Images were corrected for movement by global registration 
(Ourselin et al., 2001). Direction encoded colour (DEC) maps were visualised in 
MedINRIA (Asclepios Project); FA value calculation and tractography was 
performed in MRtrix (Tournier et al., 2007).  
 
B.3 Results  
After rehydration in PBS+Gd-DTPA, mean whole-body T2 increased from 14 to 
25ms, giving improved SNR in the subsequent diffusion images (typically 39 vs. 22, 
100!m SE data). DEC maps and values were similar between 3D-SE and FSE 
datasets (resulting 75!m DEC maps from FSE data are shown in Figure B.1). 
Subsequently, wild-type and splotch mutant mice were imaged, identifying 




Figure B.1 Axial and coronal DEC maps of a C57BL/6 wild-type embryo, imaged 
using the 75!m-FSE protocol, showing well-defined CNS anatomy and corresponding 
tissue directionality. (Arrows indicate principal eigenvector direction) 
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Figure B.2 Similar mid-sagittal DEC maps through wild-type and splotch 
homozygous embryos. Although the primary defect is the spina bifida indicated, clear 
differences may also be seen in overall brain size and regions demarcated by 
principal eigenvector, such as in the pons and midbrain. (Arrows indicate direction of 
principal eigenvector) 
 
B.4 Conclusion  
This study has shown that whole-body !DTI is able to delineate a number of 
anatomical brain regions according to diffusion directionality. 42 directions were used 
in this embryo study, achieving high-resolution (75!m) and a moderately high b-
value (1660s/mm2) in a 19h scan. Although this study concentrated on achieving high 
quality diffusion data for tractography through the acquisition of 48 images per scan, 
resorting to the minimum of 7 would give a total scan time of ~2.75 hours per 
embryo, improving throughput. As the final part of this study, the phenotype of the 
splotch model of spina bifida has been described for the first time with MR, 
characterising changes in brain structure and their relation to spinal cord phenotype. It 
is hoped that this methodology may enable wider adoption of DTI to embryo studies, 
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